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Abstract 
 
The Gram negative bacterium Pseudomonas aeruginosa is ubiquitous in the natural 
environment and responsible for various human infections. Successful P. aeruginosa 
infections require many virulence factors such as flagella, type IV pilus and alginate, whose 
expression is under tight control by transcription factors such as AmrZ. AmrZ activates 
type IV pilus-mediated twitching motility and alginate production while repressing the 
flagella machinery. However, molecular mechanisms of AmrZ-mediated activation of 
twitching motility and the alginate biosynthesis operon promoter (algD promoter) remain 
elusive and are the emphases of this study.  
Specifically, DNA microarray analyses were performed in order to identify AmrZ-
dependent gene(s) that is required for twitching motility. The AmrZ regulon contains 112 
genes, many of which are involved in virulence. However, this regulon does not contain a 
gene that is known to be necessary for twitching motility. In addition, we used multiple 
biochemical methods to show that AmrZ tetramerizes via its C-terminal domain, the loss 
of which results in diminished DNA binding and reduced efficiency during AmrZ-
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mediated activation and repression. Demonstration of AmrZ tetramerization also assists in 
understanding the activation mechanism of the algD promoter. This complex promoter 
contains a number of transcription factor binding sites with many in the far upstream 
region. It is unclear how those transcription factors from far upstream contribute to 
transcription activation. This study identified four AmrZ binding sites within this promoter 
and showed that each is required for algD transcription activation. We also illustrated 
phase-dependent activation of this promoter, suggesting interactions between upstream and 
downstream factors. Furthermore, in vitro fluorescence resonance energy transfer 
experiments indicate the formation of trans DNA-AmrZ complexes, suggesting that two 
DNA molecules are held together by AmrZ, likely via AmrZ oligomerization. These results 
thus provide new support for the DNA looping model of the algD promoter. 
Taken together, the work described in this document has significantly enhanced our 
knowledge of AmrZ-mediated regulation, full understanding of which may provide 
insights into discovering new means of interfering this regulation and successful control of 
P. aeruginosa infections. 
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Chapter 1  
 
  
Chapter 1. Introduction 
 
Pseudomonads and Pseudomonas 
Pseudomonads are amongst the earliest groups of bacteria discovered due to their 
versatile lifestyles and diverse niches. In 1894, the genus Pseudomonas was first defined 
by Walter Migula with the broad definition: “Cells with polar organs of motility. Formation 
of spores occurs in some species, but it is rare” (Migula, 1894; Sokatch, Gunsalus, & 
Ornston, 1986). Thereafter, significantly more bacterial species were discovered and 
classified as pseudomonads. In 1966, Stanier et al. (1966) conducted a comprehensive 
study characterizing phenotypic traits of pseudomonads, which by this point were defined 
as “unicellular rods, with the long axis straight or curved, but not helical. Motile by means 
of one or more polar flagella. Gram-negative. Do not form spores, stalks, or sheaths. The 
energy-yielding metabolism is respiratory, never fermentative or photosynthetic. All use 
molecular oxygen as a terminal oxidant; and some can use denitrification as an alternative, 
anaerobic respiratory mechanism. All are chemo-organotrophs; some are facultative 
chemo-lithotrophs that use H, as an energy source.” (Stanier et al., 1966). This more 
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detailed definition excluded many species from the pseudomonad group. Later more 
bacterial species were removed from this genus due to the advancement of molecular 
phylogenetics. For example, the pseudomonad Burkholderia cepacia (formerly known as 
Pseudomonas cepacia) was transferred into the new genus Burkholderia in 1992 
(Yabuuchi et al., 1992). Currently Pseudomonas is the largest Gram-negative genus with 
144 species (Gomila, Peña, Mulet, Lalucat, & García-Valdés, 2015). 
Pseudomonas species and many other pseudomonads are prevalent in natural 
environments such as soil and water as well as in/on animal and plant hosts. Strikingly, 
pseudomonads are capable of growing with very limited or unconventional nutrients, 
including hydrocarbons (such as n-dodecane and n-hexadecane) rarely utilized by other 
bacteria (Stanier et al., 1966). As a result, they have been widely used in bioremediation 
applications. 
Amongst all pseudomonads, the most studied species are P. aeruginosa, P. 
fluorescens and P. putida. All three species belong to the fluorescent pseudomonad 
subgroup that produces water-soluble, yellow-green fluorescent pigments. There are 
multiple shared traits between P. fluorescens and P. putida. Both are easily found in soil, 
water and plants. Their colonization on plants promotes plant growth and suppresses 
infections by fungal pathogens (O’Sullivan & O’Gara, 1992). They both harbor 
multitrichous polar flagella and grow optimally at 25-30 °C. These two species can be 
distinguished by the ability to liquefy gelatin, with only P. fluorescens able to do so  
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(Stanier et al., 1966). It is noteworthy that many P. putida sub-species have wide industrial 
applications such as bioremediation. 
 
Pseudomonas aeruginosa and its clinical significance 
P. aeruginosa is the type species of the genus Pseudomonas, but also is distinct 
from all other Pseudomonas species. Exclusively, P. aeruginosa has one polar flagellum 
and produces the blue-green pigment named pyocyanin. In addition, it can grow at higher 
temperatures such as 41°C and is the only Pseudomonas species that poses a significant 
threat to mammals (Stanier et al., 1966).  
P. aeruginosa is an opportunistic pathogen that rarely causes disease in healthy 
human beings. This bacterium is occasionally implicated in outbreaks associated with hot 
tubs, whirlpools and swimming pools. In one clinical case, a previously healthy woman 
died of acute pneumonia caused by P. aeruginosa, with the hot tub being the most likely 
source of infection (Huhulescu et al., 2011). Colonization by this bacterium in 
compromised patients however, can result in a variety of severe acute and chronic 
infections. P. aeruginosa is a significant pathogen that causes community-acquired 
pneumonia, and can infect virtually any traumatic wound (Hauser & Rello, 2003). It also 
poses a significant threat to individuals with indwelling medical devices, transplants, 
diabetes, and patients in intensive care units (Hauser & Rello, 2003). This pathogen is able 
to cause infection in multiple tissue environments including but not limited to the 
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respiratory tract (especially lower respiratory tract), heart, eye, ear, urinary tract and skin 
(Gellatly & Hancock, 2013; Hauser & Rello, 2003). In addition, in the lungs of cystic 
fibrosis (CF) patients, P. aeruginosa is a primary pathogen associated with pulmonary 
exacerbations and high mortality rates (Ahlgren et al., 2015; Folkesson et al., 2012).  
Two major contributing factors to the clinical significance of this bacterium are its 
prevalence and high antimicrobial resistance. P. aeruginosa is a common resident in all 
types of non-desiccated niches. This bacterium can be found in feces of 1.2-2.3% of healthy 
individuals and oral antibiotic intake often results in increased incidence of P. aeruginosa-
positive stools (Noble and White, 1969; Campa et al., 1993). More importantly, P. 
aeruginosa is easily detectable in various locations inside and outside hospitals. Outside 
hospitals, the most common source of P. aeruginosa is water reservoirs polluted by human 
or animal sources. P. aeruginosa isolates are frequently found in swimming pools and 
whirlpools. In private homes, this bacterium is present in places such as sink drains, toilets, 
showers, air humidifiers and many other devices requiring water to function. Inside 
hospitals, medical devices that work with water are frequently contaminated with P. 
aeruginosa (Campa et al., 1993). These can render immunocompromised patients highly 
susceptible to P. aeruginosa infections. Another trait that contributes to P. aeruginosa 
pathogenesis is its high resistance and recalcitrance to antimicrobial reagents. Disinfectants 
such as Cetrimide as well as numerous antibiotics have little effect on P. aeruginosa growth 
(Noble & White, 1969). During the last decade P. aeruginosa clinical isolates displayed 
increased resistance to antibiotics such as β-lactams, fluoroquinolones and 
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aminoglycosides (Table 1.1), making P. aeruginosa infections difficult to treat. It should 
be noted that although certain antibiotics remain active against free-living (planktonic) P. 
aeruginosa, this bacterium usually displays significantly higher recalcitrance to these 
agents when encased within biofilms (see details in the biofilm sub-section in Chapter 1).  
 
Pseudomonas aeruginosa pathogenesis in acute and chronic infections 
P. aeruginosa causes many infections with varying clinical manifestations and 
outcomes. Examples of acute infections include acute pneumonia, urinary tract infections, 
bacteremia and keratitis, while chronic diseases include wound infections, lung infections 
of CF patients, and infections on/in indwelling medical devices, etc. This section discusses 
how numerous P. aeruginosa virulence factors contribute to different forms of infections. 
During acute infections, P. aeruginosa expresses various virulence factors that 
combat against the host immune defenses and aid in survival within the host. These factors 
include but are not limited to alginate, flagella, type IV pili, quorum sensing, phenazines, 
the type III secretion system (T3SS), siderophores, proteases and exotoxins. Since there 
are detailed descriptions in the next section, alginate, flagella and type IV pili will be not 
discussed here.  
The quorum sensing (QS) signaling cascade is activated when concentrations of QS 
signaling molecules (homoserine lactones and quinolones in Gram-negatives; small 
  
6 
 
peptides in Gram-positives) reach the quorum. QS regulates a number of targets in P. 
aeruginosa and has significant impacts on its virulence (Bjarnsholt et al., 2005; Rutherford 
& Bassler, 2012). P. aeruginosa possesses three QS systems: LasR/I, RhlR/I and PQS 
(Pseudomonas quinolone signal). Examples of QS targets include proteases, pyocyanin and 
toxins (Rutherford & Bassler, 2012), and QS signaling also controls biofilm formation and 
antibiotic sensitivity (Bjarnsholt et al., 2005; Shrout et al., 2006; Singh et al., 2000). 
Phenazines such as pyocyanin are another class of virulence factors with broad 
antimicrobial activities and cytotoxicity to host cells including neutrophils and 
lymphocytes (Lau, Hassett, Ran, & Kong, 2004; Sorensen & Klinger, 1987). T3SS punches 
through the host cell membrane via a needle-like machinery and delivers cytotoxic 
effectors (Hauser, 2009a). Two types of siderophores (pyoverdine and pyochelin) are 
required for scavenging iron from host sequestration (Cornelis & Dingemans, 2013). A 
fine control of these virulence factors is critical for successful infections in the host. For 
instance, P. aeruginosa is able to switch between different iron uptake systems depending 
on the type of infections (Cornelis & Dingemans, 2013; Marvig et al., 2014). Similarly, an 
increase in temperature from 28°C to 37°C leads to elevated expression of genes involved 
in T3SS and phenazines (Wurtzel et al., 2012). Distinct sets of virulence factors play 
important roles during acute and chronic infections (Figure 1.1). For example, T3SS and 
exotoxins are important for host cell invasion and toxicity (Hauser, 2009b), while 
exopolysaccharide production results in enhanced immune evasion (Leid et al., 2005). 
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During chronic pulmonary infections in CF patients, P. aeruginosa is the dominant 
pathogen, colonizing 60-80% of CF patients (Cystic Fibrosis Foundation, 2013). CF is the 
most common lethal genetic disorder in Caucasians. About 1 in 25 Caucasians are 
heterozygous carriers, and 1 in 2,500 newborns carry this disease (Döring et al., 2000). CF 
patients have defects in the chloride ion channel named CFTR (CF transmembrane 
conductance regulator) and diseases manifest in multiple organs including skin, pancreas 
and lungs. CFTR mutations result in defects of ions and water transport across cell 
membranes in multiple locations. Specifically in the lung, mucus accumulation and 
impaired mucociliary clearance render CF airways highly susceptible to recurrent and 
chronic microbial infections, which are de facto the most significant cause of mortality in 
CF patients (Hoiby, 1982). CF lungs are infected by multiple bacterial species with the 
most common ones being P. aeruginosa, Staphylococcus aureus and Haemophilus 
influenzae (Coburn et al., 2015; Govan & Deretic, 1996). Identification of P. aeruginosa 
in CF patients is often a poor prognostic indicator (Govan & Deretic, 1996).  
Since initial colonization, P. aeruginosa in CF patients suffers hostile attacks 
throughout infections including immune responses, oxidative stress, and antibiotic 
treatment (Snitkin & Segre, 2014). Long-term adaptation leads to distinct traits in 
descendants compared to initial colonizers, including hyper-mutability, mucoid 
conversion, emergence of small colony variants, loss of motility and alteration of quorum 
sensing (Singh et al., 2000; Cullen and McClean, 2015). Although initial infections in CF 
patients can be attributed to a single P. aeruginosa lineage, there is significant 
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heterogeneity and diversification within one patient at later stages of infection (Markussen 
et al., 2014). Higher mutation rates enable bacteria to diversify and be prepared, as a 
community, against selective pressures from the host immunity and antimicrobial 
treatments. Typically, P. aeruginosa isolates found in chronic infections are less invasive 
but are significantly more immune evasive and persistent compared to those isolated from 
acute infections (Byrd et al., 2011; Wagner & Iglewski, 2008).  
The transition between acute and chronic infections is a multi-factorial practice. P. 
aeruginosa isolates from acute infections are considered similar to environmental isolates 
and exhibit a more invasive and motile lifestyle, while those involved in chronic infections 
resemble bacteria in biofilms (Singh et al., 2000; Coggan and Wolfgang, 2012). Bis-
(3’,5’)-cyclic diguanylate (c-di-GMP) for example is a major determining factor between 
these lifestyles in most bacteria including pathogens such as Salmonella species, Vibrio 
cholerae and P. aeruginosa (Hengge, 2009). A high level of c-di-GMP represses motility 
and expression of acute virulence factors while promoting biofilm formation and the sessile 
lifestyle. The Gac/Rsm pathway serves as another mechanism to control the switch 
between acute and chronic infections. This pathway relies on two sRNA molecules, RsmY 
and RsmZ, for modulating target mRNA stability and translation efficiency. In this 
regulatory pathway, acute virulence factors (T3SS) and chronic virulence factors (type VI 
secretion and exopolysaccharides) are inversely regulated (Coggan & Wolfgang, 2012). 
QS signaling is altered during chronic infections with many CF P. aeruginosa isolates 
displaying loss-of-function lasR mutations (Singh et al., 2000; Sousa & Pereira, 2014). 
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Meanwhile, other factors, such as the periplasmic protease CtpA and the regulator of β-
lactam resistance named AmpR, are implicated during this transition (Balasubramanian, 
Kumari, & Mathee, 2014; Seo & Darwin, 2013). Of note, these signaling pathways work 
synergistically to provide a fitness advantage for P. aeruginosa during infections. 
 
Virulence factors of Pseudomonas aeruginosa  
 The ability of this bacterium to withstand the host immune defense and 
antimicrobial treatments while successfully colonizing and establishing an infection is 
attributed to its large pool of virulence factors. Due to the length limit of this document, 
only those relevant in later chapters will be discussed here. 
 Alginate production and its regulation 
During initial colonization in CF lungs, P. aeruginosa exhibits a non-mucoid 
colony phenotype. However, mucoid variants are increasingly isolated as the disease 
progresses (Hoiby, 1982). Strikingly, the percentage of mucoid isolates may account up to 
90% of total P. aeruginosa isolates from CF patients (Govan & Deretic, 1996). Emergence 
of the mucoid phenotype is typically associated with prolonged antibody response and 
deterioration of lung functions (Hoiby, 1982).  
The mucoid phenotype is the outcome of overproduction of the exopolysaccharide 
alginate. Polymerized from the uronic acid β-D-mannuronate and C-5 epimer α-L-
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guluronate, alginate is polyanionic, highly hydrated and viscous (Gacesa, 1998). Alginate 
is known to possess anti-phagocytic properties and the polyanionic nature of alginate 
renders itself a barrier to antimicrobial agents (Hoiby, 1982; Govan and Deretic, 1996; 
Leid et al., 2005). Although often found in CF patients, anti-alginate antibodies are unable 
to clear mucoid P. aeruginosa infections. As a result of these protective functions conferred 
by alginate, mucoid P. aeruginosa is even more difficult, if not impossible, to eradicate, 
with infections lasting throughout the lifetime of a colonized CF patient. Alginate 
production is however, not exclusively found in CF patients, and mucoid P. aeruginosa 
variants have been isolated in other infected sites such as gallbladders (Govan & Deretic, 
1996). Considering that the human host is not its natural niche, alginate likely plays other 
roles when P. aeruginosa grows in fresh water or soil. It was previously shown in P. 
aeruginosa and other Pseudomonas species that alginate offers protection and increases 
survival in the soil and against desiccation (Chang et al., 2007; Hall, McLoughlin, Leung, 
Trevors, & Lee, 1998). It would be instrumental to determine other roles of alginate during 
P. aeruginosa growth in its natural niches. Interestingly, alginate is also produced by other 
bacteria such as the nitrogen fixing bacteria Azotobacter. In Azotobacter, alginate is 
produced during vegetative phases of these bacteria and the alginate casing preserves 
dormant cysts from mechanical stress and desiccation (Clementi, 1997).  
Alginate production is an energy-exhaustive process, requiring a number of 
enzymes and precursor substrates. Bacteria therefore implement a tight control on its 
production. All enzyme-encoding genes except algC are within the alginate biosynthesis 
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operon, which is thereby a focal point of regulation (Figure 1.2) (Gacesa, 1998; Ramsey & 
Wozniak, 2005). Expression of this operon is regulated by a number of transcription factors 
(TFs), including AlgR, Vfr, AlgB, AlgP (Hp-1), IHF, CysB and AmrZ (Figure 1.2) 
(Wozniak, 1994; Wozniak and Ohman, 1994; Baynham et al., 1999; Whitchurchet al., 
2005; Leech et al., 2008; Schurr, 2013). Previous studies have shown that the sigma factor 
AlgT (also referred to as AlgU/σ22) directs the transcription of the alginate biosynthesis 
operon (Boucher, Schurr, & Deretic, 2000; M J Schurr et al., 1993; D J Wozniak & Ohman, 
1994). Freed from the sequestration by the anti-sigma factor MucA, AlgT initiates 
transcription of genes such as amrZ, algB and algR (P. J. Baynham & Wozniak, 1996; A. 
K. Jones et al., 2010). These three and four additional TFs bind to the promoter region of 
the alginate biosynthesis operon (PalgD) and initiate transcription (Deretic & Konyecsni, 
1990; Kato, Misra, & Chakrabarty, 1990; Konyecsni & Deretic, 1990; Mohr et al., 1991). 
Interestingly, in the region over 100 base pairs (bp) upstream of the transcription start site, 
there are at least seven TF binding sites, exact functions of which are yet characterized. 
This promoter arrangement is rare in bacteria, and one of the aims in this study is to unveil 
the molecular mechanism of this activation (Chapter 4). 
 
Flagella and FleQ 
Mucoid P. aeruginosa strains are typically aflagellated, with the absence of 
functional flagella as an immune evasion mechanism (Cobb et al., 2004; Tart.et al., 2006; 
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Amiel.et al., 2010). However, in non-mucoid P. aeruginosa as well as other bacterial 
pathogens this cell surface appendage plays essential roles during infections. The single 
polar flagellum of P. aeruginosa is required for dissemination, chemotaxis, initial surface 
attachment and robust biofilm formation (Klausen, Heydorn, et al., 2003; O’Toole & 
Kolter, 1998; Q. Wang, Suzuki, Mariconda, Porwollik, & Harshey, 2005). In an acute 
mouse burn wound model, flagella mutants displayed significantly reduced invasiveness 
in comparison to their flagellated counterparts, thereby underscoring its essentiality during 
acute infections (D. Drake & Montie, 1988).  
The flagellum apparatus contains three main sub-structures: the motor-containing 
basal body that anchor the whole structure to the cell wall, the flagellin filament as the 
propeller and the hook connecting above two sub-structures (Jarrell & McBride, 2008). 
The flagellum apparatus is assembled starting with the basal body, the hook and lastly the 
filament. In P. aeruginosa, flagella assembly is regulated in four tiers, with FleQ being the 
master regulator in the first tier. FleQ directly or indirectly regulates most flagella 
promoters, and the absence of functional FleQ results in reduced expression of most 
flagella genes and loss of flagella-mediated swimming motility (Dasgupta et al., 2003). On 
the other hand, fleQ expression is subject to external regulation. It is well documented that 
both Vfr, a P. aeruginosa homolog of the Escherichia coli cAMP receptor CRP, and AmrZ 
(Alginate and Motility Regulator Z), repress fleQ transcription (Dasgupta et al., 2002; Tart 
et al., 2006). Additionally, FleQ receives signals from c-di-GMP and modulates expression 
of the pel operon in a c-di-GMP dependent manner (Baraquet, Murakami, Parsek, & 
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Harwood, 2012; J. Hickman & Harwood, 2008). These findings suggest an active crosstalk 
between flagella and other systems in the cell.  
 
Type IV pilus and twitching motility 
In addition to flagella-mediated swimming motility, P. aeruginosa also conducts 
twitching motility (TM) via its type IV pilus (TFP). This polar apparatus mobilizes the cell 
by means of repeating cycles of extension, tethering and retraction. Besides TM, TFP 
mediates surface adherence and biofilm formation (O’Toole and Kolter, 1998; Klausen, 
Heydorn, et al., 2003). It also plays important roles in P. aeruginosa virulence (Comolli et 
al., 1999; Zolfaghar, Evans, & Fleiszig, 2003) and is involved in swarming motility, DNA 
binding and chemotaxis (Anyan et al., 2014; Kearns, Robinson, Lawrence, Kearns, & 
Robinson, 2001; Schaik et al., 2005). Recent studies demonstrated that TFP plays 
important roles in surface sensing (Luo et al., 2015; Persat, Inclan, Engel, Stone, & Gitai, 
2015; Siryaporn, Kuchma, O’Toole, & Gitai, 2014). TFP is present in many other Gram-
negative bacteria besides P. aeruginosa such as Neisseria gonnorrhoeae and Myxococcus 
xanthus (Friedrich, Bulyha, & Søgaard-Andersen, 2013; Giltner, Nguyen, & Burrows, 
2012; Hoyne, Haas, Meyer, Davies, & Elleman, 1992). Recent studies have also identified 
this organelle in a few Gram-positive species, indicating its prevalence in bacteria with 
diverse evolutionary origins (Melville & Craig, 2013). 
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In P. aeruginosa nearly forty genes are required for TFP functions, suggesting its 
complex nature (Alm & Mattick, 1997). The current model for TFP assembly is shown in 
Figure 1.3. The main pilus filament is comprised of the major pilin PilA and five minor 
pilins (FimU, PilV, PilW, PilX and PilE). Exact roles of these minor pilins are unclear, but 
they are required for pili assembly and twitching motility (Kuchma et al., 2012). PilY1, a 
homolog to the gonococcal fimbrial tip adhesin PilC, is considered the tip adhesion in P. 
aeruginosa and shows affinity to integrin on host cells (Aim, Hallinan, Watson, & Mattick, 
1996; Johnson et al., 2011; Orans et al., 2010). Among these minor pilins, the PilVWXY1 
complex is proposed as the primer for pilus assembly (Nguyen et al., 2015). Prepilins, 
including the major pilin PilA and these minor pilins, are processed by the peptidase PilD, 
assembled by the ATPase PilB, and transported across the cytoplasmic membrane through 
PilC. Thereafter, assembled pilin subunits are extended beyond the outer membrane via 
PilQ. PilQ and the inner membrane complex are aligned by the PilMNOP alignment 
complex (Burrows, 2012). Distinct from flagella, assembly of the TFP machinery begins 
with the outer membrane complex PilQ, followed by the alignment complex and finally 
the inner membrane complex (Friedrich et al., 2013). Known tethering targets of TFP 
include inert surfaces as well as host proteins such as asialo GM1 receptors on epithelial 
cells and integrin proteins (de Bentzmann et al., 1996; Jenkins, Buckling, McGhee, & 
Ffrench-Constant, 2005; Johnson et al., 2011; Sheth et al., 1994). After adhering to specific 
targets, the filament is retracted back into cells by the ATPases PilT and PilU (Whitchurch 
& Mattick, 1994).  
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Transcription of the major pilin gene pilA requires the sigma factor RpoN and the 
two-component system PilR/S (Hobbs, Collie, Free, Livingston, & Mattick, 1993). TFP-
mediated TM also requires the Chp chemotaxis system, which is composed of a histidine 
kinase ChpA and two CheY-like response regulators PilG and PilH (Bertrand, West, & 
Engel, 2010).  
The TFP machinery is also subject to control by a number of external regulators, 
such as the AlgR/FimS two-component system, c-di-GMP, and AmrZ (Alm, Bodero, Free, 
& Mattick, 1996; P. J. Baynham, Ramsey, Gvozdyev, Cordonnier, & Wozniak, 2006; 
Belete, Lu, & Wozniak, 2008). In the AlgR/FimS two-component system, AlgR 
phosphorylation is necessary for AlgR-mediated activation of TM (Whitchurch, Erova, et 
al., 2002). Since this phosphorylation is dispensable for AlgR-mediated activation of 
alginate production, it is intriguing what TM-pertinent signals FimS senses (S. Ma et al., 
1998). A recent study identified the interaction between FimS and the methyl-accepting 
protein PilJ, suggesting FimS might receive signals from PilJ (Luo et al., 2015). Although 
it remains undetermined how c-di-GMP impacts TFP, two TFP proteins FimX and PilZ 
bind to c-di-GMP while c-di-GMP production is activated by PilY1 signaling, suggesting 
communications between these two systems (Amikam & Galperin, 2006; Huang, 
Whitchurch, & Mattick, 2003; Jain, Behrens, Kaever, & Kazmierczak, 2012; Kazmierczak, 
Lebron, & Murray, 2006; Luo et al., 2015).  The mechanism of AmrZ-mediated activation 
of TM is unknown and is one focus of this study (see Chapter 2 and Appendix A). 
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Biofilm and its significance 
Since the last century, there have been tremendous advances in our knowledge of 
microorganisms, but most research has focused on free-living (planktonic) cells. In fact, 
microorganisms rarely exist as single-cell suspensions; instead, they are mainly found 
within complex communities called biofilms (Donlan & Costerton, 2002; Hall-Stoodley, 
Costerton, & Stoodley, 2004). Biofilms were defined by IUPAC in 2002 as “aggregates of 
microorganisms in which cells that are frequently embedded within a self-produced matrix 
of extracellular polymeric substance (EPS) adhere to each other and/or to a surface” (Vert 
et al., 2012). This lifestyle however, is not simply passive aggregation of cells, but an active 
and complex process requiring cooperation across the community. These communities can 
be formed by a single or multiple species, the latter of which is likely to be the norm in 
natural environment and during infections (Hall-Stoodley, Costerton, & Stoodley, 2004).  
In bacterial biofilms, EPS is composed of a variety of biopolymers including 
proteins, polysaccharide and extracellular DNA (eDNA) (Flemming et al., 2007). In the 
model organism P. aeruginosa, three exopolysaccharides (alginate, Psl and Pel) are 
involved in biofilm formation (Chew et al., 2014; Mann & Wozniak, 2012). For instance, 
disruption of Psl biosynthesis abolishes biofilm architecture (L. Ma, Jackson, Landry, 
Parsek, & Wozniak, 2006). Studies have also revealed important roles of proteins such as 
IHF and CdrA in biofilms (Borlee et al., 2010; Brockson et al., 2014; Devaraj, Justice, 
Bakaletz, & Goodman, 2015). Antibodies targeting the DNA binding protein IHF disrupt 
biofilms and offer potential as a future therapeutic option (Brockson et al., 2014). In 
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addition, eDNA is abundant in biofilms with DNase I treatments preventing biofilm 
formation and disrupting pre-formed biofilms (Gloag et al., 2013; Whitchurch, Tolker-
Nielsen, Ragas, & Mattick, 2002).  
In general biofilm formation is divided into three stages: initial attachment to 
surfaces, growth and maturation, and dispersal (Figure 1.4) (Sauer et al., 2002; Stoodley et 
al., 2002). Initial attachment may occur on a biotic or abiotic surface and requires flagella, 
type IV pili and Psl (L. Ma et al., 2006; O’Toole & Kolter, 1998). Attached bacteria 
undergo subsequent proliferation and develop three-dimensional biofilm architecture. 
Matured P. aeruginosa biofilms can be flat or “mushroom”-shaped depending on nutrition 
sources (Shrout et al., 2006). The biofilm structure is also modulated by QS, alginate, Psl, 
flagella, TFP, and the catabolite repression control (Crc) protein (D G Davies et al., 1998; 
Klausen, Aaes-Jørgensen, Molin, & Tolker-Nielsen, 2003; Klausen, Heydorn, et al., 2003; 
O’Toole, Gibbs, Hager, Phibbs, & Kolter, 2000; Stoodley et al., 2002). After biofilm 
maturation, small quantities of cells may detach from biofilms and become free-flowing 
again. These cells may find a new niche and re-initiate the biofilm cycle. Successful 
detachment is dependent on factors such as flagella, TFP and rhamnolipid (Boles, 
Thoendel, & Singh, 2005; Hall-Stoodley, Costerton, & Stoodley, 2004). Biofilm dispersal 
is also affected by carbon sources (K Sauer et al., 2004), nitric oxide (Barraud et al., 2006), 
metal chelators (Banin, Brady, & Greenberg, 2006), the fatty acid cis-2-decenoic acid (D. 
G. Davies & Marques, 2009), and the Pf4 prophage (Rice et al., 2009). Importantly, Chua 
et al. showed that dispersed cells exhibited higher virulence against macrophages and 
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Caenorhabditis elegans compared to planktonic cells, indicating that cells dispersed from 
biofilms are distinct from planktonic ones (Chua et al., 2014). 
Compared to the planktonic counterpart, bacteria in biofilms display distinct 
phenotypes and significantly higher survival rates in adverse environments. In 2001, 
Whiteley et al. compared transcriptional profiles between biofilm-grown and planktonic 
bacteria and 73 genes exhibited differential expression (Whiteley et al., 2001). This 
suggests the lifestyle of bacteria in biofilms is distinct from planktonic cells. Bacteria in 
biofilms are more tolerant to various detrimental forces such as antibiotics, phagocytosis 
and reactive oxygen species. As an example, planktonic P. aeruginosa is susceptible to 
imipenem, but the same strain becomes 1,000-fold more tolerant when grown in biofilms 
(Donlan & Costerton, 2002). Increased resistance is a result of EPS protection and natural 
persistence in this growth mode (Hall-Stoodley et al., 2004; Ryder et al., 2007). A thick 
layer of EPS may act as a physical barrier preventing/delaying the penetration of 
antimicrobial agents. In addition, bacteria in mature biofilms grow significantly more 
slowly than planktonic cells and are thereby naturally more recalcitrant to antimicrobials, 
especially β-lactams (Donlan & Costerton, 2002; Hall-Stoodley et al., 2004). Another 
contributing factor is an increased proportion of persister cells in biofilms. Albeit being a 
tiny fraction of cells in exponential phases during planktonic growth, persister cells can 
account up to 1% in biofilms and stationary phases. These persister cells are not 
metabolically active and thus insensitive to antibiotic treatment. However, they can revert 
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to metabolically active cells and repopulate the community after antibiotic treatment 
(Wood, Knabel, & Kwan, 2013). 
 
Control by transcription factors 
The Central Dogma of molecular biology dictates that transcription is an essential 
step to decode the information carried by DNA and products of this process (mRNAs) 
direct protein synthesis (Crick, 1970). During transcription, the RNA polymerase (RNAP) 
recognizes specific transcription initiation DNA sequences (i.e., promoters), unwinds 
double stranded DNA, and uses it as the template to synthesize RNA. In bacteria, a RNAP 
holoenzyme is composed of a sigma factor and the core enzyme. Most prokaryotic 
organisms encode only one type of the core enzyme with five subunits (2 α, β, β’ and ω). 
The core enzyme is catalytically competent, but requires the sigma factor for promoter 
recognition and transcription initiation. The active site of the polymerase that mediates 
binding of the template DNA and the RNA product, is formed by β and β’ subunits. Two 
α subunits dimerize via their N-terminal domains, which are also responsible for the 
assembly of the β and β’ subunits. C-terminal domains of α subunits (αCTD) bind to 
upstream DNA and are important sites for TFs to interact with and then execute regulation 
(Browning & Busby, 2004). Specific roles of the ω subunit are not known, but the ω subunit 
binds ppGpp (Ross et al., 2013) and increases transcription efficiency (Gunnelius et al., 
2014). Some Gram-positive bacteria express additional accessary RNAP components 
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including δ and ε. These subunits are not essential for RNAP functions but contribute to 
proper functions of RNAPs (Weiss & Shaw, 2015). There are multiple types of sigma 
factors in the cell, with σ70 being the predominant one and the focus in this section. During 
transcription initiation, the sigma factor and the RNAP core form the holoenzyme and 
recognize specific promoter sequences. The holoenzyme unwinds the promoter DNA and 
forms the open complex. Transcription is initiated by the synthesis of a nascent RNA chain 
from the DNA template strand. When transcription proceeds into elongation, the sigma 
factor is released and the RNAP core completes synthesis of remaining RNA (Borukhov 
& Nudler, 2008). Transcription can be terminated by protein-dependent and protein-
independent mechanisms (Cooper GM., 2000).  
In all forms of life, transcription regulation serves as a major and efficient form of 
gene regulation. Both prokaryotic and eukaryotic organisms have complex mechanisms to 
fine-tune transcription. Most transcription control events occur during initiation in which 
TFs bind to target DNAs and activate/repress transcription. TFs are DNA-binding proteins 
that specifically interact with DNA and modulate gene expression. All organisms possess 
a significant number of TFs regulating almost all transcription events. For instance, in the 
model organism Escherichia coli, ~6.5% (300/4605) of open reading frames encode TFs 
(Martínez-Antonio, 2011). Organismal complexity positively correlates with the ratio and 
number of TFs per genome (Levine & Tjian, 2003). 
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TFs have evolved to use various mechanisms to mediate regulation and different 
classes of these proteins include helix-turn-helix (HTH) proteins, zinc-finger and steroid-
binding proteins, leucine zipper proteins, homeodomains and β-sheet DNA binding 
proteins (Pabo & Sauer, 1992). HTH proteins are the dominant family of TFs, and their 
HTH motifs are composed of two α-helices separated by a turn. Although the second helix 
directly interacts with the major groove of target DNA, other contacts by the first helix and 
other portions of TFs are important for specific recognition (Pabo & Sauer, 1992). Most 
TFs, including all types of proteins except β-sheet DNA binding proteins, contact with 
major grooves of DNA via their α-helices, indicating the predominance of α-helices in 
protein-DNA interactions. The α-helix was thought as the only motif to interact with DNA 
until the discovery of the ribbon-helix-helix (RHH) protein superfamily, in which each 
protein contains a β-sheet followed by two α-helices. In this protein superfamily, β-sheets 
interact with DNA major grooves (Schreiter & Drennan, 2007). The RHH protein 
superfamily contains multiple proteins such as Arc and Mnt from the phage P22, MetJ from 
E. coli, NikR from Helicobacter pylori and AmrZ from P. aeruginosa (Figure 1.5) 
(Vershons et al., 1985; Rafferty et al., 1989; Chivers and Sauer, 1999; Waligora et al., 
2010). 
Transcription can be positively or negatively regulated by TFs. Transcriptional 
repression is often mediated by physically blocking the access of the RNA polymerase to 
promoters. This hindrance can be achieved by either binding of repressors to the sigma 
factor binding sequence (for σ70, -35 bp to +1 bp relative to the transcription start site, same 
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denotations below) or altering DNA conformation, to prevent promoters from being 
recognized by the RNAP. Most repressors fall into one of these two categories, and in 
microorganisms such as E. coli, the region downstream of -30 is an “exclusive zone of 
repression” where few activators bind (Neidhardt & Curtiss, 1996). Some other repressors 
can, however, interact with transcriptional activators and prevent them from activating 
transcription (Browning & Busby, 2004). Transcriptional activators function via more 
diverse mechanisms. Transcription activation is typically accomplished by interactions 
between its activators and αCTDs or sigma factors (Neidhardt & Curtiss, 1996). Therefore, 
binding sites of transcription activators are typically found between -31 to -80 bp. Remote 
elements however, exist in some promoters, but they usually pair with proximal factors. 
TFs that bind to remote elements may make contact with proximal proteins by bending the 
intervening DNA or inducing DNA looping (Neidhardt & Curtiss, 1996). In rare examples 
certain TFs regulate transcription solely by interacting with RNAP without making contact 
with DNA (Beck et al., 2007). 
The majority of these TFs share a similar modular arrangement containing DNA-
binding domains and modules with other functions, the latter of which may mediate 
protein-protein interactions, small molecule binding, or signal transduction (Balleza et al., 
2009). Many TFs bind to DNA as homo- or hetero- oligomers via their oligomerization 
domains. On the other hand, DNA binding affinity of some TFs is modulated by binding 
of small molecules. The lac repressor loses DNA binding affinity when bound by 
allolactose, relieving repression of the lac operon (Lewis et al., 1996). In contrast, nickel 
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binding to H. pylori NikR stimulates DNA binding (Schreiter et al., 2003). On the other 
hand, some TFs such as DNA-binding response regulators use their signal reception 
domains as an on/off switch for DNA binding in the presence/absence of certain signals. 
These response regulators, when phosphorylated by their cognate kinases, become 
activated and execute transcriptional control (Okkotsu, Tieku, Fitzsimmons, Churchill, & 
Schurr, 2013; Whitchurch, Erova, et al., 2002). Modular arrangement in TFs has become 
a useful tool in biotechnology and various artificial TFs have been developed for 
application purposes (Ansari & Mapp, 2002; Sera, 2009). 
 
The versatile transcription factor AmrZ 
The global transcription factor AmrZ plays significant roles during P. aeruginosa 
pathogenesis. AmrZ contains 108 residues with the molecular weight of 12.34 kDa. It 
belongs to the Arc protein superfamily, in which proteins bind to DNA via their RHH 
domains and the basic functional unit is dimeric. This protein superfamily is composed of 
members from various origins, including several bacterial species and the bacteriophage 
P22 (Schreiter & Drennan, 2007). Representative proteins in this superfamily are shown in 
Figure 1.5. Albeit their RHH domains exhibit similar structures, these proteins have limited 
sequence similarity even within RHH domains (Figure 1.5). Their C-terminal domains 
(CTDs) carry diverse functions (Figure 1.5). Proteins such as Arc and CopG are short (~50 
residues) and contain solely RHH domains. These proteins bind to DNA as tetramers but 
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are dimeric in solution (Vershons et al., 1985; Brigitte E. Raumann  Carl O. Pabo & Robert 
T. Sauer, 1994). Mnt tetramerization via its CTD enhances DNA binding (Waldburger & 
Sauer, 1995). Both Arc and Mnt are encoded in the genome of the bacteriophage P22 and 
are important to repress anti-repressor genes during lytic and lysogenic forms of the phage, 
respectively (Waldburger & Sauer, 1995). The repressor MetJ inhibits transcription of 
genes involved in methionine and S-adenosylmethionine (SAM) synthesis, and MetJ DNA 
binding activity is significantly enhanced when bound by SAM (Rafferty et al., 1989). 
Similarly, nickel-bound NikR exhibits increased DNA binding and repressor activities, 
which are important during the control of nickel transport (P T Chivers & Sauer, 1999; 
Muller et al., 2011; Schreiter et al., 2003). 
AmrZ is composed of three segments: the N-terminal motif (residues 1-11), the 
ribbon-helix-helix domain (residues 12-66), and the CTD (residues 67-108) (Figure 1.6A). 
The N-terminal motif is highly flexible and does not seem to be essential during AmrZ-
mediated regulation (Waligora et al., 2010). The ribbon-helix-helix domain mediates DNA 
binding and AmrZ dimerization (Pryor et al., 2012). Specifically, a short β-sheet (residues 
15-23) within this domain is critical for DNA binding, and single amino acid mutations at 
certain residues within this motif lead to abolished DNA binding (Waligora et al., 2010). 
However, the role of the AmrZ CTD remains unknown and is one of the goals in this study 
(Chapter 3). Based on the recently solved crystal structure, the CTD-truncated variant 
AmrZ1-66 binds to its target DNA as a dimer of dimers (Figure 1.6B). In addition, residues 
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such as Lys18, Val20, Arg22 and Arg28 within the β sheet of each monomer make direct 
contacts with the major groove of target DNA (Pryor et al., 2012). 
While most Arc superfamily proteins act as repressors, AmrZ functions as both an 
activator and repressor. AmrZ activates transcription of the alginate biosynthesis operon 
and TM, yet represses flagella-mediated motility, Psl production and c-di-GMP synthesis 
(Baynham and Wozniak, 1996; Ramsey et al., 2005; Baynham et al., 2006; Tart et al., 
2006; Jones et al., 2013, 2014). Specifically, increased levels of AmrZ in mucoid strains 
activate alginate production and repress flagella-mediated motility and Psl production (C. 
J. Jones et al., 2013; Tart et al., 2006). However, the intracellular AmrZ concentration is 
much lower in non-mucoid strains, allowing flagella assembly and Psl-mediated biofilm 
formation. In non-mucoid strains, AmrZ is also required for TM and repression of gcbA 
(also referred to as adcA, PA4843), which encodes a diguanylate cyclase (C. J. Jones et al., 
2014; Petrova, Cherny, & Sauer, 2014). Deletion of amrZ in non-mucoid strains therefore 
results in an increased c-di-GMP level and enhanced biofilm formation (C. J. Jones et al., 
2014). 
 
Key methods used in this study 
A number of laboratory techniques were used during this work, but only three 
methods will be described here while the rest will be covered in following chapters. 
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DNA microarray analysis 
Traditional approaches to study transcriptional regulation include genetic methods 
such as reporter assays, and biochemical methods including northern blot, and quantitative 
real-time PCR (qRT-PCR). However, all these methods are performed on the scale of 
single genes. Developed in 1995, DNA microarrays revolutionized almost every biological 
science field by enabling the examination of thousands of genes in parallel (Schena et al., 
1995). There are two types of microarrays: oligo-based DNA arrays and cDNA arrays. In 
cDNA arrays, mRNAs are reverse-transcribed into cDNAs, which are subsequently 
converted to double strands and amplified. These dsDNA molecules are then used as 
probes in microarray analyses (Trevino, Falciani, & Barrera-Saldana, 2007). In this 
document only oligo-based DNA arrays are used and discussed. Millions of oligo-
nucleotides, i.e., probes, are covalently attached to a solid surface (glass or a silicon chip) 
in designated wells. These probes are ~25 nucleotides long and designed from protein open 
reading frames (ORFs) in a certain genome. Expression of each gene is monitored by 
multiple probes. During sample preparation, mRNAs are purified and reverse-transcribed 
to single stranded cDNA. This cDNA library is then labeled with fluorescent dyes and 
hybridized to probes in the microarray chip. Perfect matches with specific probes result in 
the formation of strong hydrogen bonds and are therefore resistant to subsequent washes. 
Relative amounts of mRNAs are quantified by fluorescence intensity measurements of 
respective wells.  
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After twenty years of development, DNA microarrays have become a mature 
technology that is relatively easy to perform and analyze. Data analyses have become 
straightforward and efficient with sharing of open-source analysis tools across the research 
community. As a great example, the Bioconductor project has provided the platform for 
sharing extensible software packages in computational biology and bioinformatics 
(Gentleman et al., 2004). Bioconductor has allowed researchers to collaborate and share 
software packages rather than to repetitively design similar scripts. Currently over a 
thousand open-source software packages are publically available for various data analyses.  
However, there are a few limitations of DNA microarrays. First of all, data 
interpretation can vary significantly using different analytical methods, and proper controls 
as well as statistical analyses are required for drawing appropriate conclusions. Results 
from DNA microarrays therefore often require validation by other methods. Moreover, 
since DNA microarrays are based on sample hybridization to probes, issues with 
hybridization efficiency and specificity have been great concerns. DNA microarrays rely 
on existing knowledge of target genomes, so they are only capable of measuring expression 
of known genes (Wang et al., 2009). 
 
Next-generation sequencing 
Next-generation sequencing (also referred to as second-generation sequencing) 
(NGS) first appeared in the market in 2005 and is another revolution that has dramatically 
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altered the course of biological research (Margulies et al., 2005). NGS is referred to as non-
Sanger-based high-throughput DNA sequencing. The basic principle of Sanger-based 
DNA sequencing is tricking DNA polymerase with dideoxynucleotides (ddNTPs), so new 
syntheses stop whenever ddNTPs are incorporated. A collection of terminated DNA 
fragments are generated after DNA amplification. These fragments were originally 
analyzed by slab gels, and later by capillaries (Mardis, 2013). Although it is a significant 
improvement to this technique, the Sanger-based sequencing method has the weakness of 
limited parallelism and high per-sample cost. The need for high throughput and low cost-
yield ratios led to the development of NGS. Although there are multiple NGS platforms, 
the fundamental principle is similar. Sample DNA is randomly fragmented and ligated to 
adaptor sequences in arrays, generating a library of short labeled DNA fragments. 
Sequencing of this library is performed by alternating cycles of amplification and data 
acquisition (Shendure & Ji, 2008). When compared to Sanger-based DNA sequencing, 
NGS achieves high throughput via in vitro construction of the sequencing library and the 
use of arrays. Strikingly, the transition from Sanger-based DNA sequencing to NGS has 
reduced the cost per genome by over 1,000 fold (Wetterstrand, 2015).  
The development of NGS has not only revolutionized the sequencing of whole 
genomes, but also fostered subsequent applications in ChIP-Seq (CHromatin 
ImmunoPrecipitation-sequencing), RNA-Seq and metagenomic sequencing (Shendure & 
Ji, 2008). ChIP-Seq is widely used to determine binding sites of a DNA binding protein 
throughout the genome. RNA-Seq, also known as transcriptome sequencing, is used to 
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quantify gene expression and to identify unknown transcripts, etc. RNA-Seq is considered 
a superior transcriptomics method than DNA microarrays owing to its minimized artifacts 
and applications in species with unknown genome sequences (Wang et al., 2009). 
Metagenomic sequencing allows the study of multiple species in a microbial community, 
and therefore has been applied extensively during microbiome research (Eloe-fadrosh et 
al., 2015; Van Dijk, Auger, Jaszczyszyn, & Thermes, 2014). 
 
Fluorescence resonance energy transfer 
Fluorescence is a type of luminescence conferred by a certain molecule 
(fluorophore) that when excited by light at a specific wavelength, absorbs this light and 
then re-emits light (photons) at a longer wavelength (Ishikawa-Ankerhold et al., 2012). 
Fluorescence/Föster resonance energy transfer (FRET) involves two fluorophores and 
occurs when the emission wavelength of one fluorophore (donor) matches the excitation 
wavelength of the other (acceptor). Emitted photons by the donor fluorophore are absorbed 
by and excite the acceptor fluorophore when two fluorophores are very close, leading to 
the loss of emission by the donor fluorophore and emission from the acceptor, i.e., energy 
transfer. Detectible FRET requires extreme proximity between two fluorophores (2-10 nm) 
(Blair, Goodrich, & Kugel, 2013).  
FRET has been widely used to determine proximity between molecules and is able 
to detect intra/inter-molecule interactions well below the resolution of normal optical 
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microscopy (Zadran et al., 2012). Its applications include analyzing protein-protein and 
protein-DNA interactions as well as monitoring protein conformational changes. 
Importantly, these interactions can be assessed both in vitro and in vivo, offering more 
versatility for diverse applications.  
Albeit a powerful tool, FRET has its limitations. First of all, there are a limited 
number of donor/acceptor pairs for FRET experiments, which can restrain its application 
from the studies of certain sensitive cellular mechanisms (Ishikawa-Ankerhold et al., 2012; 
Zadran et al., 2012). In addition, other artifacts such as auto-fluorescence and protein-
induced fluorescence enhancement may complicate FRET data interpretation (Hwang & 
Myong, 2014; Zadran et al., 2012). FRET experiments require careful experimental design 
and proper controls, and concerns with fluorescence fading, fluorophore and analyte 
concentrations should be considered (Zadran et al., 2012). 
 
Overall goals in this dissertation 
The overall goal of this work is to further understand mechanisms of AmrZ-
mediated regulation in Pseudomonas aeruginosa. Specifically, we have performed 
experiments with the aim of identifying the target(s) of AmrZ during its activation of 
twitching motility (Chapter 2 and Appendix A). In addition, we are also interested in 
determining the oligomeric state of AmrZ and identifying the domain(s) that mediates this 
oligomerization, which will be discussed in Chapter 3. AmrZ and many other transcription 
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factors are known to activate the transcription of the alginate biosynthesis operon; however, 
the mechanism remains elusive how remote factors activate transcription. Our new 
discovery in Chapter 4 has shed new insights into this activation mechanism. 
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Figure 1.1. Virulence factors in acute and chronic infections.   
P. aeruginosa causes both acute and chronic infections with distinct sets of virulence 
factors. Expression of these factors is regulated by at least three signaling systems: c-di-
GMP, the Gac/Rsm system and quorum sensing. T3SS/T6SS: type III/VI secretion system. 
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Figure 1.2. Assembly of the type IV pilus apparatus.  
This apparatus is composed of four sub-complexes shown in four shades. The assembled 
pilus (in white) contains the major pilin PilA, a few minor pilins (mp) and the tip adhesin 
PilY1. During extension, prepilins are processed by the peptidase PilD and then assembled 
into the pilus by the ATPase PilB across the cytoplasm via PilC. During retraction, the 
ATPases PilT and PilU mediate the disassembly. These five proteins (PilBCD, PilT and 
PilU) are the inner membrane motor sub-complex (in light grey). The assembled pilus 
traverses the outer membrane via the outer membrane sub-complex PilQ and PilF (in 
black). In addition, the outer membrane sub-complex is aligned with the inner membrane 
motor sub-complex by the alignment sub-complex composed of PilMNOP and FimV (in 
dark grey). This image is adapted from (Burrows, 2012).  
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Figure 1.3. The alginate biosynthesis operon and its promoter region.  
The string of colored boxes represents 12 genes within the alginate biosynthesis operon, 
and boxes in the lower panel are binding sites of different transcription factors and the 
sigma factor AlgT. Colors in the upper panel represent their subcellular localizations. 
Yellow: periplasmic; orange: cytoplasmic membrane; green: outer membrane; red: 
cytoplasmic. The picture of the operon is adapted from the pseudomonas.com website 
(Winsor et al., 2011). Numbers in the lower panel are the distance in base pairs relative to 
the transcription start site, which is marked as the black arrow. Two Hp-1 (AlgP) binding 
sites are not shown here due to their imprecisely mapped positions (Michael J Schurr, 
2013). 
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Figure 1.4. Simplified life cycle of a biofilm.  
Microorganisms attach to surfaces (Stage 1), and continue to grow and mature with distinct 
biofilm three-dimensional structures (Stage 2). A proportion of cells within the biofilm 
may detach and undergo the dispersal process (Stage 3), returning to the free-flowing phase 
and potentially reinitiating the biofilm life cycle. Adapted from (Stoodley et al., 2002). 
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Figure 1.5. Examples of proteins in the Arc superfamily.  
Apart from the ribbon-helix-helix (RHH) domain, these proteins share limited sequence or 
function similarities. CTD: C-terminal domain. Adapted from (Schreiter & Drennan, 
2007).  
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Figure 1.6. AmrZ primary structure and crystal structure when bound to DNA.  
(A.) Full-length form of AmrZ and the truncated variant lacking its C-terminal domain. N: 
N-terminus; B: DNA-binding domain; Z: oligomerization domain. (B.) The crystal 
structure of AmrZ1-66 when binding to its target DNA amrZ1. Each monomer within the 
dimer of dimers of AmrZ (shown in four colors) interacts with the major groove of DNA 
via its β-sheet. Panel (B.) is adapted from (Pryor et al., 2012).
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Table 1.1. Rates of antibacterial resistance among P. aeruginosa isolates from hospitals and ICUs  
(Adapted from (Lister et al., 2009))  
Antibiotic  
% of P. aeruginosa strains exhibiting resistance 
Hospital study, 
2006  
(n = 606) 
Hospital 
study, 2005  
(n = 589) 
Hospital 
study, 2002  
(n = 9,896) 
ICU study, 
2002 
(n = 951) 
ICU study, 
2000-2002  
(n ≥ 7,500) 
Hospital 
study, 2001 
 (n ≥ 2,157) 
ICU study, 
2001 (n ≥ 
543) 
Hospital 
study, 2000 
(n = 882) 
β-Lactams 
  Cefepime 6 5 9 25 12 8 10 9 
 Ceftazidime 13 10 13 19 17 9 9 13 
 Piperacillin-
tazobactam 
11 9 11 10 14 8 8 13 
 Aztreonam  12  32     
 Imipenem 11 7 16 23 22 12 16 16 
 Meropenem 6 7   18 11 16 10 
Fluoroquinolones 
Ciprofloxacin 21 22 35 32 33 26 25 25 
Levofloxacin 22 22  34 32 27 25 27 
Aminoglycosides 
  Amikacin   5 10  4 3  
 Tobramycin 8 10 12 16     
 Gentamicin 12 12 16  22 15 15 14 
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Chapter 2  
 
  
Chapter 2. Development of a novel method for analyzing Pseudomonas aeruginosa 
twitching motility and its application to define the AmrZ regulon 
 
Abstract 
Twitching motility is an important migration mechanism for the Gram-negative 
bacterium Pseudomonas aeruginosa. In the commonly used subsurface twitching assay, 
the sub-population of P. aeruginosa with active twitching motility is difficult to harvest for 
high-throughput studies. Here we describe the development of a novel method that allows 
efficient isolation of bacterial sub-populations conducting highly active twitching motility.  
The transcription factor AmrZ regulates multiple P. aeruginosa virulence factors including 
twitching motility, yet the mechanism of this activation remains unclear. We therefore set 
out to understand this mechanism by defining the AmrZ regulon using DNA microarrays 
in combination with the newly developed twitching motility method. We discovered 112 
genes in the AmrZ regulon and many encode virulence factors. One gene of interest and 
the subsequent focus was lecB, which encodes a fucose-binding lectin. DNA binding 
assays revealed that AmrZ activates lecB transcription by directly binding to its promoter. 
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The lecB gene was previously shown to be required for twitching motility in P. aeruginosa 
strain PAK; however, our lecB deletion had no effect on twitching motility in strain PAO1. 
Collectively, in this study a novel condition was developed for quantitative studies of 
twitching motility, under which the AmrZ regulon was defined.  
 
Introduction 
Microorganisms are ubiquitous in all types of habitats, ranging from hot springs in 
deep seas to underneath thick ice sheets in the Antarctic continent. Occasionally, 
environmental bacteria such as Pseudomonas aeruginosa find a human host and become 
pathogenic. Efficient colonization and dissemination of P. aeruginosa is dependent on its 
multiple motility mechanisms –swimming, twitching, and swarming (Kohler et al., 2000; 
Rashid and Kornberg, 2000; Jarrell and McBride, 2008; Murray and Kazmierczak, 2008). 
Under laboratory settings, swimming motility occurs in liquid culture or on semi-solid 
surfaces (0.3% agar) yet this is suppressed on solid surfaces (Jarrell & McBride, 2008; 
Murray & Kazmierczak, 2006). In contrast, swarming motility is observed on softer agar 
surfaces (0.5-0.7% agar) compared to twitching motility (TM) (1% agar) (Kohler et al., 
2000; Rashid & Kornberg, 2000). Therefore, growth conditions significantly impact 
activities of different motility organelles. TM is conducted by type IV pili (TFP), which 
also contribute to adherence onto epithelial cells, biofilm formation, DNA uptake, and 
virulence (Burrows, 2012; Doig et al., 1988; Huang et al., 2003; Klausen, Aaes-Jørgensen, 
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et al., 2003; Klausen, Heydorn, et al., 2003; R. M. Miller et al., 2008; Zolfaghar et al., 
2003).  
TFP are present in a variety of bacterial genera including Proteobacteria, 
Cyanobacteria and Firmicutes (Pelicic, 2008). The TFP machinery mediates cell motion 
by repeating cycles of pili extension, tethering to surfaces and retraction. Almost 40 P. 
aeruginosa genes have been shown to be involved in TM (J. Mattick, 2002), and assembly 
of the TFP apparatus is efficiently coordinated by these gene products. Briefly, in P. 
aeruginosa, pre-major pilin PilA and other minor pilins are processed by the peptidase 
PilD, assembled into the pilus fiber by the ATPase PilB, and translocated across the 
cytoplasmic membrane via the transmembrane protein PilC. With the guidance by the 
alignment complex composed of PilMNOP and potentially FimV, polymerized pilus 
filaments pass through the outer membrane complex (PilQ and PilF) (Burrows, 2012). 
During retraction, pilus filaments are depolymerized by the ATPase PilT with probable 
assistance from PilU (11,12). 
TM has been studied by multiple approaches such as macroscopic observations of 
colony edges, macro-/micro-scopic subsurface twitching assays and video-microscopy in 
flow cells (Henrichsen, 1983; Semmler et al., 1999; Gibianskyet al., 2010; Turnbull and 
Whitchurch, 2014). Macroscopic observations of colony edges provided the platform for 
two independent transposon mutant screening studies (Hobbs et al., 1993; Jacobs et al., 
2003). Currently the most popular method is the macroscopic subsurface twitching assay, 
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in which bacteria are stabbed underneath the agar and grow at the agar/Petri dish interface 
(J. Mattick, 2002; Semmler et al., 1999; Turnbull & Whitchurch, 2014). At interstitial 
surfaces, TM-proficient P. aeruginosa produces both TM-active and TM-inactive sub-
populations (Semmler et al., 1999). Despite its convenience for imaging studies, this 
method is limited by the difficulty to recover sufficient quantities of TM-active bacteria 
from underneath the agar. This might explain why limited high-throughput (a.k.a. omics) 
studies have been published focusing specifically on TM-active sub-populations. We 
therefore designed a novel approach to achieve this goal. In this method, cellophane sheets 
placed above the agar surface allow diffusion of nutrients from the underlying media, 
supporting bacterial growth; more importantly, cellophane sheets provide moist and 
smooth surfaces required for TM activation. We showed that TM-proficient P. aeruginosa 
strains exhibited active TM under this condition and were easily distinguishable from TM-
deficient ones. 
 We next sought to take advantage of this approach to understand AmrZ-mediated 
regulation in P. aeruginosa. AmrZ (alginate and motility regulator Z) is a global regulator 
of multiple virulence factors, including the metabolism of bis-(3’,5’)-cyclic diguanylate (c-
di-GMP), extracellular polysaccharide production, and flagella (Baynham and Wozniak, 
1996; Tart et al., 2006; Joneset al., 2013, 2014). Although AmrZ was also shown to be 
necessary for TM, its mechanism requires further investigation (P. J. Baynham et al., 
2006). Therefore, we harvested TM-active bacterial sub-populations with the cellophane-
based approach, and used DNA microarrays to compare transcriptional profiles between 
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WT P. aeruginosa and two isogenic amrZ mutants. The AmrZ regulon under this condition 
contained 112 genes, and the lectin-encoding gene lecB was the only one known necessary 
for TM (Sonawane, Jyot, & Ramphal, 2006) in this gene list. The fucose-specific LecB 
(formerly known as PA-IIL) is abundantly present intracellularly and on the outer 
membrane of P. aeruginosa, and it plays important roles in host cell adherence and 
reduction of the ciliary beat frequency of the airway epithelium (Chemani et al., 2009; 
Loris, Tielker, Jaeger, & Wyns, 2003; Tielker et al., 2005). We provide evidence that AmrZ 
activates lecB expression by specifically binding to its promoter. However, lecB 
overexpression was not sufficient to restore TM in the ΔamrZ mutant, indicating lecB is 
either not required for TM in strain PAO1 or AmrZ-dependent genes in addition to lecB 
are necessary for TM. In support of the former, we were unable to recapitulate the TM-
deficient phenotype seen previously with the PAK ΔlecB mutant (Sonawane et al., 2006) 
in our PAO1 strain background.  
 In conclusion, in this study we developed a novel approach to harvest actively 
twitching P. aeruginosa cells, and applied this new method to define the AmrZ regulon.  
 
Materials & methods 
Bacterial strains, plasmids, oligonucleotides and growth conditions  
Information of bacterial strains, plasmids, and oligonucleotides employed in this 
study is summarized in Table 2.1. Bacteria (Escherichia coli and Pseudomonas 
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aeruginosa) were grown as previously (Waligora et al., 2010). Briefly, E. coli strains were 
grown in LB (each liter LB contains 10 g tryptone, 5 g yeast extract, 5 g sodium chloride) 
or on LA (LB with 1.5% (w/v) agar). 100 µg/ml ampicillin was used to maintain plasmids 
in E. coli. All P. aeruginosa strains were grown in LBNS or on LANS (LB or LA without 
sodium chloride, respectively). In P. aeruginosa, 300 µg/ml carbenicillin was used to 
maintain plasmids. All strains were grown at 37°C unless stated otherwise. All 
oligonucleotides were ordered desalted from Sigma Aldrich. 
 In-frame deletion mutants were generated through overlap extension PCR using the 
gene replacement vector pEX18Ap (Hoang et al., 1998; Heckman and Pease, 2007). Multi-
copy pHERD20T-based plasmids were transferred into P. aeruginosa strains through bi-
parental mating with the E. coli helper strain S17-1 (Qiu, Damron, Mima, Schweizer, & 
Yu, 2008; Simon, Priefer, & Pühler, 1983). 
 
Subsurface twitching assays  
Subsurface twitching assays were modified from a previously described study (J. 
Mattick, 2002). Briefly, a single colony of a strain of interest was resuspended in 400 µl 
LBNS, and P10 tips were immersed in the above suspension and used to stab through the 
agar of 1-day-old 1% LANS plates. Plates were incubated upright in a humid chamber at 
room temperature for 5 days, and imaged through white epiluminescence via a ChemicDoc 
imaging system (Bio-Rad). 
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Twitching motility assays on cellophane sheets.  
Square sterile cellophane sheets (Bioexpress, catalog #: E-3077-14) were placed on 
top of 1-day-old 1% LANS plates. A single colony of each strain was resuspended in 400 
µl LBNS, and 2 µl spotted in the middle of the sheet. After air-drying, plates were 
incubated upright in a humid chamber at room temperature for 48 h. Microscopic images 
were taken by the Olympus DP71 camera mounted onto the inverted light microscope 
Olympus CKX41.  
 
Quantitative real-time PCR (qRT-PCR)  
To isolate total RNA, bacteria were harvested from different growth conditions. 
Cells grown on LANS plates were harvested by flooding with LBNS, while those on 
cellophane sheets were scraped off using P200 tips and then resuspended in LBNS. 1 ml 
bacteria (OD600=1) were lysed by the addition of 100 µl TE containing 1 mg/ml RNase-
free lysozyme (Sigma Aldrich), and then underwent RNA isolation (RNeasy RNA isolation 
kit, Qiagen). To obtain cDNA, ~1 µg RNA was used for reverse transcription (Superscript 
III cDNA preparation kit, Invitrogen) following manufacturer protocols. Amounts of 
cDNA were determined by SYBR Green Mix (Bio-Rad) and CFX1000 thermal cyclers 
(Bio-Rad). The housekeeping gene rpoD was used as reference, and the ΔΔCt method was 
used to calculate relative gene expression (Livak and Schmittgen, 2001; Jones et al., 2014).  
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DNA microarray analysis  
Bacteria from the “edge” sub-population on cellophane sheets were scraped off by 
P200 tips, and resuspended in fresh LBNS. Total RNA was isolated as for qRT-PCR. 
Thereafter, 10 µg RNA for each strain was used to generate cDNA libraries and then 
analyzed using GeneChip P. aeruginosa Genome Array (Affymetrix) following 
manufacture instructions. Microarray “.cel” raw files were analyzed with RMA 
normalization, BH adjust, cutoff of p.value=0.05, lfc=1, using “affy” and “limma” 
packages in Bioconductor, in the environment of R 3.0.2 (Ihaka and Gentleman, 1996; 
Gautier et al., 2004; Gentlemanet al., 2004; Smyth, 2005). Microarray raw and result files 
have been deposited in NCBI Gene Expression Omnibus (Accession number: GSE68066). 
 
DNA binding studies  
Electrophoretic mobility shift assays (EMSA) were used to evaluate AmrZ-DNA 
binding as previously described (Jones et al., 2014). Each EMSA reaction contained 5 nM 
[FAM]-labeled DNA. After electrophoresis, EMSA gels were imaged via a Typhoon 
scanner (GE Lifescience) with the following settings: fluorescence, PMT800, 520BP 40 
CY2 Blue FAM, 100 µm pixel size. 
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Results 
Development of a novel TM-promoting condition for easy cell harvest  
Traditionally, TM activity is measured using subsurface twitching assays, in which 
bacteria grow at the agar-Petri dish interface (J. Mattick, 2002; Turnbull & Whitchurch, 
2014). One caveat of this method is the difficulty of harvesting sufficient actively twitching 
cells for downstream high-throughput analyses, such as transcriptomics and proteomics. 
Therefore, a novel growth condition using cellophane sheets was developed taking into 
consideration previous studies describing the significance of inert smooth surfaces (most 
important) and a humid environment (Semmler et al., 1999; Mattick, 2002). It is also more 
convenient to harvest cells from the surface of cellophane sheets as opposed to the 
interstitial space between agar and Petri dishes. The design of this approach is shown in 
Figure 2.1A. Following 48-hour growth on cellophane, P. aeruginosa formed a large 
smear-like colony and we observed two distinct sub-populations of bacteria (“edge” and 
“center”; Figure 2.1A).  
In order to evaluate if the cellophane-air interface promotes TM gene expression, 
we harvested WT P. aeruginosa (strain PAO1) from both sub-populations, and measured 
transcript levels of the type IV major pilin gene pilA. We used qRT-PCR to compare pilA 
mRNA levels among four different conditions: overnight broth culture (stationary phase), 
agar surfaces (heterogeneous populations), cellophane “edge”, and cellophane “center”. 
On agar surfaces, pilA expression was significantly higher compared to broth culture 
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(Figure 2.1B), consistent with a previous study (Kuchma et al., 2012). Strikingly, bacteria 
from the “edge” sub-population on cellophane sheets exhibited 14 or 8-fold elevation of 
the pilA mRNA level compared to cells harvested directly from agar surfaces or the 
“center” sub-population, respectively (Figure 2.1B). This observation is consistent with a 
previous finding using subsurface TM assays that the edge subpopulation produced 
significantly more PilA than the center (Semmler et al., 1999). Therefore, we conclude that 
under this newly developed condition, the “edge” sub-population on cellophane surfaces 
conducts highly active TM and is an ideal subject for downstream TM studies. 
 
TM phenotypes of P. aeruginosa strains on cellophane surfaces  
On surfaces where flagella-mediated swimming motility is suppressed, TFP 
provide opportunities for bacteria to explore new territories via TM (9, 34). The subsurface 
twitching assay is a valuable tool to distinguish TM-proficient from TM-deficient P. 
aeruginosa. We therefore sought to determine whether there is a TFP-dependent phenotype 
using the new cellophane-based method. Four P. aeruginosa strains were tested, including 
two TM-proficient strains (PAO1 and the flagella mutant ΔfliC) and two TM-deficient 
strains (ΔpilA and ΔamrZ). When the subsurface twitching method was used, TM-
proficient strains exclusively formed twitching zones outside of the central colony as 
expected (Figure 2.2A). In cellophane-based assays, to discern differences between TM-
proficient and TM-deficient strains, it was necessary to use phase contrast microscopy. 
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These differences were not readily apparent by the naked eye. Microscopic examinations 
revealed any strain capable of TM (PAO1 and ΔfliC) displayed tendril-like structures at 
colony edges on cellophane sheets, which were absent in TM defective strains (ΔpilA and 
ΔamrZ) (Figure 2.2B). Notably, formation of these tendril-like structures is flagella-
independent, as the flagella mutant ΔfliC still formed tendrils similar to its parental strain 
PAO1. In conclusion, this cellophane approach can serve as a new method to identify TM-
proficient from deficient strains. 
 
Definition of the AmrZ regulon under this TM-promoting condition  
It is unknown how the transcription factor AmrZ activates P. aeruginosa TM 
(Baynham et al., 2006). We hypothesized that AmrZ activates TM by modulating the 
transcription of target TM gene(s). Therefore, we sought to apply this newly-developed 
method to understand the mechanism of AmrZ-mediated TM activation. DNA microarray 
analyses were performed to identify AmrZ-dependent targets using cells harvested from 
“edge” sub-populations of the parental strain PAO1, two isogenic amrZ mutants (ΔamrZ 
and AmrZV20A), and a complemented ΔamrZ strain. AmrZV20A harbors a V20A point 
mutation that renders the protein deficient in DNA binding, a property required for its role 
in controlling TM (P. J. Baynham et al., 2006; Waligora et al., 2010). The complemented 
ΔamrZ strain was constructed by placing the amrZ gene with its native promoter back into 
the ΔamrZ mutant at the native amrZ locus (P. J. Baynham et al., 2006). Our rationale was 
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that any gene transcriptionally regulated by AmrZ would exhibit differential expression in 
amrZ mutants including ΔamrZ and AmrZV20A (AmrZ-) compared to strains expressing 
WT amrZ (PAO1 and the complemented strain; AmrZ+). It should be noted that during 
bacterial cell harvest, although amrZ mutants do not twitch and their colony edges appeared 
distinct from TM-proficient strains, we still harvested cells from their colony edge portions. 
As shown in Figure 2.3A, the AmrZ regulon contains 112 genes.  
Multiple virulence pathways were affected by amrZ mutations (Figure 2.3B). A 
complete list of AmrZ-dependent genes is summarized in Table 2.2. We confirmed mRNA 
levels of selected targets by qRT-PCR (Figure 2.4). Key virulence pathways regulated by 
AmrZ are categorized and discussed below.  
i) Diguanylate cyclase. AmrZ inhibited the expression of the diguanylate cyclase 
(DGC)-encoding gene gcbA (PA4843, also referred to as adcA), confirming previous 
findings (Jones et al., 2014; Petrovaet al., 2014). GcbA is required for surface attachment 
and regulates flagella-mediated motility in P. fluorescens, and gcbA deletion led to reduced 
biofilms in P. aeruginosa (C. J. Jones et al., 2014; Petrova et al., 2014). Deletion of this 
DGC gene results in reduced c-di-GMP levels, which serves as a crucial second messenger 
regulating numerous processes involved in transitions between sessile and motile lifestyles 
(Hengge, 2009; C. J. Jones et al., 2014; Luo et al., 2015).  
ii) Lectins. Both lecA and lecB exhibited reduced expression in amrZ mutants. 
Galactose-specific lectin LecA and fucose-specific lectin LecB mediate P. aeruginosa 
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adhesion and cytotoxicity towards epithelial cells, as well as contribute to lung damage in 
an acute mouse infection model (Tielker et al., 2005; Chemaniet al., 2009). In addition, 
lecB was shown to be necessary for robust TM and caseinolysis (Sonawane et al., 2006). 
Since lecB was the only AmrZ-dependent gene found in our profiling studies known to be 
involved in TM, we focused on this in more detail (see below).  
iii) Pyocin. AmrZ activated pyocin genes such as pys2 and prtN. The pys2 gene 
encodes the large component of the bacteriocin pyocin 2, and exhibits DNase activity (Sano 
et al., 1993). PrtN functions as the activator for all types of pyocins (Matsui, Sano, Ishihara, 
& Shinomiya, 1993).  
iv) Rhamnolipids. AmrZ also activated rhlA expression. The rhlA gene encodes 
chain A of the rhamnosyltransferase, and is required for the synthesis of 3-(3-hy-
droxyalkanoyloxy) alkanoic acids (HAAs) and the fatty acid moiety of rhamnolipids 
(Déziel et al., 2003; Soberón-Chávezet al., 2005). The biosurfactant rhamnolipids are 
involved in multiple processes such as swarming and sliding motilities, biofilm 
detachment, and have antimicrobial activities against other bacteria (Boles et al., 2005; 
Kohler et al., 2000; Murray & Kazmierczak, 2008). 
v) Iron. Under this condition, AmrZ modulated iron metabolism via activating the 
expression of hasAp and repressing hemH. HasAp is necessary for haemoglobin uptake in 
P. aeruginosa, while the ferrochelatase HemH is the final enzyme involved in the heme 
biosynthesis pathway (Létoffé et al., 1998; Schobert and Jahn, 2002).  
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vi) Denitrification. AmrZ regulated transcription of multiple operons involved in 
denitrification. The majority of genes within nirS and nosR operons showed significantly 
reduced expression in amrZ mutants. These genes are required for anaerobic respiration 
using nitrate/nitrite as electron receptors, indicating the impact of AmrZ on denitrification. 
 
AmrZ activates lecB transcription by directly binding to its promoter  
One goal in this study was to use this novel approach to identify AmrZ-dependent 
genes necessary for TM. As discussed above, only lecB within the defined AmrZ regulon 
was reported to be necessary for TM (Sonawane et al., 2006). Therefore, we determined if 
AmrZ activates lecB transcription directly by binding to its promoter. A 5’-[6FAM]-
labeled DNA fragment containing the lecB promoter region was amplified (Figure 2.5A), 
and its binding by AmrZ was determined through the electrophoretic mobility shift assay 
(EMSA). Addition of AmrZ caused mobility retardation of this DNA fragment, suggesting 
AmrZ-DNA binding. Moreover, this retardation required a DNA binding-proficient AmrZ, 
since the DNA binding deficient protein AmrZR22A was unable to cause a shift. In this 
EMSA assay, promoter fragments from algD and algB were used as positive and negative 
controls respectively. From this, we conclude that AmrZ specifically binds to the lecB 
promoter. 
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The lecB gene is not necessary for TM in P. aeruginosa PAO1  
We hypothesized that since lecB was the only AmrZ-dependent gene known to be 
required for TM, lecB ectopic expression in the ΔamrZ mutant would restore TM. 
Therefore, we placed the lecB gene into the backbone of the arabinose-inducible vector 
pHERD20T. However, pHERD20T-lecB failed to restore TM in the ΔamrZ mutant after 
arabinose induction (Figure 2.6B).  
In P. aeruginosa strain PAK, lecB deletion led to the absence of surface pili and 
defective TM (Figure 2.6A) (Sonawane et al., 2006). Therefore, to examine the role of lecB 
in the PAO1 strain, we constructed an in-frame ΔlecB mutant, and measured its TM via the 
subsurface twitching assay. Surprisingly, the ΔlecB mutant displayed normal TM 
compared to its parental strain PAO1 (Figure 2.6B). This result was confirmed by 
microscopic observations using the cellophane-based method (Figure 2.7). 
 
Discussion 
In this study, we developed a novel cellophane-based approach for harvesting TM-
active bacterial cells. This approach provides the convenience of recovering enough cells 
for downstream studies, the validity of which was confirmed by multiple assays. We then 
applied this method to define the AmrZ regulon through DNA microarray analyses and 
discover AmrZ-dependent genes. Absence of functional AmrZ led to global changes in 
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gene expression, including the lectin-encoding gene lecB. We also revealed that lecB was 
not required for TM in P. aeruginosa strain PAO1.  
P. aeruginosa is capable of thriving under diverse environments. Adaptation into 
new environments usually requires detection of external stimuli, intracellular signal 
transduction, and corresponding responses. In this study, we showed that pilA transcript 
levels were 69 times higher when grown on cellophane sheets than in broth culture. This 
suggests that P. aeruginosa has a remarkable capability of maintaining low pilA expression 
in liquid culture, but activating it when grown on surfaces, especially smooth ones such as 
cellophane sheets. Presumably minimal pilA expression in broth culture may conserve 
resources for bacteria when TFP are not necessary. In contrast, on surfaces where TFP are 
critical for migration, pilA expression is enhanced. On cellophane sheets, cells appeared to 
differentiate into “edge” and “center” sub-populations, and the “edge” sub-population 
displayed significantly higher TM activities than “center”, similar to previous findings 
using the subsurface twitching assay (Semmler et al., 1999). Activation of P. aeruginosa 
TFP responses on surfaces involves effective surface recognition, which requires multiple 
systems, including but likely not limited to the Wsp signal transduction system, the Chp 
chemotaxis system, and PilY1 in the TFP system (Bertrand et al., 2010; Fulcher, Holliday, 
Klem, Cann, & Wolfgang, 2010; Güvener & Harwood, 2007; Luo et al., 2015; O’Connor, 
Kuwada, Huangyutitham, Wiggins, & Harwood, 2012). Surface attachment resulted in 
phosphorylation and clustering of the response regulator WspR and an increased level of 
the second messenger cAMP, leading to a rise of the c-di-GMP concentration and the 
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activation of the cAMP-binding regulator Vfr, respectively (Güvener & Harwood, 2007; 
Luo et al., 2015). Downstream effects involve elevated PilY1 expression and its secretion 
by the TFP system, serving as one plausible mechanism to explain our observation of 
increased pilA expression on surfaces versus liquid. 
Twitching motility is a well-coordinated group behavior, resulting in the formation 
of “bacterial rafts” on interstitial spaces (Semmler et al., 1999; Gloaget al., 2013). Our 
microscopic observations on cellophane sheets were consistent with those findings. 
Tendril-like structures were observed at leading edges of exclusively TM+ P. aeruginosa 
similar to those rafts described previously. It is intriguing how bacteria aggregate and 
properly arrange themselves in these rafts. The Psl exopolysaccharide fibers and 
extracellular DNA (eDNA) are two factors involved in this phenomenon. Previous studies 
observed that Psl fibers held bacteria together and linked aggregates, which were absent in 
TM-deficient strains (L. Ma et al., 2009; S. Wang, Parsek, Wozniak, & Ma, 2013). In 
another elegant study, Gloag et al. showed that DNase I treatment inhibited the formation 
of lattice-like networks formed by TFP (Gloag et al., 2013). Potential roles of Psl and DNA 
on TM under our cellophane condition require further investigation. 
With this new TM-promoting approach, we defined the AmrZ regulon through 
DNA microarray analyses. Absence of functional AmrZ led to global gene expression 
changes, and multiple pathways associated with pathogenesis were impacted. Previously 
we and others defined the AmrZ regulon via RNA-Seq of mid-log phase bacteria grown in 
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liquid culture, one in P. aeruginosa and the other one in P. fluorescens (Jones et al., 2014; 
Martínez-Graneroet al., 2014). A comparison was made between the current DNA 
microarray analysis and the previous P. aeruginosa RNA-seq study (C. J. Jones et al., 
2014). The AmrZ regulons from both studies shared multiple genes, such as the DGC-
encoding gene gcbA, and hypothetical genes PA0102, PA3235, etc. (Table 2.2). However, 
there were significant differences between these two studies. First, growth conditions were 
dissimilar in these two studies. We and others have shown that pilA expression varies 
depending on growth conditions (activated on surfaces while repressed in liquid) (Figure 
2.1B; (Kuchma et al., 2012)), and it is likely that other genes would behave differently in 
these conditions. Second, in the RNA-Seq study, the comparison was made between a 
ΔamrZ mutant and an amrZ-overexpressing strain, which mimics alginate-overproducing 
mucoid P. aeruginosa (C. J. Jones et al., 2014). However, in the current study all strains 
are in the non-mucoid PAO1 background and have significantly lower AmrZ levels, which 
may lead to distinct regulatory outcomes. 
Our DNA microarray results compared transcriptional profiles between AmrZ- and 
AmrZ+ strains. Within the four strains used, one AmrZ- strain encodes a DNA binding-
deficient variant AmrZV20A and is TM deficient, while the complemented strain re-
obtained WT AmrZ and has restored TM (Baynham et al., 2006). Thus, the comparison 
between AmrZ- and AmrZ+ strains should only reveal targets that are modulated by DNA 
binding-proficient AmrZ. It was therefore surprising that 62 genes had differential 
expression between the complemented strain and PAO1. However, the majority of these 
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genes had differential expression only slightly above the 2-fold threshold. Only 10 genes 
showed more than 3-fold difference, and the largest difference was 6.4-fold. Nevertheless, 
the possibility of unknown artifacts introduced during strain construction cannot be 
excluded. Therefore, these 62 genes have been excluded from the AmrZ regulon. 
This study discovered that both lectin-encoding genes lecA and lecB exhibited 
differential expression between AmrZ- and AmrZ+ strains. In addition, AmrZ specifically 
bound to the lecB promoter, indicating direct AmrZ activation. Interestingly, in a previous 
study when ChIP-Seq was used to determine AmrZ binding sites throughout the P. 
aeruginosa genome, AmrZ was not observed to bind to the lecB promoter (Jones et al., 
2014). This could also be attributed to different growth conditions. It is plausible that in 
broth culture and possibly other conditions, certain signals suppress AmrZ binding to the 
lecB promoter thereby preventing its transcriptional activation.  
Our original hypothesis was that AmrZ activates TM through lecB, which was 
shown to be required for TM in P. aeruginosa strain PAK. Surprisingly, our ΔlecB mutant 
in PAO1 did not show a TM defect, in contrast to the study in the PAK strain background 
(Sonawane et al., 2006). To determine if the lecB gene differs between these two strains, 
we sequenced the lecB coding and flanking sequences. There was a single nucleotide 
variation at the 48th nucleotide in the lecB coding sequence: a deoxythymidine in PAO1 
and a deoxycytidine in PAK (data not shown). However, this polymorphism does not lead 
to a change in the amino acid sequence, since both codons (ACU and ACC) encode 
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threonine. Nevertheless, it is possible that with a different genetic background the lecB 
gene in PAK might play a different role compared to our PAO1 strain. A comprehensive 
transposon mutant library was constructed in another PAO1 strain MPAO1 and screened 
to identify TM-necessary genes (Jacobs et al., 2003). This screening did not identify any 
lecB mutant that lost TM. Meanwhile, there was no overlap between tfp genes identified in 
the transposon mutant screening (Jacobs et al., 2003) and AmrZ-dependent genes in the 
current study. Therefore, the AmrZ regulon described in this study does not contain any 
known gene(s) necessary for TM. Therefore, despite our efforts, the mechanism for AmrZ-
mediated control of TM therefore remains unknown. It is a formal possibility that AmrZ 
may regulate TM at a post-transcriptional level, e.g. via small RNAs, during translation or 
through protein-protein interactions. This is less likely because of the stringent requirement 
of DNA binding-proficient AmrZ for TM. The most likely explanation therefore is that TM 
genes controlled by AmrZ have not been identified in previous genetic strategies to identify 
TM-defective strains. Our current aim is to use alternative approaches to identify these 
targets. 
Overall, this study described a novel TM-promoting approach that facilitates the 
harvest of TM-active cells for downstream transcriptomics studies. We defined the AmrZ 
regulon under this growth condition, and uncovered the role of AmrZ as a global regulator 
in P. aeruginosa. This novel approach may be applied to other bacterial species capable of 
TM and facilitate more high-throughput research aiming at understanding regulatory 
mechanisms of this unique form of motility. 
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Figure 2.1. Cellophane-air interface stimulates P. aeruginosa twitching motility.  
(A.) Illustration of the cellophane-based TM-promoting condition. (B.) Quantification of 
pilA transcript levels from indicated growth conditions via qRT-PCR. “Broth” refers to 
overnight broth culture (stationary phase). Transcript levels of pilA were normalized to 
those isolated from single colonies on agar surfaces (“agar”) with rpoD as the reference 
gene. Unpaired two-tailed student t-test was used for statistical analysis of three 
independent experiments. *: P<0.05; **: P<0.01; ***: P<0.001. 
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Figure 2.2. TM-proficient and TM-deficient strains retain their TM phenotypes on 
cellophane.  
(A.) TM measurement of four P. aeruginosa strains by subsurface twitching assays. Scale 
bar: 5 mm. (B.) Phase contrast microscopy of edge sub-populations of the same strains 
above cellophane sheets. Dashed lines illustrated tendril-like structures. Scale bar: 100 µm. 
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Figure 2.3. Identification of the AmrZ regulon from the TM-active “edge” sub-
population.  
(A.) Venn diagram of the AmrZ regulon under the TM-promoting condition. 112 genes in 
the red box were included in the AmrZ regulon as they displayed differential expression 
between both amrZ mutants (ΔamrZ and AmrZV20A) and strains encoding WT AmrZ 
(PAO1 and the complemented strain ΔamrZ/amrZ). The other three numbers indicate the 
total number of genes that exhibited distinct expression from PAO1, respectively. (B.) 
Representative virulence pathways regulated by AmrZ. Red arrows indicate activation, 
while green bars represent repression.  
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Figure 2.4. Verification of representative AmrZ-dependent genes.  
Bacteria growth conditions and RNA isolations were the same as for microarray analyses. 
Gene expression in the ΔamrZ mutant was compared to the parental strain PAO1 by qRT-
PCR. The horizontal dashed line represented normalized mRNA levels as seen in the 
parental strain PAO1. Unpaired two-tailed student t-test was used for statistical analysis of 
three independent experiments. *: P<0.05; **: P<0.01; ***: P<0.001. 
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Figure 2.5. AmrZ specifically binds to the lecB promoter.  
(A.) Design of the lecB DNA fragment used in (B.). The star represents [6FAM] used to 
label the 5’ end of the lecB fragment. The arrow indicates the lecB transcription start site. 
(B.) EMSA was used to determine AmrZ binding to the lecB promoter, the positive control 
“algD” DNA, and the negative control “algB” DNA. Black arrows point at delayed 
mobility of DNA. Two AmrZ variants (AmrZ and the DNA binding-deficient variant 
AmrZR22A) were used in the experiment. “-“: No protein added; “+”: 50 nM protein; 
“++”: 100nM protein. 
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Figure 2.6. The lecB gene is required for TM in P. aeruginosa strain PAK, but not in 
strain PAO1.  
(A.) TM of the parental strain PAK and its derivative lecB::GmR via subsurface twitching 
assays (Sonawane et al., 2006). (B.) Subsurface twitching assays of strains in PAO1 
background. In the ΔamrZ strain with the plecB plasmid, 1% arabinose was added as the 
inducer. Scale bar: 5 mm. 
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Figure 2.7. lecB is required for TM in PAK, but not in PAO1 using the cellophane-
based method.  
Phase contrast microscopy was used to examine edge subpopulations of PAO1, PAK, and 
their respective lecB mutants after growth using the cellophane-based method. Dashed 
lines and arrows illustrated tendril-like structures. 
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Table 2.1. Strains, plasmids, and oligonucleotides used in Chapter 2 
Strains /Plasmids Relevant genotype/description/sequence Sources 
Strains   
Escherichia coli   
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
New England 
Biolabs 
S17λpir pro thi hsdR+ TpR SmR; chromosome::RP4-2 
Tc::Mu-Kan::Tn7/λpir 
(Simon et al., 
1983) 
P. aeruginosa   
PAO1 strain 
background 
  
PAO1 PAO1 wild type (P. J. Baynham 
et al., 2006) 
WFPA205 ΔamrZ (P. J. Baynham 
et al., 2006) 
WFPA513 AmrZV20A  (P. J. Baynham 
et al., 2006) 
WFPA510 amrZ complemented in WFPA205 (P. J. Baynham 
et al., 2006) 
JJH283 ΔfliC J.J. Harrison 
PAO-JP3 ΔlasR&ΔrhlR (Mittal, 
Sharma, 
Chhibber, & 
Harjai, 2006) 
OSUPA239 ΔlecB This study 
OSUPA268 ΔpilA This study 
PAK strain 
background 
  
PAK PAK wild type (Sonawane et 
al., 2006) 
PAK ΔlecB PAK lecB::GmR (Sonawane et 
al., 2006) 
Plasmids   
pEX18Ap Deletion construct backbone. Cb300 (Hoang et al., 
1998) 
pBX27 PAO1 lecB deletion construct in pEX18Ap. This 
plasmid was constructed by lecB_ABCD primers 
This study 
pBX38 PAO1 pilA deletion construct in pEX18Ap. This 
plasmid was constructed by pilA_ABCD primers 
This study 
   
  Continued 
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Table 2.1. Continued  
pBX39 PAO1 amrZ deletion construct in pEX18Ap. This 
plasmid was constructed by primers amrZ122-125  
This study 
pHERD20T Arabinose-inducible vector (Qiu et al., 
2008) 
plecB (pBX14) pHERD20T-lecB. Primers lecB_CDS_F and 
lecB_CDS_R were used to amplify the lecB coding 
sequence 
This study 
pJN105 Empty vector. Cb300 (J. W. 
Hickman, 
Tifrea, & 
Harwood, 
2005) 
pJN2133 pJN105-PA2133. Cb300 (J. W. Hickman 
et al., 2005) 
Oligonucleotides   
lecB_CDS_F cgctctagaAGGCAGGCCAGGTATTCAGTG This study 
lecB_CDS_R cgcgcatgcCCATCCCGTCCCTTCCGAAC This study 
pilA_RT_F CGACGATCAACCCGCTGAAGAC   This study 
pilA_RT_R ACTTGTTGGCATCCGGCTCGA    This study 
lecA_RT_F CGTTTTGTGGTGCGCTGGTC This study 
lecA_RT_R TAGGTTCCGGGCACGTCGTT This study 
lecB_RT_F AGTGTTCACCCTTCCCGCCA This study 
lecB_RT_R GTGCTTTGCCCGCTGAAGGT This study 
pys2_RT_F GGAAGCAGAAGCCCAGCGAG This study 
pys2_RT_R TGGCGTTGGATTGGTCAGTTGAG This study 
prtN_RT_F GAACGCTGGTTTCGCAACCTG This study 
prtN_RT_R GGCGCTTCCGGCTTGGTTC This study 
rhlA_RT_F CGCTCAACGATCGGGGCTAC This study 
rhlA_RT_R CTCCACCCGCGAGAAACTGC This study 
nirS_RT_F GCGAATCGTGGAAGGTGCTG This study 
nirS_RT_R TGACCTTGACGATCTTCTTGCTG This study 
norC_RT_F CCTGACCTACCACACCGAGAAG This study 
norC_RT_R GCAGCCGACGCAGTTGTTC This study 
hemH_RT_F CGAGAACAGCCGCAACGTCA This study 
hemH_RT_R GCGACTGGAACGACACCGAC This study 
hasAp_RT_F GACAGCCAGGAGGTGAGCTTC This study 
hasAp_RT_R CGTCGATCTGCCCCTGCAG This study 
rpoD_RT_F GCCGAGCTGTTCATGCCGAT    (C. J. Jones et 
al., 2014) 
rpoD_RT_R GAACAGGCGCAGGAAGTCGG   (C. J. Jones et 
al., 2014) 
lecB_A cccctctagaTTGATCGGGAGTCATAGGGTAC This study 
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Table 2.1. Continued  
lecB_B GTCCCTTCCGAACTCCTAGCGTTGCCATGG
TGTATCTCCACT 
This study 
lecB_C AGTGGAGATACACCATGGCAACGCTAGGA
GTTCGGAAGGGAC 
This study 
lecB_D ccgaagcttGGAGGTGGCGGTGATCAAC This study 
pilA_A tgctctagaGCTTTTCGCTGATGGCGTC This study 
pilA_B AACAAGCCACCTTCGATCACCGAATCTCTC
CGTTGATTATGTA 
This study 
pilA_C TACATAATCAACGGAGAGATTCGGTGATCG
AAGGTGGCTTGTT 
This study 
pilA_D aactgcagCGCATAGCACCCGGCAAG This study 
amrZ122 tgctctagaGGAGCGTGGATTTGCCGGAG This study 
amrZ123 TACGCGTGGGCTTCGGCGCACATTGAACCT
GTAGAGTCAGG 
This study 
amrZ124 CCTGACTCTACAGGTTCAATGTGCGCCGAA
GCCCACGCGTA 
This study 
amrZ125 cccaagcttCCACAGATACAGGTAGGCGATC This study 
lecB_EMSA_F [6FAM]CGGCATCGGCAATAGATCGTTAC This study 
lecB_EMSA_R GAACCGGGTGTTGGCGGGAAG This study 
algB68 [6FAM]CGCATGCCAGCCTTTCTGA This study 
algB69 TTCACTGCCATTCGGCTTCTG This study 
algD71 [6FAM]ACCGTTCGTCTGCAAGTCATG This study 
algD73 ACCAACTTGATGGCCTTTCCG This study 
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Table 2.2. Complete gene list from microarray analyses 
ID Fold change 
(mutant/WT) 
Adj.P.Val Notes 
PA0045_at 2.285 0.011 Hypothetical lipoprotein. Homolog of 
CsgG.  
PA0067_prlC_at 2.002 0.011 75% similarity to oligopeptidase A. 
PA0102_at 0.457 0.015 Probable carbonic anhydrase 
PA0129_gabP_at 2.603 0.001 bauD. Amino acid permease  
PA0130_at 2.098 0.008 bauC. 3-Oxopropanoate dehydrogenase  
PA0167_at 2.379 0.003 Bacterial regulatory proteins, tetR family 
signature 
PA0296_s_at 2.240 0.003 spuI/pauA1. Glutamyl polyamine 
synthetase  
PA0298_at 2.356 0.004 spuB/pauA2. Glutamyl polyamine 
synthetase  
PA0509_nirN_at 0.290 0.007 Gene involved in denitrification processes 
PA0510_at 0.237 0.002 Gene involved in denitrification processes 
PA0511_nirJ_at 0.171 0.006 Gene involved in denitrification processes 
PA0512_at 0.392 0.002 Gene involved in denitrification processes 
PA0513_at 0.218 0.003 Gene involved in denitrification processes 
PA0514_nirL_at 0.170 0.007 Gene involved in denitrification processes 
PA0515_at 0.112 0.010 Gene involved in denitrification processes 
PA0516_nirF_at 0.177 0.003 Gene involved in denitrification processes 
PA0517_nirC_at 0.113 0.013 Gene involved in denitrification processes 
PA0518_nirM_at 0.083 0.011 Gene involved in denitrification processes 
PA0519_nirS_at 0.075 0.012 Gene involved in denitrification processes 
PA0534_at 2.026 0.003 pauB1.  FAD-dependent oxidoreductase  
PA0610_prtN_at 0.450 0.003 Transcriptional regulator PrtN. Pyocin 
activator 
PA0612_i_at 0.432 0.008 prtB. DnaK suppressor protein  
PA0614_at 0.282 0.002 Hypothetical protein. Transmembrane 
protein 
PA0617_at 0.362 0.002 Phage protein 
PA0618_at 0.392 0.002 Phage protein 
PA0620_at 0.373 0.001 Phage protein 
PA0622_at 0.368 0.001 Phage protein 
PA0639_at 0.378 0.002 Phage protein 
PA0643_at 0.384 0.001 Phage protein 
   Continued 
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Table 2.2. Continued   
PA0743_at 0.427 0.016 Probable 3-hydroxyisobutyrate 
dehydrogenase 
PA0866_aroP2_at 3.862 0.002 Aromatic amino acid transport protein 
AroP2 
PA0887_acsA_at 2.997 0.004 acsA. Acetyl-coenzyme A synthetase  
PA0911_at 0.374 0.002 Hypothetical protein. 
PA1070_braG_at 2.022 0.007 Branched-chain amino acid transport 
protein BraG 
PA1072_braE_at 2.285 0.007 Branched-chain amino acid transport 
protein BraE 
PA1150_pys2_at 0.415 0.001 pys2. Pyocin S2  
PA1338_ggt_at 2.539 0.012 ggt. Gamma-glutamyl transpeptidase 
precursor. Amino acid biosynthesis and 
metabolism 
PA1494_at 0.346 0.001 Conserved hypothetical protein. Contains 
type I secretion signal. 
PA1545_at 0.423 0.002 Hypothetical protein 
PA1732_at 0.314 0.004 Conserved hypothetical protein. May be 
involved in amino acid transport and 
metabolism 
PA1736_at 0.480 0.009 Probable acyl-CoA thiolase 
PA1737_at 0.494 0.011 Probable 3-hydroxyacyl-CoA 
dehydrogenase 
PA1757_thrH_at 3.010 0.001 Homoserine kinase 
PA1818_at 2.749 0.002 ldcA. Lysine-specific pyridoxal 5'-
phosphate-dependent carboxylase, LdcA  
PA1978_at 2.245 0.004 Response regulator ErbR. Involved in 
ethanol oxidation pathway. 
PA1983_exaB_at 2.336 0.006 Cytochrome c550 
PA2015_at 2.186 0.005 liuA. Putative isovaleryl-CoA 
dehydrogenase  
PA2080_at 2.025 0.003 kynU. Kynureninase KynU. 
PA2081_at 2.326 0.007 Kynurenine formamidase, KynB 
PA2134_at 0.150 0.002 Hypothetical protein. Contains type I 
secretion signal. 
PA2146_i_at 0.100 0.001 Conserved hypothetical protein 
PA2169_at 0.341 0.016 Hypothetical protein 
PA2174_at 0.266 0.002 Hypothetical protein 
PA2190_at 0.171 0.002 Conserved  hypothetical protein 
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Table 2.2. Continued   
PA2204_at 2.534 0.004 Probable binding protein component of 
ABC transporter. Periplasmic protein 
PA2329_at 2.660 0.001 Probable ATP-binding component of ABC 
transporter. Cytoplasmic membrane 
PA2445_gcvP2_at 2.094 0.002 gcvP2. Glycine cleavage system protein 
P2  
PA2446_gcvH2_a
t 
3.290 0.001 Glycine cleavage system protein H2 
PA2531_at 0.312 0.001 Probable aminotransferase 
PA2570_pa1L_at 0.122 0.008 lecA 
PA2711_at 2.053 0.008 Probable periplasmic 
spermidine/putrescine-binding protein 
PA2788_at 0.408 0.013 Probable chemotaxis transducer 
PA2843_at 2.781 0.009 Probable aldolase 
PA2862_lipA_at 2.619 0.040 Lactonizing lipase precursor 
PA2937_at 0.286 0.002 Hypothetical protein 
PA2945_at 2.557 0.001 Conserved hypothetical protein 
PA2946_at 2.542 0.002 Hypothetical protein 
PA3032_at 0.394 0.004 Cytochrome c Snr1 
PA3234_at 2.209 0.021 Probable sodium: solute symporter 
PA3235_at 2.304 0.023 Conserved hypothetical protein 
PA3284_at 0.483 0.004 Hypothetical protein 
PA3356_at 2.086 0.003 Glutamyl polyamine synthetase PauA5 
PA3361_at 0.198 0.003 lecB. Fucose-binding lectin PA-IIL. (lecB 
is required for TFP biogenesis)  
PA3365_at 2.176 0.013 Probable chaperone 
PA3393_nosD_at 0.376 0.004 Denitrification gene 
PA3394_nosF_at 0.281 0.006 Denitrification gene 
PA3396_nosL_at 0.450 0.007 Denitrification gene 
PA3407_hasAp_at 0.430 0.010 Heme acquisition protein HasAp 
PA3415_at 0.327 0.009 Probable dihydrolipoamide 
acetyltransferase 
PA3416_at 0.302 0.011 Probable pyruvate dehydrogenase E1 
component, beta chain 
PA3417_at 0.314 0.009 Probable pyruvate dehydrogenase E1 
component, alpha subunit 
PA3479_rhlA_at 0.221 0.009 rhlA  
PA3520_at 0.165 0.002 Hypothetical protein 
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Table 2.2. Continued   
PA3539_at 2.603 0.023 Conserved hypothetical protein 
PA3836_at 2.122 0.002 hypothetical protein 
PA3837_at 2.767 0.001 Probable permease of ABC transporter 
PA3872_narI_at 0.270 0.048 Respiratory nitrate reductase gamma 
chain. narI 
PA3920_at 0.396 0.019 Probable metal transporting P-type 
ATPase 
PA3923_at 2.559 0.021 Hypothetical protein 
PA4033_at 4.045 0.002 MucE 
PA4129_at 2.275 0.021 Hypothetical protein 
PA4130_at 2.359 0.003 Probable sulfite or nitrite reductase 
PA4182_at 2.427 0.001 Hypothetical protein 
PA4211_g_at 0.386 0.036 phzB1. Probable phenazine biosynthesis 
protein  
PA4294_at 0.479 0.004 Hypothetical protein 
PA4442_cysN_at 2.277 0.006 ATP sulfurylase GTP-binding 
subunit/APS kinase 
PA4443_cysD_at 2.190 0.016 ATP sulfurylase small subunit 
PA4448_hisD_at 2.047 0.016 Histidinol dehydrogenase 
PA4655_hemH_at 2.467 0.007 hemH.  Ferrochelatase. 
PA4675_at 2.223 0.002 Probable TonB-dependent receptor 
PA4703_at 0.293 0.011 Hypothetical protein 
PA4843_at 3.993 0.004 Probable two-component response 
regulator 
PA5098_hutH_at 2.168 0.019 Histidine ammonia-lyase 
PA5100_hutU_at 2.583 0.002 Urocanase 
PA5131_pgm_at 2.033 0.010 Phosphoglycerate mutase 
PA5154_at 2.252 0.002 Probable permease of ABC transporter 
PA5168_at 2.367 0.005 DctQ 
PA5169_at 2.990 0.002 DctM 
PA5312_at 2.099 0.004 PauC.  Aldehyde dehydrogenase  
PA5313_at 2.358 0.007 gabT2. Transaminase 
PA5429_aspA_at 2.256 0.010 Aspartate ammonia-lyase 
PA5519_at 2.387 0.020 Conserved hypothetical protein 
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Chapter 3  
 
 
Chapter 3. The Pseudomonas aeruginosa AmrZ C-terminal domain mediates 
tetramerization and is required for its activator and repressor functions 
 
Abstract 
Pseudomonas aeruginosa is an important bacterial opportunistic pathogen, 
presenting a significant threat towards individuals with underlying diseases such as cystic 
fibrosis. The transcription factor AmrZ regulates expression of multiple P. aeruginosa 
virulence factors. AmrZ belongs to the ribbon-helix-helix protein superfamily, in which 
many members function as dimers, yet others form higher-order oligomers. In this study, 
four independent approaches were undertaken and demonstrated that the primary AmrZ 
form in solution is tetrameric. Deletion of the AmrZ C-terminal domain leads to loss of 
tetramerization and reduced DNA binding affinity to both activated and repressed target 
promoters. Additionally, transcriptional fusion experiments showed that the C-terminal 
domain is essential for AmrZ-mediated activation of the alginate biosynthesis operon. 
Repression of gcbA by AmrZ is also compromised upon removal of the C-terminal domain. 
To summarize, this study identified that the AmrZ C-terminal domain mediates 
  
75 
 
tetramerization, and AmrZ tetramers comprised of DNA binding-proficient monomers are 
necessary for efficient activation and repression of AmrZ-dependent genes. 
 
Introduction 
The Gram-negative bacterium Pseudomonas aeruginosa is ubiquitous. It can be 
widely found in fresh water and soil, and as an opportunistic pathogen, also imposes a 
threat to immunocompromised human populations. As an example, emergence of this 
bacterium is considered poor prognosis in lung infections for cystic fibrosis patients 
(Govan & Deretic, 1996). P. aeruginosa versatility is achieved by rapidly adapting to new 
environments, in which multiple levels of regulation are involved. A large pool of 
transcription factors participate in this regulation, and one such factor AmrZ (Alginate and 
Motility Regulator Z) functions as a global activator and repressor. Well-studied AmrZ 
targets include those involved in exopolysaccharide production (alginate, Psl and Pel), 
flagella, twitching motility, and the metabolism of the second messenger bis-(3’, 5’) cyclic 
di-guanylate (c-di-GMP) (P. J. Baynham et al., 2006; P. J. Baynham & Wozniak, 1996; C. 
J. Jones et al., 2014, 2013; Martínez-Granero et al., 2014; Ramsey et al., 2005; Tart et al., 
2006). For instance, AmrZ is necessary for transcription of the alginate biosynthesis 
operon, the promoter of which is designated as PalgD since algD is the first gene of this 
operon. Alginate is responsible for the mucoid phenotype and contributes to increased 
resistance to antimicrobials and host immunity (P. Baynham et al., 1999; Gacesa, 1998; 
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Ramsey & Wozniak, 2005). AmrZ also represses transcription of gcbA (also referred to as 
adcA), which encodes a diguanylate cyclase enzyme that synthesizes c-di-GMP (Jones et 
al., 2014; Petrova et al., 2014). Deletion of gcbA results in increased motility and reduced 
biofilm production (C. J. Jones et al., 2014; Petrova et al., 2014). The ΔamrZ mutant 
displays increased levels of Psl and c-di-GMP, and therefore forms enhanced biofilms 
compared to the wild type strain (C. J. Jones et al., 2014, 2013).  
AmrZ is composed of three segments: a flexible N terminus (residues 1-11), a 
ribbon-helix-helix domain (residues 12-66), and a C-terminal domain (CTD, residues 67-
108). The ribbon-helix-helix domain mediates DNA binding and its structure is highly 
similar to other members, such as Arc, Mnt and MetJ, in the Arc superfamily (Knight et 
al., 1989; Schreiter & Drennan, 2007; Vershons et al., 1985; Waligora et al., 2010). All 
proteins within this superfamily form dimers or higher order oligomers, which are often 
necessary for their functions (Schreiter & Drennan, 2007; Waldburger & Sauer, 1995). In 
our previous studies, glutaraldehyde cross-linking experiments suggested that cross-linked 
AmrZ forms oligomers independent of its N terminus (Waligora et al., 2010). However, it 
remains unknown which AmrZ domain(s) mediates oligomerization, or what roles this may 
play during AmrZ-mediated activation or repression.  
In this study, size exclusion chromatography (SEC) revealed that AmrZ exists 
primarily as tetramers in solution under the physiological ionic strength (150 mM NaCl). 
This result was confirmed by nano electrospray ionization mass spectrometry (nano-ESI 
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MS). Additionally, as expected with proteins that function as oligomers, a DNA binding-
deficient variant AmrZR22A, when overproduced, exhibits a dominant-negative effect on 
expression of AmrZ-dependent genes. We showed that the AmrZ CTD is responsible for 
oligomerization, and loss of the domain leads to reduced DNA binding affinity as well as 
diminished ability of AmrZ to mediate activation and repression. 
Taken together, our findings have unveiled that the primary form of AmrZ is 
tetrameric. Moreover, we highlight the significance of the AmrZ CTD during AmrZ-
mediated regulation of multiple target genes.  
 
Materials and Methods 
Bacterial strains, plasmids, oligonucleotides, and culture conditions 
All bacterial strains, plasmids, and DNA oligonucleotides are listed in Table 3.1. 
Strains of Escherichia coli and Pseudomonas aeruginosa were incubated as previously 
described (Jones et al., 2013). All E. coli strains were cultured in LB (1 liter LB contains 
10 g tryptone, 5 g yeast extract, 5 g sodium chloride) or on LA (LB with 1.5% (w/v) agar). 
If necessary, 100 µg*ml-1 ampicillin or 15 µg*ml-1 tetracycline was used to maintain 
plasmids in E. coli. All P. aeruginosa strains were cultured in LBNS or on LANS (LB or 
LA without sodium chloride). For P. aeruginosa cultures, 300 µg*ml-1 carbenecillin or 100 
µg*ml-1 tetracycline was used when needed. All strains were grown at 37°C unless stated 
otherwise. All oligonucleotides were ordered desalted from Sigma Aldrich.  
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Size exclusion chromatography  
A 29.4 nmol aliquot of purified AmrZ was loaded onto a Superose 12 10/300 GL 
gel filtration column equilibrated and eluted in the same protein buffer (100 mM Bis-Tris 
pH 6.5, 150 mM NaCl, 5% glycerol) (Pryor et al., 2012). Gel filtration standards (Bio-Rad, 
#151-1901) were used to generate a standard curve describing the relationship between 
retention time and protein molecular weights for this column. The protein extinction 
coefficient of AmrZ WT was calculated as 1490 M-1*cm-1 by the ExPASy ProtParam tool 
(Artimo et al., 2012).  
 
Mass Spectrometry  
Purified proteins (native AmrZ or AmrZ1-66, monomeric concentrations at 147 µM 
and 150 µM respectively) were buffer exchanged into 500 mM ammonium acetate by a 
size exclusion spin column (Micro Bio-Spin 6, Bio-Rad, Hercules, CA). Proteins were 
charge reduced by mixing 100 mM triethylammonium acetate (Sigma, Milwaukee, WI) 
with protein solutions (in 500 mM ammonium acetate) to 20% by mole. Nano-electrospray 
ionization mass spectrometry was used to analyze protein solutions on a Synapt G2S 
instrument (Waters MS Technologies, Manchester, U.K.). The quadrupole profile was set 
to 2500 for AmrZ to minimize low m/z of impurities and salts after charge reduction. The 
glass capillary was pulled in-house using a Sutter Instrument (Novato, CA) P-97 
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micropipette puller and a platinum wire was inserted into the capillary to apply a voltage 
of 1.0~1.2 kV. The cone voltage was kept at 20 V and the source temperature at 25°C to 
minimize in source activation and denaturation of proteins. 
 
DNA binding studies 
We used EMSAs (electrophoretic mobility shift assays) modified from a previously 
described protocol (Jones et al., 2014) to study DNA-protein interactions. 5’-[6FAM] 
labeled DNA used for EMSA was amplified using Quick-load® Taq 2X Mastermix (New 
England Biolabs), [6FAM]-labeled forward primers and non-labeled reverse primers, and 
PAO1 genomic DNA as the template. Each EMSA reaction contained 20 mM Bis-Tris pH 
6.5, 4 mM MgCl2, 200 µg*ml-1 acetylated BSA, 130 mM NaCl, 1 mM DTT, 5% glycerol, 
150 ng*µl-1 Poly d[(I-C)] (Roche), 10 nM [6FAM] labeled DNA, and a specified 
concentration of purified AmrZ or AmrZ1-66. Protein-DNA binding was equilibrated at 
room temperature (25°C) for 20 min after adding all reagents to each reaction. 10 µl of 
each reaction was loaded onto a cold pre-equilibrated 4% non-denaturing acrylamide gel. 
Electrophoresis was conducted for 25 min at 200 V in 0.5% TBE on ice. A Typhoon 
scanner (GE Lifescience) (Settings: fluorescence, PMT800, 520BP 40 CY2 Blue FAM, 
100 µm pixel size) was used to detect FAM fluorescence of gels. DNA fragments used 
were amplified using following primers – algD: algD71 + algD73; non-specific control: 
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algD111 + algD112; gcbA: adcA_FAM_F_EMSA + adcA_R_EMSA (C. J. Jones et al., 
2014). 
 
Transcriptional reporter assays  
All transcriptional reporters were constructed in the mini-CTX-lacZ plasmid 
(Becher & Schweizer, 2000). After digestion by HindIII and BamHI (New England 
Biolabs), the algD promoter (PalgD) (-633 - +368 relative to its transcriptional start site) 
was cloned into mini-CTX-lacZ using primers algD65 and algD66. Transcriptional 
reporters were then transferred and integrated into the chromosomes of the mucoid P. 
aeruginosa strain FRD1 and its isogenic ΔamrZ mutant FRD1200 as previously described 
(Wyckoff & Wozniak, 2001). A 96-well plate reader (Molecular Devices SpectraMax M2) 
was used to measure absorbance at 420 nm and 550 nm, and β-galactosidase activities were 
determined as previously described (J. H. Miller, 1992). 
 
Quantitative real-time PCR 
Transcript levels of genes of interest were measured through quantitative real-time 
PCR (qRT-PCR) assays. To isolate total RNA, overnight LANS-grown bacteria were 
harvested after flooding with LBNS. 1 ml OD600=1.0 bacteria were lysed by addition of 
100 µl TE containing 1 mg*ml-1 RNase-free lysozyme (Sigma Aldrich), and then 
underwent RNA isolation (RNeasy RNA isolation kit, Qiagen). To obtain cDNA, ~1 µg 
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RNA was used for reverse transcription (Superscript III cDNA preparation kit, Invitrogen) 
following manufacturer protocols. Amounts of cDNA were determined by SYBR Green 
Mix (Bio-Rad) and CFX1000 thermal cyclers (Bio-Rad). Gene expression was normalized 
to that of the housekeeping gene rpoD, and the ΔΔCt method was used to calculate relative 
gene expression (Livak and Schmittgen, 2001; Jones et al., 2014).  
 
Protein cross-linking experiments 
Cross-linking by glutaraldehyde was performed as previously described (Waligora 
et al., 2010). Briefly, purified AmrZ was incubated with 0.1 M glutaraldehyde for 5 min. 
Reactions were reduced by an equimolar concentration of sodium borohydride, chilled, and 
neutralized by 167 mM Tris-HCl (pH 8.0). Samples were resolved by 12% SDS-PAGE 
and stained with Coomassie Brilliant Blue. 
 
Western blot analyses 
AmrZ and His-tagged protein levels were measured by Western blot. After growing 
to exponential phases in the presence/absence of arabinose/Carbenecillin, bacteria 
equivalent to 150 µl OD600=1.0 were resuspended by 75 µl SDS-PAGE sample buffer 
(100 mM Tris-HCl pH=6.8, 0.04% sodium dodecyl sulfate, 3.6% glycerol, 2% 2-
mercaptoethanol, 0.008% Bromophenol Blue), and lysed at 100°C for 5 min. After cooling 
down to room temperature, cell debris was removed by centrifugation at top speed for 1 
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min. 30 µl cell lysates were loaded into 15% Criterion™ (Bio-Rad) Tris-glycine SDS-
PAGE gels. Proteins were transferred onto nitrocellulose membranes via a semi-dry 
transfer system (Bio-Rad), and detected by the rabbit anti-AmrZ polyclonal antibody 
(1:5,000) or the mouse anti-His tag monoclonal antibody (1:2,000, Thermo Scientific, 
Product #: MA1-21315). After secondary antibody was applied, membranes were imaged 
by the Clarity™ Western ECL Blotting Substrate (Bio-Rad) and ChemicDoc (Bio-Rad). 
 
Subsurface twitching motility assays  
Subsurface twitching assays were conducted as previously described (Baynham et 
al., 2006). In brief, a single bacterial colony was resuspended in 400 µl LBNS, and a P10 
tip dipped into the resuspension was stabbed into 1% LANS with antibiotics and/or 
arabinose if necessary. Plates (at minimum triplicates for each strain) were then incubated 
at room temperature in a humid chamber for five days. Twitching zones were imaged 
through white epiluminescence by ChemicDoc (Bio-Rad). The twitching motility activity 
for each strain was represented by the ratio of the twitching zone diameter divided by that 
of the central colony. 
 
 
 
  
83 
 
Results 
AmrZ forms tetramers in solution via its C-terminal domain  
In the Arc protein superfamily, the basic functional unit is dimeric; however, 
proteins such as Mnt and TrwA form tetramers in solution and even higher-order oligomers 
when bound to DNA (Schreiter & Drennan, 2007). To determine the AmrZ oligomeric 
state in solution, we performed SEC of purified AmrZ at the physiological ionic strength 
(150 mM NaCl). SEC is widely used for protein purification and molecular weight 
measurements of proteins/protein complexes without the need of changing protein buffers 
(Berek, 2010). AmrZ eluted as one major species with a molecular weight of approximately 
51.76 kDa, which is consistent with a slightly non-globular tetramer (49.36 kDa) (Figure 
3.1A&B). Additionally, nano-ESI MS was used to determine the AmrZ oligomeric state. 
This MS method is powerful due to its small sample requirement and measurement when 
proteins/protein complexes remain folded (Karas, Bahr, & Dülcks, 2000; X. Ma et al., 
2014). Nano-ESI MS showed that the majority of AmrZ exists as native tetramers, yet some 
dimers were also detected (Figure 3.2B). Collectively, results from both assays suggest that 
the primary form of AmrZ in solution is tetrameric. We also used nano-ESI MS to 
determine the stoichiometry when AmrZ binds to its DNA target amrZ1 from the amrZ 
promoter (Pryor et al., 2012). We observed a complex with the size of ~64000 Da (Figure 
3.3), corresponding to a DNA molecule bound by four AmrZ monomers. This is consistent 
with previous studies (Pryor et al., 2012). 
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We next determined which part of AmrZ mediates oligomerization. AmrZ is 
comprised of three segments. Previous work showed that removal of N-terminal residues 
1-11 does not prevent AmrZ oligomerization, and the ribbon-helix-helix domain (residues 
12-66) is responsible for DNA binding and dimerization (Figure 3.2A) (Pryor et al., 2012; 
Waligora et al., 2010). Specifically, AmrZ1-66 was used in determining the crystal 
structure of DNA-bound AmrZ, and this truncation variant interacts with the same DNA 
sequence as a dimer of dimers (Pryor et al., 2012). Therefore, the AmrZ CTD does not 
appear to affect DNA recognition and we hypothesized that the AmrZ CTD mediates 
tetramerization. To test this, we determined the oligomeric state of purified AmrZ in the 
absence of the CTD (AmrZ1-66). Nano-ESI MS of this truncated protein revealed that 
AmrZ1-66 exists as dimers and monomers, but no tetramer was observed (Figure 3.2C). 
This is consistent with data obtained from protein cross-linking experiments with full 
length and CTD-truncated AmrZ (Figure 3.4). Based on the results above, we conclude 
that the AmrZ CTD mediates tetramerization in solution.  
A genetic method was also used to indirectly probe the AmrZ oligomeric state. In 
most biological systems that require protein oligomers for function, expression of 
dysfunctional subunit(s) in complexes with wild type (WT) ones can exert a negative effect 
on the function of the entire protein complex (i.e. dominant negative). We therefore 
determined the effects of overproducing a DNA binding-deficient variant (AmrZR22A) in 
wild type P. aeruginosa. AmrZR22A harbors a point mutation at the 22nd residue (arginine 
to alanine), leading to loss of DNA binding affinity and subsequent effects on AmrZ-
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dependent gene expression (Waligora et al., 2010). However, AmrZR22A still forms 
tetramers as revealed by nano ESI-MS (Figure 3.5). Plasmids containing amrZ genes 
encoding different AmrZ variants (AmrZ WT or AmrZR22A) were transferred into the 
FRD1 strain carrying a chromosomal algD-lacZ transcriptional fusion (note, this strain 
harbors a chromosomal WT amrZ allele), and PalgD activities were measured after 
induction by various arabinose concentrations. The algD gene is the first gene in the 
alginate biosynthesis operon, and previously we showed transcriptional activation of this 
operon requires AmrZ (P. J. Baynham & Wozniak, 1996). Western blot analyses suggested 
that AmrZ and AmrZR22A were induced by arabinose at comparative levels (Figure 3.6). 
The empty vector pHERD20T did not affect algD transcription (Figure 3.7B), while 
overproduction of plasmid-borne AmrZ elevated PalgD activation (Figure 3.7B), likely 
due to gene dosage. However, the PalgD activity was reduced significantly when 
AmrZR22A was overproduced (Figure 3.7B), suggesting a dominant negative effect of 
AmrZR22A.  
 
Impact of the AmrZ C-terminal domain on DNA binding, activation and repression 
 We next sought to determine effects of removing the AmrZ CTD on DNA binding 
affinity. Purified AmrZ and AmrZ1-66 proteins were tested for DNA binding affinity to 
promoters of AmrZ targets. A [6FAM]-labeled DNA fragment containing the AmrZ 
binding site (ZBS) was amplified from its activated target PalgD (P. J. Baynham & 
Wozniak, 1996), and the AmrZ binding affinity determined by EMSA (Figure 3.8A). 
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Results showed that AmrZ1-66 has significantly reduced affinity to PalgD compared to 
full length AmrZ (Figure 3.8B&C). However, the CTD is not absolutely necessary for 
DNA binding, since DNA binding activities were seen when higher AmrZ1-66 
concentrations were used (Figure 3.8B&C). Both AmrZ and AmrZ1-66 recognize the DNA 
target specifically, as no binding was seen when a non-specific DNA was tested in this 
assay (Figure 3.8D). Similar results were observed when the repressed target PgcbA (Jones 
et al., 2014) was used (Figure 3.9), indicating this reduced DNA binding affinity of 
AmrZ1-66 is likely to be conserved for different AmrZ targets. 
To test roles of the AmrZ CTD in vivo, arabinose-inducible plasmids encoding 
either AmrZ or AmrZ1-66 were transferred into a P. aeruginosa FRD1 ΔamrZ strain that 
contained a chromosome-borne algD-lacZ transcriptional fusion. PalgD activities were 
measured after AmrZ or AmrZ1-66 production was induced by addition of arabinose. 
PalgD activation required a significantly higher amount of AmrZ1-66 compared to full 
length AmrZ (Figure 3.10). For instance, substantially more arabinose was needed to 
restore 15% PalgD activity for pHERD20T-AmrZ1-66 (pAmrZ1-66) (0.5% arabinose) 
compared to pAmrZWT (0.1% arabinose). We also measured AmrZ amounts after 0.1% 
arabinose induction, which showed that the intracellular level of AmrZ1-66 was 53% of 
that of AmrZ after taking into account reduced antibody recognition in the absence of the 
CTD (Figure 3.11). We therefore conclude that the observed reduction in PalgD activation 
by AmrZ1-66 is likely to be contributed by both decreased protein levels and reduced DNA 
binding affinity. In this transcriptional fusion assay, an empty vector (pHERD20T) was 
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introduced into the FRD1 ΔamrZ strain as a negative control, and no PalgD activity was 
seen at any arabinose concentration (Figure 3.10). 
Finally, we sought to investigate the significance of the AmrZ CTD in the type 
strain PAO1. In a previous study, we showed that AmrZ activates PA2146 transcription 
and represses gcbA transcription (Jones et al., 2014; Petrova et al., 2014). The hypothetical 
gene PA2146 is 92% similar to Escherichia. coli yciG, which is associated with bacterial 
responses to glucose pulses (Sunya, Gorret, Delvigne, Uribelarrea, & Molina-Jouve, 2012). 
Moreover, PA2146 expression is repressed when P. aeruginosa is treated with inhibitory 
compounds such as protoanemonin and azithromycin (25, 26). We compared the ability of 
AmrZ1-66 and full length AmrZ to regulate these two targets. In the PAO1 ΔamrZ strain 
with plasmids containing AmrZ or AmrZ1-66, mRNA levels of PA2146 and gcbA were 
quantified at various arabinose concentrations. Consistent with findings in RNA-Seq (C. J. 
Jones et al., 2014), gcbA transcription remained de-repressed in the PAO1 ΔamrZ strain 
when the empty vector pHERD20T was introduced. However, even at 0% arabinose, 
pHERD20T-WT AmrZ (pAmrZWT) was sufficient to restore AmrZ-mediated repression 
of gcbA, while regulation by AmrZ1-66 was not observed until 0.1% arabinose was used 
(Figure 3.12A). Similar results were observed with the activated target PA2146, as it 
required a much higher amount of AmrZ1-66 for transcription compared to full length 
AmrZ (Figure 3.12B).  
Our prior studies in the type strain PAO1 also revealed a role for AmrZ in activation 
of type IV-fimbriae dependent twitching motility (Baynham et al., 2006). Although the 
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mechanism of AmrZ-mediated activation of twitching motility (TM) has yet been 
identified, the AmrZ CTD remains important during activation of this behavior (Table 3.2).   
With all data above, we conclude that AmrZ tetramerization through the CTD is 
essential for efficient activation and repression of AmrZ-dependent targets. 
 
Discussion 
In this study, we found that AmrZ exists primarily as tetramers in solution. In 
addition, the AmrZ CTD is responsible for tetramerization and necessary for efficient 
transcriptional regulation of activated and repressed targets of AmrZ. 
Protein-protein interactions are prevalent throughout biological systems and are 
critical for flexible and rapid regulation of biological functions (Matthews et al., 2012). A 
common example of protein-protein interactions is homo- or hetero- 
dimerization/oligomerization. In fact, monomers are likely to be the minority form of 
proteins. For example, in the Brenda enzyme database (http://www.brenda-enzymes.org, 
as of April 2015), when searched through the “subunits” field, enzymes known as 
“monomer” only comprise ~15% of the total (1769/11964). Oligomerization not only 
provides an economic way to form large complexes, but also enables proteins, such as 
transcription factors, to flexibly modulate their DNA binding specificity and affinity. 
Differential sequence specificity can be achieved through oligomerization of different 
combinations of transcription factors (Matthews et al., 2012). In some circumstances 
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oligomerization significantly enhances DNA binding affinity. For example, the λ repressor 
CTD is responsible for high affinity binding to its operator sites in the phage genome (Bell, 
Frescura, Hochschild, & Lewis, 2000). In the present study, we provide evidence that after 
removing the CTD, AmrZ loses the ability to form tetramers and exhibits reduced DNA 
binding affinity to both activated and repressed targets, suggesting the significance of the 
CTD during AmrZ-mediated regulation. Although it is clear that this domain mediates 
tetramerization, further investigations are required to determine if it has other functions. 
Members in the Arc protein family represent diverse DNA binding proteins in various 
phage and bacterial species, and some also contain CTDs. CTDs in proteins such as Mnt 
and TrwA mediate tetramerization (Madl et al., 2006; Moncalián & De La Cruz, 2004; 
Waldburger & Sauer, 1995), while at least two members (NikR and MetJ) exhibit 
significantly higher DNA binding activities when their CTDs are bound by ligands (nickel 
and S-adenosylmethionine, respectively) (Peter T. Chivers & Sauer, 2002; Rafferty et al., 
1989). To determine if the sequence of the AmrZ CTD is similar to its homologs within 
the Arc protein superfamily, ClustalW2 alignment was performed between AmrZ with 
other Arc family members including Mnt, TrwA, NikR and MetJ (W. Li et al., 2015). 
However, no significant similarity was observed (Figure 3.13) and AmrZ does not appear 
to harbor motifs required for ligand (nickel and S-adenosylmethionine) binding. While our 
current data support the requirement of the AmrZ CTD for tetramerization, with effects on 
DNA binding and subsequent gene expression, we cannot exclude a role of the CTD in 
other functions, such as ligand binding. 
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A number of biophysical, biochemical and genetic methods have been developed 
to study protein oligomerization. In this study we used four independent approaches 
(glutaraldehyde cross-linking, SEC, nano-ESI MS, and genetics) to demonstrate the 
oligomeric state of native AmrZ as tetrameric, and identified that the CTD mediates 
tetramerization. Chemical cross-linking can be achieved using reagents such as 
glutaraldehyde to link different subunits of the same protein or different proteins. This 
approach is convenient and cost-effective, but cross-linked products may not reflect native 
states of proteins/protein complexes, thus the results need wary interpretation (Kluger & 
Alagic, 2004). In SEC, proteins are loaded into and eluted off columns in their native 
buffers, so proteins retain native folding and remain oligomerized. Molecular weights of 
proteins/complexes are calculated through the standard curve generated by globular 
standard proteins. Since protein shapes affect elution rates, calculated weights of 
proteins/complexes are typically estimated. In contrast, nano-ESI MS has the advantages 
of small sample volume requirement and precise detection of protein/complex masses. This 
method becomes even more powerful in structural elucidation of proteins/complexes when 
combined with tandem MS such as surface-induced dissociation (X. Ma et al., 2014). 
However, MS requires protein buffers changed to volatile reagents such as ammonium 
acetate, which might affect native states of proteins/complexes. In the current study results 
of above three approaches are consistent, providing clear evidence of AmrZ tetramerization 
via its CTD. We also used a genetic approach as additional evidence. DNA binding-
deficient AmrZR22A was overproduced in a wild type P. aeruginosa strain, and a 
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dominant negative effect on PalgD activation was observed. The most likely explanation 
is that non-functional monomers are incorporated into hetero-tetramers that then are non-
functional. This dominant negative phenomenon has been widely observed in other 
oligomer-forming regulators, such as E. coli LacI and the Shigella flexneri AraC homolog 
VirF (Betz & Fall, 1988; Porter & Dorman, 2002).  
To unveil how the AmrZ CTD contributes to tetramerization, we used multiple 
tools to predict the secondary structure and properties of this domain. The NCBI conserved 
domain database failed to identify any conserved domain homologous to this CTD 
(Marchler-Bauer et al., 2014). The online prediction tools PSIPRED (Figure 3.14A) and 
Jpred (B. Xu, unpublished) predicted that most residues in the AmrZ CTD form two α-
helices (Drozdetskiy, Cole, Procter, & Barton, 2015; D. T. Jones, 1999). Alpha-helices, 
which mediate DNA binding and are essential for transmembrane domain formation, are 
the most common secondary structure of proteins. Many proteins, such as G-protein 
coupled receptors, form dimers or oligomers via helix-helix packing (Breitwieser, 2004). 
Therefore, these two α-helices are likely to be responsible for AmrZ oligomerization. 
Typically a small number of residues, called hot spot residues, are important for successful 
helix-helix interactions (Bullock, Jochim, & Arora, 2011). Although hydrophobic and 
aromatic amino acids constitute the majority of hot spot residues, polar and charged 
residues such as arginine remain significant players at monomer-monomer interfaces 
(Bogan & Thorn, 1998; Bullock et al., 2011; Matthews et al., 2012). The ExPASy 
ProtScale tool (Gasteiger et al., 2005) predicted most residues within the AmrZ CTD 
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domain are polar/hydrophilic (Figure 3.14B). In addition, the overall hydropathicity of this 
domain is hydrophilic, with the grand average of hydropathicity at -0.512 (minus values 
suggest hydrophilic) (ProtParam, (Gasteiger et al., 2005; Kyte & Doolittle, 1982)). The 
AmrZ CTD contains five arginine residues, which, together with other polar residues, may 
contribute to oligomerization through hydrogen bonding and salt bridges (Ali & Imperiali, 
2005; Matthews et al., 2012).  
Overall, we have investigated the significance of the AmrZ CTD for AmrZ 
oligomerization as well as AmrZ-mediated activation and repression. Tetramers composed 
of four DNA binding-proficient monomers are critical for AmrZ-mediated regulation. 
Further work is necessary to understand which residues are at the interface between 
monomers and mediate inter-monomer interactions. Since this CTD does not appear to be 
present in other proteins, more understanding of this domain may provide insights of a 
novel oligomerization mechanism and potentially other unknown functions of this domain. 
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Figure 3.1. The primary form of AmrZ in solution is tetrameric.  
Size exclusion chromatography was used to determine the oligomerization state of AmrZ 
under physiological ionic strength. (A.) AmrZ was loaded into the gel filtration column, 
and eluted proteins were monitored by absorbance at 280 nm. The vertical dashed line 
indicates a single peak was observed with the AmrZ sample. The small peaks at ~20 mL 
were from the buffer wash. (B.) A standard curve depicting the relationship between 
molecular weight (Y-axis) and elution volume (X-axis) was generated using protein 
standards. The molecular weight of the peak at 12.76 mL corresponded to 51.76 kDa.  
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Figure 3.2. The C-terminal domain of AmrZ mediates tetramerization.  
(A.) Proposed domains of full length AmrZ and AmrZ1-66. N: N terminus; B: DNA 
binding domain; Z: oligomerization domain. Numbers above indicate residues flanking 
each domain. (B.) & (C.) Nano-ESI MS measurements of purified AmrZ (B.) and AmrZ1-
66 (C.). The X-axis represents mass/charge (m/z) ratios, while the Y-axis was calculated 
by normalizing to the highest signal intensity. 
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Figure 3.3. AmrZ binds to DNA as a tetramer. 
Nano-ESI MS was used to determine the molecular weight of the AmrZ-DNA complex. 
10 µM 18-bp amrZ1 dsDNA was incubated with 40 µM recombinant AmrZ. Black arrows 
point to a complex with the size ~64246 Da, which corresponds to the combined size of 
one DNA molecule and four AmrZ monomers. The Y-axis was calculated by normalizing 
to the highest signal intensity. 
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Figure 3.4. The C-terminal domain of AmrZ is required for tetramerization.  
(A.) Domain structure of AmrZ. N: N-terminal tail. B: DNA binding domain. Z: 
oligomerization domain. (B.) & (C.) His-tagged AmrZ was cross-linked by glutaraldehyde. 
Samples were resolved in 12% SDS-PAGE gels and stained with Coomassie Brilliant Blue. 
The protein amount in each reaction was as below: (-) glutaraldehyde 500 ng; (+) 
glutaraldehyde 250 ng, 500 ng, 750 ng, 1 µg, 1.5 µg, 2 µg, 2.5 µg, and 5 µg. M: monomer; 
D: dimer; T: tetramer. 
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Figure 3.5. AmrZR22A forms tetramers in solution.  
Nano-ESI MS of purified AmrZR22A after buffer exchange into 500 mM ammonium 
acetate. The X-axis represents mass/charge (m/z) ratios, while the Y-axis was calculated 
by normalizing to the highest signal intensity. 
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Figure 3.6. Similar amounts of AmrZR22A and WT AmrZ protein levels were 
produced after arabinose induction.  
(A.) P. aeruginosa strains were grown with/without arabinose to mid-log phases. Identical 
amounts of bacterial cells were lysed, loaded on 15% SDS-PAGE, followed by western 
blots with the α-AmrZ antibody. 0%, 0.1%, and 1% represent arabinose concentrations. A 
non-specific cross-reacting band (~25 kDa) was used as the loading control (LC) for each 
western blot assay. (B.) AmrZ and AmrZR22A band intensities after 1% arabinose 
induction from panel A were quantified by densitometry via ImageJ (v. 1.46r) and 
normalized to the loading control.   
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Figure 3.7. Dominant negative effect of AmrZR22A.  
(A.) Depiction of the point mutation (arginine to alanine) at the 22nd residue of AmrZ. (B.) 
Three arabinose-inducible plasmids (pHERD20T, pAmrZWT and pHis-AmrZR22A) were 
transferred into the FRD1 strain with integrated algD-lacZ transcriptional fusion. Various 
arabinose concentrations were used to induce plasmid-borne protein production in broth 
culture, and algD promoter activities were measured and normalized to that in the wild 
type FRD1 strain with the empty vector without arabinose. Error bars (only above bars 
were shown for a cleaner graph) represent standard errors of the mean from three 
independent experiments. Unpaired two-tailed t-tests of three independent experiments 
were performed to determine statistically significant differences. **: P<0.01; ***: 
P<0.001. 
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Figure 3.8. Truncation of the C-terminal domain results in reduced binding to PalgD.  
[6FAM]-labeled DNA fragments containing the ZBS in PalgD (B) and a control DNA (D) 
were incubated with various concentrations of AmrZ or AmrZ1-66 and analyzed by EMSA 
(B. & D.). Relative amounts of free DNA in (B.) were quantified via densitometry of non-
shift bands using ImageJ (v1.46r) and plotted at various AmrZ concentrations (C.). AmrZ 
monomeric protein concentrations were as below: Lane 1, 10: 0 nM; 2, 6, 11, 15: 10 nM; 
3, 7, 12, 16: 20 nM; 4, 8, 13, 17: 50 nM; 5, 9, 14, 18: 100 nM. The arrow in (A.) represents 
the transcription start site of PalgD. Arrows in (B.) indicate DNA mobility shifts induced 
by AmrZ or AmrZ1-66 binding. Triangles in (B. & D.) indicate non-specific bands, which 
are also present in no protein control lanes. 
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Figure 3.9. AmrZ1-66 displays reduced binding to the gcbA promoter.  
A [6FAM] labeled DNA fragment containing the AmrZ binding site (ZBS) was amplified, 
purified and tested for AmrZ binding. AmrZ protein concentrations were as below: Lane 
1, 5: 0 nM; 2, 6: 10 nM; 3, 7: 20 nM; 4, 8: 30 nM. The arrow in (A.) represents the 
transcription start site of the gcbA promoter. Arrows in (B.) indicate DNA mobility shifts 
induced by AmrZ or AmrZ1-66 binding.  
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Figure 3.10. Efficient activation of PalgD requires the AmrZ C-terminal domain.   
Arabinose-inducible plasmids encoding AmrZ or AmrZ1-66 were transferred into a FRD1 
∆amrZ mutant (FRD1200) harboring an algD-lacZ transcriptional fusion. Levels of AmrZ 
or AmrZ1-66 were modulated using indicated arabinose concentrations (0%-1%). PalgD 
activities were measured by β-galactosidase assays and normalized to that in the ∆amrZ 
mutant with the empty vector without arabinose. Unpaired two-tailed student t-tests were 
used for statistical analyses of three independent experiments. ***: P<0.001. 
  
  
104 
 
 
Figure 3.11. Western blot analyses of AmrZ1-66 after arabinose induction.  
(A.) Western blots of purified AmrZ and AmrZ1-66 using the polyclonal α-AmrZ antibody. 
Protein concentrations used for both AmrZ and AmrZ1-66 from left to right are as below: 
2 µg, 1 µg, 500 ng and 200 ng. (B.) Western blots of OSUPA211 with different plasmids 
with/without induction by 0.1% arabinose. Same amounts of cells were used. (C.) 
Densitometry of band intensities in (A.) and (B.) by ImageJ (v. 1.46r). The first (antibody 
recognition ratio) and second columns (apparent recognition ratio) were calculated and 
averaged from (A.) and (B.) (0.1% arabinose), respectively. The third column (actual ratio 
of protein amount) was calculated by dividing the apparent recognition ratio by the 
antibody recognition ratio in order to take into account the effect of reduced antibody 
recognition of AmrZ1-66. 
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Figure 3.12. The AmrZ C-terminal domain is required for efficient repression and 
activation of its targets.  
Arabinose-inducible plasmids encoding AmrZ or AmrZ1-66 were transferred into a PAO1 
∆amrZ mutant. After induction by various arabinose concentrations, cells were harvested, 
and mRNA levels of gcbA (A.) and PA2146 (B.) quantified by qRT-PCR. Relative gene 
expression was compared to the PAO1 ∆amrZ mutant with the empty vector in the absence 
of arabinose. Unpaired two-tailed student t-tests were used for statistical analyses of three 
independent experiments. ***: P<0.001; ns: not significant. 
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Figure 3.13. ClustalW2 alignment of AmrZ with other Arc proteins.  
ClustalW2 alignment v2.1 was used to align above protein sequences using the Gonnet 
protein weight index (W. Li et al., 2015). The colon symbol “:” and the period symbol “.” 
indicate conservation of strongly and weakly similar properties –scoring >0.5 and =<0.5 in 
the Gonnet PAM 250 matrix, respectively.  
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Figure 3.14. Predicted AmrZ secondary structure and polarity of the AmrZ CTD.  
(A.) The AmrZ secondary structure was predicted by Psi Pred (D. T. Jones, 1999). (B.) 
Polarity scores of the AmrZ CTD (residues 67-108) by ProScale (Gasteiger et al., 2005). 
Higher scores (Y-axis) represent more polar amino acid residues. The X-axis represents 
the position of a certain residue within the domain.  
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Table 3.1. Strains, plasmids, and oligonucleotides used in Chapter 3 
Strains 
/Plasmids 
Relevant genotype/description/sequence Sources 
Strains   
Escherichia coli   
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New England 
Biolabs 
S17λpir pro thi hsdR+ TpR SmR; chromosome::RP4-2 Tc::Mu-
Kan::Tn7/λpir 
(Simon et al., 
1983) 
P. aeruginosa   
FRD1 strain 
background 
  
FRD1 mucA22 (Ohman & 
Chakrabarty, 
1981) 
FRD1200 amrZ::xylE-aacC1 in FRD1 (Wozniak et 
al., 2003) 
OSUPA211 
(FRD1/PalgD-lacZ) 
algD-lacZ transcriptional fusion at the attB site in 
FRD1 
This study 
OSUPA213 Promoterless lacZ at the attB site in FRD1 This study 
OSUPA226 amrZ deletion; WT algD-lacZ transcriptional fusion at 
the attB site in FRD1 
This study 
PAO1 strain 
background 
  
PAO1 PAO1 wild type D. J. 
Wozniak 
WFPA205 amrZ::tet (P. J. 
Baynham et 
al., 2006) 
Plasmids   
mini-CTX-lacZ Vector for transcriptional fusion analyses. TetR (Hoang TT 
Becher A, 
Schweizer 
HP., 2000) 
pBX1 mini-CTX-PalgD-lacZ. Two primers (algD65, 
algD66) were used to amplify the PalgD 
This study 
pHERD20T Arabinose-inducible vector (Qiu et al., 
2008) 
pBX29 (pAmrZWT) pHERD20T-WT AmrZ. Primers amrZ118, amrZ119 
were used to amplify the amrZ coding sequence. 
This study 
pBX30 (pAmrZ1-66) pHERD20T-AmrZ1-66. Primers amrZ118-121 were 
used to construct an amrZ mutant encoding a stop 
codon TGA at 67th residue 
This study 
 
Continued 
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Table 3.1. Continued 
 
  
pCJ3 (pHis-
AmrZWT) 
pHERD20T-His6-AmrZ WT (C. J. Jones 
et al., 2014) 
pCJ4 (pHis-
AmrZR22A) 
pHERD20T-His6-AmrZR22A C. J. Jones 
Oligonucleotides   
algD65 CCCCAAGCTTCTCTTTCGGCACGCCGAC This study 
algD66 CCGGGATCCCCGACATAGCCCAAACCAAAG This study 
algD71 [6FAM] ACCGTTCGTCTGCAAGTCATG This study 
algD73 ACCAACTTGATGGCCTTTCCG This study 
algD111 [6FAM] CAAACGGCCGGAACTTCCCT (C. J. Jones 
et al., 2014) 
algD112 TAGTTCGGTCCATAGAATTCAAG (C. J. Jones 
et al., 2014) 
amrZ118 TGCTCTAGACGAGAACAATGAACGCTTCCTC This study 
amrZ119 CCCAAGCTTCTTCGGCGCTCAGGCCTG This study 
amrZ120 CTGTCCAGTCAAACACCGAG This study 
amrZ121 CTCGGTGTTTGACTGGACAG This study 
CTX1 CCTCGTTCCCAGTTTGTTCC (Tart et al., 
2006) 
attB2 GTCGCCGCCGGCGATGC (Tart et al., 
2006) 
attB4 CGCCCTATAGTGAGTCG (Tart et al., 
2006) 
attB5 CGCCCCAACCTCGCTGG (Tart et al., 
2006) 
rpoD_F2 GCCGAGCTGTTCATGCCGAT    (C. J. Jones 
et al., 2013) 
rpoD_R2 GAACAGGCGCAGGAAGTCGG   (C. J. Jones 
et al., 2013) 
gcbA_RT_F GGTTCTGGAGGTCTGGCAAC This study 
gcbA_RT_R CTGGGCATGCTCGGCTTG This study 
adcA_FAM_F_EMS
A 
[6FAM] CGTAGTCCGTCGCACAAAG (C. J. Jones 
et al., 2014) 
adcA_R_EMSA GCGCTTCTTTCGTGGTCTTC (C. J. Jones 
et al., 2014) 
PA2146_RT_F GCACAGCATCAAGGTGGTAAAG This study 
PA2146_RT_R CTTTCTTGCCAGCCTCGGAG This study 
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Table 3.2. The AmrZ CTD is required for efficient activation of twitching motility 
  
  
                                                 
a Arabinose concentration. 
b TM was measured and normalized to percentages of PAO1. 
c Standard errors of the mean were calculated from three independent experiments, each with three replicates. 
 0%a 0.01% 0.1% 
∆amrZ/vector 0.0b ± 0.0c 0.0 ± 0.0 0.0 ± 0.0 
∆amrZ/pAmrZWT 65.7 ± 8.7 65.7 ± 13.9 97.3 ± 4.4 
∆amrZ/pAmrZ1-66 0.0 ± 0.0 1.0 ± 2.3 93.9 ± 16.4 
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Chapter 4  
 
 
Chapter 4. Pseudomonas aeruginosa AmrZ binds to four sites in the algD promoter and 
induces trans DNA-AmrZ complex formation 
 
Abstract 
During late stages of cystic fibrosis pulmonary infections, Pseudomonas 
aeruginosa often overproduces the exopolysaccharide alginate, protecting the bacterial 
community from host immunity and antimicrobials. The major target of regulation is the 
alginate biosynthesis operon, whose transcription is under tight control by a number of 
transcription factors including AmrZ. Interestingly, multiple transcription factors interact 
with the far upstream region of this promoter (PalgD). Transcription is proposed to be 
activated via DNA looping, yet this model has little supporting evidence. Prior, ChIP-Seq 
analyses revealed what appeared to be two AmrZ binding regions in PalgD. Further 
examinations here allowed the identification of four AmrZ binding sites in this promoter, 
disruption of which eliminated AmrZ binding and promoter activation. We proposed that 
AmrZ induces DNA looping of PalgD. In support of this, PalgD transcription was 
abolished when the relative phase was reversed (5 bp), while a full-DNA-turn insertion (10 
bp) restored promoter activity. Since AmrZ forms oligomers in solution and when bound 
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to DNA, we sought to determine if AmrZ brings its binding sites together and induces 
DNA-AmrZ complex formation. Our in vitro fluorescence resonance energy transfer 
experiments suggested that AmrZ holds two binding sites together and induces trans DNA-
AmrZ complex formation. Taken together, our studies have unveiled three previously 
unknown AmrZ binding sites in the PalgD promoter. We also highlight the significance of 
correct phasing and demonstrate the formation of trans DNA-AmrZ complexes, suggesting 
looping of the algD promoter in vivo. 
 
Introduction 
In cystic fibrosis (CF) patients, the Gram negative bacterium Pseudomonas 
aeruginosa is a major pathogen. Infection with P. aeruginosa, especially the mucoid strain 
that overproduces the exopolysaccharide alginate, often results in a poor prognosis for 
those patients (Govan & Deretic, 1996). During CF lung infections, P. aeruginosa first 
colonizes as a non-mucoid strain with minimal alginate production. However, at late stages, 
up to 70% of P. aeruginosa isolates are mucoid (Cystic Fibrosis Foundation, 2013; 
Doggett, 1969; Leid et al., 2005; Ramsey et al., 2005; Stapper et al., 2004). Alginate-
dominant biofilms form a thick protective layer against host immune attacks and 
antimicrobials (Leid et al., 2005; Lovewell, Patankar, & Berwin, 2014). However, 
overproduction of this exopolysaccharide is an energy-exhaustive process, requiring a 
number of enzymes and precursor substrates. Therefore, alginate production is under tight 
regulation involving multiple regulatory factors (Ramsey & Wozniak, 2005). Previous 
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studies have shown that the sigma factor AlgT (also referred to as AlgU/σ22) is the key 
component necessary for expression of the alginate biosynthesis operon (Boucher et al., 
2000; M J Schurr et al., 1993; D J Wozniak & Ohman, 1994). Freed from sequestration by 
the anti-sigma factor MucA, AlgT initiates transcription of genes encoding transcription 
factors (TFs) AmrZ, AlgB and AlgR (P. J. Baynham & Wozniak, 1996; A. K. Jones et al., 
2010). These three and at least four other TFs bind to the promoter of the alginate operon 
(PalgD) and initiate transcription (Deretic & Konyecsni, 1990; Kato et al., 1990; 
Konyecsni & Deretic, 1990; Mohr et al., 1991). Interestingly, the region over 100 base 
pairs (bp) upstream of the transcription start site contains at least seven TF binding sites, 
and it is yet known how these TFs mediate activation from such a long distance. Although 
a DNA loop model has been proposed, there is little supporting evidence (Michael J Schurr, 
2013). 
Remote regulatory elements are commonly seen in bacterial promoters, but these 
elements are almost obligated to couple with proximal elements (Neidhardt & Curtiss, 
1996). Generally speaking proteins between remote and proximal elements make contacts 
via looping out of the intervening DNA. This DNA looping phenomenon has been widely 
observed in different transcription regulatory systems such as the regulation by the lac 
repressor, the deo repressor and AraC (Amouyal, Mortensen, Buc, & Hammer, 1989; 
Krämer et al., 1987; Lobell & Schleif, 1990). DNA looping plays important roles during 
transcription regulation, such as allowing remote proteins to execute regulation and 
blocking the access of RNA polymerase to the promoter. 
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As a global regulator, AmrZ functions as both an activator and a repressor of 
multiple processes. Well-studied targets include those involved in exopolysaccharide 
production (alginate, Psl and Pel), flagella, twitching motility and the metabolism of bis-
(3’,5’)-cyclic diguanylate (P. J. Baynham et al., 2006; P. J. Baynham & Wozniak, 1996; 
C. J. Jones et al., 2014, 2013; Martínez-Granero et al., 2014; Ramsey et al., 2005; Tart et 
al., 2006). AmrZ is composed of three domains, including a flexible N terminus (residues 
1-11), a DNA binding ribbon-helix-helix domain (residues 12-66) and a C-terminal domain 
(CTD, residues 67-108). The ribbon-helix-helix domain is highly similar to other members 
in the Arc superfamily such as Arc, CopG and MetJ (Knight et al., 1989; Schreiter & 
Drennan, 2007; Vershons et al., 1985; Waligora et al., 2010). AmrZ tetramerizes in 
solution and its CTD truncation variant AmrZ1-66 binds to DNA as a dimer of dimers, 
suggesting that AmrZ interacts with its DNA targets as oligomers, likely as tetramers 
(Pryor et al., 2012; Waligora et al., 2010).  
This study sought to dissect AmrZ-mediated activation mechanism of PalgD. We 
demonstrate the presence of four AmrZ binding sites (ZBSs) in PalgD, each of which is 
required for promoter activation. In addition, correct phasing between these ZBSs is crucial 
for PalgD activation and AmrZ induces the formation of trans DNA-AmrZ complexes 
when bound to a PalgD fragment in vitro. These results suggest DNA looping during PalgD 
activation. 
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Materials & Methods 
Bacterial strains, plasmids, oligonucleotides and culture conditions. 
 All bacterial strains, plasmids and DNA oligonucleotides are listed in Table 4.1. 
Strains of Escherichia coli and Pseudomonas aeruginosa were incubated as previously 
described (C. J. Jones et al., 2013). All E. coli strains were cultured in LB (1 liter LB 
contains 10 g tryptone, 5 g yeast extract, 5 g sodium chloride) or on LA (LB with 1.5% 
(w/v) agar). Where necessary, 15 µg/ml tetracycline was used to maintain plasmids in E. 
coli. All P. aeruginosa strains were cultured in LBNS or on LANS (LB or LA without 
sodium chloride, respectively). In P. aeruginosa, 100 µg/ml tetracycline was used if 
needed. All strains were grown at 37oC unless stated otherwise. All oligonucleotides were 
ordered desalted from Sigma Aldrich with the exception of DNA primers for FRET 
experiments, which were ordered with PAGE purification from Midland Certified Reagent 
Company.  
 
Nucleotide manipulations.  
PalgD variants with mutations or truncations were generated by overlap extension 
PCR as previously described (Heckman & Pease, 2007). For scrambling of nucleotide 
sequences, the CLC sequence viewer software was used to randomize the order of 
nucleotide sequences. In the DNA phasing experiments, sequences of 5bp and 10bp 
insertions are “CATGC” and “CATGCATGCA”, respectively. 
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Transcriptional reporter assays.  
All transcriptional reporters were constructed in the mini-CTX-lacZ plasmid 
(Becher & Schweizer, 2000). PalgD fragments (-633 - +368 relative to the transcription 
start site) were cloned into mini-CTX-lacZ after digestion by HindIII and BamHI (New 
England Biolabs). Transcriptional reporters were then transferred and integrated into 
chromosomes of specified P. aeruginosa strains. A 96-well plate reader (Molecular 
Devices SpectraMax M2) was used to measure absorbance at 420 nm and 550 nm, and β-
galactosidase activities were determined as previously described (J. H. Miller, 1992).  
 
DNA binding studies. We used EMSA (electrophoretic mobility shift assays) 
modified from a previously described protocol (C. J. Jones et al., 2014) to study DNA-
protein interactions. 5’-[6FAM] labeled DNA used for EMSA was amplified using Quick-
load® Taq 2X Mastermix (New England Biolabs), [6FAM]-labeled forward primers and 
non-labeled reverse primers, and PAO1 genomic DNA as the template. Each EMSA 
reaction contained 20 mM Bis-Tris pH 6.5, 4 mM MgCl2, 200 µg/ml acetylated BSA, 130 
mM NaCl, 1 mM DTT, 5% glycerol, 150 ng/µl Poly d[(I-C)] (Roche), 10 nM [6FAM] 
labeled DNA, and a specified concentration of recombinant AmrZ or its variants. Protein-
DNA binding was equilibrated at room temperature (25°C) for 20 min after the addition of 
all reagents. 10 µl of each reaction was loaded onto a cold pre-equilibrated 4% non-
denaturing acrylamide gel. Electrophoresis was conducted for 25 min at 200 V in 0.5% 
TBE on ice in the dark. A Typhoon scanner (GE Lifescience) (Settings: fluorescence, 
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PMT800, 520BP 40 CY2 Blue FAM, 100 µm pixel size) was used to detect FAM 
fluorescence within gels. 
 
Fluorescence Resonance Energy Transfer (FRET) 
DNA preparation: 5’ termini of oligonucleotides (algD157 and algD160) (Midland 
Certified Reagent Company) were conjugated with Cyanine5 NHS ester and Cyanine3 
NHS ester (Lumiprobe) respectively, as recommended by the manufacturer. Labeled 
oligonucleotides were purified by HPLC using a Poroshell 120 (50 x 4.6 mm) RP column 
with an EC-C18 stationary phase (Agilent). Samples were dissolved in 0.1 M 
triethylammonium acetate (TEAA) pH 7.0 and eluted with a 3-30% acetonitrile (ACN) 
gradient at 1% ACN/min. Labeled fractions were collected and acetonitrile removed by 
rotary vacuum. Oligonucleotides were concentrated and buffer exchanged to TE with 
Amicon Ultra-4 3kDa centrifugal filter units. Oligonucleotides were used as primers in a 
PCR reaction using pBX1 as the template to generate the DNA fragment (Quick-Load® 
Taq 2X Master mix, New England Biolabs). PCR products were PAGE purified on a 4% 
acrylamide gel and concentrated using Amicon Ultra-4 10kDa centrifugal filter units.  
FRET measurement: The composition of each final FRET reaction mixture was the 
same as EMSA, with the exception of a different glycerol concentration (2%), and the 
addition of 1.5 mM Trolox and 4% PEG8000 (polyethylene Glycol 8000). Trolox and 
PEG8000 were added as a triplet state quencher and the crowding agent, respectively (Ge, 
Luo, & Xu, 2011; Paudel & Rueda, 2014). The mixture was placed in a quartz cuvette 
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(Starna, 16.12F-Q-1.5/Z8.5) and measured for fluorescent response with AmrZ 
concentrations up to 10 µM. Fluorescence measurements were performed on a Fluoromax-
4 (Horiba Jobin Yvon), with attached circulating water bath set to 25oC. Samples were 
excited at 548 nm (Cy3) or 646 nm (Cy5), and emission spectra were scanned from 560 
nm to 700 nm. Apparent FRET values were calculated by dividing the emission intensity 
at 666nm by the combined intensities at 562nm and 666nm. 
 
Results 
Identification of four AmrZ binding sites in PalgD  
A previous study identified one AmrZ binding site centered at -289 bp relative to 
the transcription start site and its importance for PalgD activation (P. J. Baynham & 
Wozniak, 1996). In addition, we utilized ChIP-Seq to uncover AmrZ binding sites 
throughout the P. aeruginosa genome  and discovered a second AmrZ binding region in 
PalgD (Figure 4.1B; (C. J. Jones et al., 2014)). Two ZBSs were therefore anticipated in 
this promoter based on sequence similarity to the consensus. They are designated as ZBS2 
(-289bp relative to the transcription start site, the one identified previously) and ZBS3 (-
130bp) respectively (Figure 4.1A). This nomenclature will be explained later in this 
section. EMSAs (electrophoretic mobility shift assays) were then used to verify AmrZ 
binding to ZBS3. Three [6FAM]-labeled DNA fragments were amplified such that they 
contain ZBS2, ZBS3, or neither ZBS, respectively. AmrZ bound to each fragment that 
contains a ZBS but showed no binding to the negative control DNA (Figure 4.1C). The 
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DNA binding-deficient variant AmrZR22A was also included in this assay and did not 
exhibit binding to any DNA fragment (Figure 4.1C). Overall, these results demonstrate that 
AmrZ specifically recognizes both AmrZ binding sites within PalgD.  
We next sought to understand the significance of both ZBSs during PalgD 
activation. One or both ZBSs were disrupted by randomly scrambling their nucleotide 
sequences and their effects on AmrZ binding and PalgD activation were determined. 
EMSA studies showed that disruption of both ZBSs impaired, but did not eliminate, AmrZ 
binding to the DNA (Figure 4.2A). To study their effects on algD transcription in vivo, four 
algD-lacZ transcriptional fusions were constructed, including PalgD wild type (WT) and 
PalgD with scrambled ZBS2, ZBS3, or both, respectively. These fusions were integrated 
into the chromosome of the parental FRD1 or its isogenic ΔamrZ mutant. In FRD1, ZBS2 
scrambling caused dramatic reduction of PalgD activity (57%) compared to WT while the 
loss of intact ZBS3 had a modest effect (11% reduction). Mutations of both ZBSs resulted 
in further reduction (74%). However, the PalgD activity was completely eliminated in the 
FRD1 ΔamrZ strain (Figure 4.2B), validating that amrZ is absolutely required for algD 
transcription activation (P. J. Baynham & Wozniak, 1996). Since disrupting the AmrZ 
binding to both ZBSs did not recapitulate the results seen in the ΔamrZ strain, we explore 
additional mechanisms of regulation.  
We propose two possible explanations for different outcomes of scrambling both 
ZBSs and amrZ deletion. 1.) AmrZ activates PalgD indirectly via interacting with or 
regulating expression of other proteins that are required for PalgD activation. 2.) AmrZ 
still binds to PalgD despite the scrambling of both ZBSs. The first scenario is unlikely 
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since neither RNA-Seq nor DNA microarrays revealed an AmrZ-dependent alginate 
regulator (C. J. Jones et al., 2014; Xu & Wozniak, 2015). In addition, co-
immunoprecipitation experiments did not demonstrate AmrZ binding to other TFs (C. J. 
Jones and S. W. Harshman, unpublished data). Secondly, observed partial AmrZ binding 
could be conferred by ineffective scrambling or additional ZBS(s) in the DNA fragments. 
To test if residual AmrZ binding is due to ineffective scrambling, we determined AmrZ 
binding to a ZBS2-containing DNA fragment after ZBS2 deletion or replacement by a 
sequence known not to bind to AmrZ (Ramsey et al., 2005). Surprisingly, AmrZ still bound 
to this fragment after either deletion or replacement (Figure 4.3), suggesting the presence 
of another AmrZ binding site. ChIP-Seq analyses indicate additional ZBS(s) is not likely 
to be outside of the two regions (Figure 4.1B). Therefore, we concluded that within each 
AmrZ binding region (~100bp) there is more than one ZBS. In consideration of the length 
of a ZBS (~18bp) and the sequence similarity constraint to the consensus (C. J. Jones et 
al., 2014; Pryor et al., 2012), we proposed two additional ZBSs (ZBS1 and ZBS4) within 
each region, that is total four ZBSs in PalgD. This hypothesis was tested via EMSA assays 
(Figure 4.4). The DNA fragment containing only ZBS1 or ZBS4 still retained AmrZ 
binding while no binding was seen with any ZBS-free DNA fragment (Figure 4.4B). 
Therefore, our DNA binding studies demonstrate four AmrZ binding sites within PalgD. 
Proposed positions and sequences of these four ZBSs are shown in Figure 4.5, with ZBS1 
and ZBS4 located at 321bp and 74bp upstream of the transcription start site, respectively.  
In order to evaluate the significance of these ZBSs during algD transcription, we 
scrambled DNA sequences of ZBSs and measured effects on AmrZ binding and PalgD 
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activation. Since effects of losing ZBS2 and ZBS3 have been determined (Figure 4.2), we 
scrambled ZBSs in pairs (ZBS1/2 and ZBS3/4) (Figure 4.6A). Scrambling of ZBS1/2 or 
ZBS3/4 eliminated AmrZ binding of their respective DNA fragment (Figure 4.6B). 
Importantly, the PalgD activity suffered dramatic reduction from disruption of either ZBS 
pair while losing all four had a similar effect as an amrZ deletion (Figure 4.6C). Taken 
together, above results validate the significance of four ZBSs during PalgD activation. 
 
Correct phasing between ZBS2 and ZBS3 is critical during PalgD activation  
Since all four ZBSs are necessary for PalgD activation and AmrZ forms oligomers, 
we investigated whether AmrZ oligomers bound to these ZBSs form higher order 
complexes and thus induce PalgD DNA looping. If true, the relative phasing between ZBSs 
would be critical. We therefore inserted 5 bp between ZBS2 and ZBS3 (Figure 4.7A), 
cloned this promoter variant into the lacZ transcriptional fusion and integrated it into the 
FRD1 chromosome. The algD promoter activity reduced significantly (70%) with this 
insertion (Figure 4.7B). This reduction was not due to the insertion event itself, since a 10 
bp insertion, which restores DNA phasing, did not affect PalgD activity (Figure 4.7B). We 
therefore conclude that proper DNA phasing between these ZBSs is crucial for PalgD 
activation.  
 
 
 
  
122 
 
AmrZ binding induces trans DNA-AmrZ complex formation 
The DNA phase-dependent activation of PalgD suggests that transcription 
activation of this promoter requires contacts between upstream and downstream factors. 
These interactions are likely to occur via looping out of the intervening DNA. We therefore 
hypothesize that AmrZ induces DNA looping when binding to four ZBSs. If true, the 
interaction between AmrZ oligomers may result in proximity between ZBSs. Fluorescence 
resonance energy transfer (FRET) is widely used to measure proximity (<10 nm) during 
protein-protein and protein-DNA interactions and was therefore used to test this 
hypothesis. The DNA fragment used for FRET experiments was amplified from PalgD 
with ZBS1 and ZBS4 at two ends respectively and underwent end-labeling by two 
fluorophores (Cy3 and Cy5) (Figure 4.8A). The FRET efficiency peaked at 1µM AmrZ 
while an excessive amount of AmrZ inhibited FRET (Figure 4.8B), which is intriguing and 
will be addressed further in Discussion. Successful FRET depends on the AmrZ DNA 
binding ability, as the DNA binding deficient variant AmrZR22A failed to induce FRET 
(Figure 4.8D). These FRET observations indicate that AmrZ-DNA interactions result in 
proximity between Cy3 and Cy5 fluorophores, suggesting complex formation between 
AmrZ and DNA. These complexes can be formed in cis (within same DNA molecule) or 
in trans (between two separate DNA molecules). The cis complex is formed when AmrZ 
binding induces DNA bending/looping and in this case ZBSs from two ends of the same 
DNA molecule are very close (<10 nm). On the other hand, the formation of trans 
complexes suggests proximity between two DNA molecules when they are bound and held 
together by AmrZ. To differentiate between these two possibilities, we constructed a DNA 
fragment with a 105bp (10 DNA turns) truncation (-250bp to -146bp) between ZBS2 and 
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ZBS3 (Figure 4.8C), in which the intervening DNA is shortened to 47bp. Considering the 
steric effects of AmrZ oligomers on the DNA, the length of flexible DNA is expected to 
be even shorter, which would be problematic for DNA looping due to high bending energy 
(Allemand, Cocco, Douarche, & Lia, 2006). Moreover, the distance between two operator 
sites is well over a hundred base pairs in most DNA looping examples (Allemand et al., 
2006; Cournac & Plumbridge, 2013). Therefore, the intervening DNA is likely to be too 
short, if not impossible, to bend, preventing cis complex formation. This truncation 
however, does not affect the formation of trans complexes. No reduction of the FRET 
efficiency was observed after this truncation (Figure 4.8D), suggesting that AmrZ binding 
to PalgD induces trans DNA-AmrZ complex formation.  
 
Discussion 
Alginate production in P. aeruginosa is under tight control by a number of 
regulators. In this study, we identified four ZBSs in PalgD and showed that each is 
necessary for transcription activation. Our results also highlight the significance of proper 
phasing between ZBSs and reveal the formation of trans DNA-AmrZ complexes.  
Alginate is a key virulence factor responsible for P. aeruginosa persistence in CF 
lung infections. Since activation of alginate production is frequently observed during late 
stages of CF infections when the gain of fitness exceeds the cost of alginate production, it 
provides an excellent example of bacterial patho-adaptability. Alginate production requires 
at least 13 biosynthesis enzymes, whose expression is under the control by numerous 
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regulators (Ramsey et al., 2005). All biosynthesis genes, except algC, reside within the 
alginate biosynthesis operon. The promoter of this operon is particularly complex. So far 
it is known to contain binding sites for 7 different TFs, and strikingly, many of these sites 
are ≥250 bp upstream of the transcription start site (Figure 4.1A). In this study, we 
discovered three additional AmrZ binding sites (ZBS1, ZBS3 and ZBS4) within this 
promoter. It is interesting that ZBS4 overlaps with IHF1.2 (Figure 4.1A; (D J Wozniak, 
1994)). However, since IHF is dispensable for alginate production under our growth 
condition (Delic-Attree, Toussaint, Froger, Willison, & Vignais, 1996), the observed effect 
of scrambling ZBS3/4 is therefore likely solely due to the loss of AmrZ binding (Figure 
4.6). 
It is common for a promoter to contain two or more binding sites of one TF, and 
~75% of negatively and ~25% of positively regulated promoters are bound by a TF at 
several locations in E. coli (Neidhardt & Curtiss, 1996). Multiple binding sites have distinct 
functions in different promoters during transcription regulation. For instance, the arginine 
biosynthesis regulator ArgR interacts with the ARG box of its target promoters and this 
ARG box contains two ArgR binding sites separated by 3 bp. Removal of one site results 
in 100-fold reduction of the ArgR binding affinity to the other one, indicative of 
cooperative binding between two sites (Tian, Lim, Carey, & Maas, 1992). Based on our 
EMSA data, there does not seem to be cooperative binding between ZBS1 and ZBS2 or 
ZBS3 and ZBS4 (Figure 4.4).  
The presence of multiple binding sites is often required for DNA loop formation, 
which may be induced by oligomerization of TFs from two or more binding sites. DNA 
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looping is commonly seen and plays a central role during transcriptional control in both 
eukaryotic and prokaryotic organisms (Allemand et al., 2006). DNA looping was first 
demonstrated in the araBAD system in E. coli (Dunn, Hahn, Ogdent, & Schleif, 1984; 
Lobell & Schleif, 1990). The araBAD operon encodes proteins necessary for arabinose 
catabolism, whose expression is tightly controlled by AraC. AraC functions as an 
activator/repressor depending on the presence/absence of arabinose. Without arabinose, 
AraC dimers bind to two sites --araO2 and a half site of araI (araI1). AraC induces DNA 
loop formation when binding to these two sites, preventing transcription initiation. 
However, arabinose-bound AraC alters conformation and shifts its position from araO2 to 
araI2, leading to a broken DNA loop and subsequent transcription initiation of this operon 
(Lobell & Schleif, 1990).  
DNA loop formation requires proper phasing between protein binding sites. Since 
each DNA turn is approximately 10.5 bp, an insertion/deletion of 5 bp between protein 
binding sites would place two proteins in an opposite orientation, reducing protein-protein 
interactions and subsequent DNA looping. This phase requirement of DNA looping has 
been employed to support DNA loop formation induced by AraC and the lac repressor 
(Dunn et al., 1984; Han et al., 2009; Krämer et al., 1987). In this study, our results 
demonstrate that a correct phase between ZBS2 and ZBS3 is crucial, suggesting 
interactions between upstream and downstream factors, likely achieved by DNA looping, 
are required for PalgD activation. 
In order to provide direct evidence for PalgD DNA looping, we designed FRET 
experiments in which two pairing fluorophores (Cy5 and Cy3) are placed 5bp away from 
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ZBS1 and ZBS4, respectively. This 5bp spacing is designed to reduce protein-induced 
fluorescence enhancement, which occurs when a protein is very close to a fluorophore 
(Hwang & Myong, 2014). When incubated with this DNA fragment, AmrZ, but not a DNA 
binding-deficient variant AmrZR22A, induces energy transfer from Cy3 to Cy5, indicating 
proximity (<10nm) between these two fluorophores. As this energy transfer occurs 
between fluorophores from two DNA molecules (Figure 4.8), we speculate that each trans 
complex is composed of two AmrZ tetramers and two DNA fragments. These interactions 
are likely to be stable, as the FRET efficiency did not fluctuate over time (up to 20min) 
(data not shown). Additionally, a temperature increase from 25°C to 37°C did not affect 
FRET efficiency (data not shown), suggesting that these interactions are likely to be similar 
during human infections. The FRET efficiency is calculated as the proportion of the Cy3 
energy transferred to Cy5 and is the average of the whole solution. Since other 
conformations of trans DNA-AmrZ complexes, such as Cy3 DNA-AmrZ-Cy3 DNA, are 
present with the same probability but do not elicit FRET, actual FRET of Cy3 DNA-AmrZ-
Cy5 DNA is expected to more efficient, indicating even a shorter distance between ends of 
two DNA molecules. It is intriguing that excessive AmrZ inhibits FRET (Figure 4.8D), 
which might be explained by oligomerization of all DNA-bound AmrZ with a saturated 
amount of free AmrZ in solution. Although we are unable to provide a direct evidence of 
AmrZ-induced DNA looping, this study reveals that AmrZ holds multiple ZBSs together 
in vitro, which may be critical for PalgD DNA loop formation in vivo. Additional factors, 
such as the DNA bending protein IHF and the nucleotide-associated protein Hp-1, may 
contribute to looping of this promoter in the cell. This is corroborated by the in vivo 
observation that removing the 105bp region used in the truncation experiment (Figure 
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4.8C&D) resulted in abolished PalgD transcription (Figure 4.9). Further investigations are 
required to validate this theory. 
With data obtained here and from previous studies, we propose a model of PalgD 
activation. A DNA loop forms when PalgD is bound by AmrZ, IHF, and Hp-1. Formation 
of this DNA loop brings remote elements closer to the transcription start site and allows 
interactions between remote proteins and RNA polymerase. Specifically, two remote AlgR 
dimers interact with the 3rd AlgR dimer that is bound to a proximal site, which further 
optimizes the DNA conformation and allows direct contacts by Vfr and the NtrC homolog 
AlgB to RNA polymerase. Both proper DNA conformation and interactions with RNA 
polymerase stabilize promoter binding by the polymerase and transcription is then initiated. 
Of note, this complex activation mechanism allows the integration of different activation 
signals during activation and the loss of any activating signal often prevents transcription 
initiation. This is important for bacteria as alginate production is an energy-exhausting 
process. In this model, a high intracellular AmrZ level is necessary for PalgD activation 
because DNA looping requires all four ZBSs bound by AmrZ. Therefore, the intracellular 
AmrZ concentration may serve as an additional means of regulation, and it was previously 
shown that mucoid P. aeruginosa produces significantly more AmrZ than non-mucoid 
strains (C. J. Jones et al., 2013). 
Overall, in this study we have identified four AmrZ binding sites in PalgD and 
provided support for the DNA looping model of this complex promoter. Further 
understanding of this promoter may allow exploitation of this activation mechanism and 
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development of novel means to prevent or disrupt alginate production during P. aeruginosa 
infections. 
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Figure 4.1. Identification of a second AmrZ binding site in PalgD.  
(A.) Schematic of PalgD and transcription factor binding sites. Note: the AlgB binding site 
(~-274bp to -224bp), the CysB binding site (~+90 to +116) and two Hp-1 (AlgP) binding 
sites (~-432 to -332, ~-116 to +111) are not shown here due to their unprecise locations 
(Michael J Schurr, 2013). Designed algD fragments used in (C.) are also shown here. 
Numbers indicate the distance relative to the transcription start site. (B.) An example image 
of ChIP-Seq shows two AmrZ binding peaks in PalgD. “Before IP” and “After IP” 
represent DNA samples before and after chromatin immuno-precipitation (IP) with AmrZ 
(C. J. Jones et al., 2014). (C.) EMSA experiments were performed to determine AmrZ 
binding to above four DNA fragments. “-” indicates free DNA. “+” means the addition of 
50 nM AmrZ or a DNA-binding deficient variant AmrZR22A. Arrows point to retardation 
of DNA mobility. 
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Figure 4.2. Scrambling of ZBS2 and ZBS3 results in reduced DNA binding and 
impaired PalgD activation.  
(A.) Sequences of ZBS2 and ZBS3 were randomly scrambled and resulting affinities AmrZ 
were measured by EMSA. “-” indicates no protein, while “+” lanes each contained 40 nM 
AmrZ. Arrows point to retardation of DNA mobility. “F”: Free DNA. (B.) Scrambling of 
ZBS2 and ZBS3 led to impaired PalgD activities. “No” represents promoterless lacZ as the 
negative control, and “WT” represents wild type PalgD. “ZBS2”, “ZBS3” and “ZBS23” 
refer to corresponding AmrZ binding sites which were randomly scrambled in the algD-
lacZ transcriptional fusion constructs. Y axis is the relative PalgD activity as the percentage 
of WT. ***: P<0.001 using unpaired two-tailed student t-test analyses of three independent 
experiments. 
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Figure 4.3. Deletion of ZBS2 or replacement by an algB sequence does not eliminate 
AmrZ binding.  
(A.) Wild type ZBS2 sequence and the selected algB sequence which has the same GC%. 
(B.) EMSA assays to determine AmrZ binding to DNA fragments containing mutated 
ZBS2. “F”: Free DNA. “+” represents the addition of 40nM AmrZ. Arrows point to the 
shifts of DNA on the gel. 
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Figure 4.4. Identification of two additional ZBSs in PalgD.  
(A.) Proposal of two additional ZBSs (ZBS1 and ZBS4) and design of DNA fragments 
used for EMSA assays in (B.). The control DNA fragment “4” was used as the negative 
control. (B.) EMSA assays to determine the presence of two additional ZBSs. Arrows point 
to retardation of DNA mobility. Addition of 50 nM AmrZ was labeled as “+”. “F”: Free 
DNA. 
  
  
133 
 
 
Figure 4.5. Proposed positions and nucleotide sequences of four ZBSs.  
The PalgD DNA sequence was examined, and positions (B.) and nucleotide sequences (C.) 
of four ZBSs were proposed based on EMSA results and their sequence similarities to the 
AmrZ binding consensus sequence (A.). Numbers in (B.) represent the distance from the 
transcription start site. (A.) is adapted from (C. J. Jones et al., 2014). 
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Figure 4.6. Scrambling of all ZBSs results in abolished PalgD activation.  
(A.) ZBSs were randomly scrambled in pairs as shown in grey boxes. Design of DNA 
fragments used for EMSA experiments (B.) is also shown here. (B.) AmrZ binding 
affinities of WT or scrambled DNA fragments were determined by EMSA. Each DNA was 
tested for its binding affinity to 50nM AmrZ. Arrows represent DNA shifts caused by 
AmrZ binding. “F”: Free DNA. (C.) PalgD activities were determined after scrambling 
two or four ZBSs. Y axis is the relative PalgD activity as percentage compared to WT. 
***: P<0.001 using unpaired two-tailed student t-test analyses of three independent 
experiments. 
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Figure 4.7. Correct DNA phasing between ZBSs is critical for PalgD activation.  
(A.) The lightning symbol indicates the insertion location and insertion sizes (5bp or 10bp). 
(B.) After a 5bp or 10bp insertion, the PalgD activity was measured. “No” is the lacZ fusion 
without a promoter. ***: P<0.001; ns: not significant. Unpaired, two-tailed student t-tests 
were performed based on data from three independent experiments. 
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Figure 4.8. AmrZ binding results in formation of trans DNA-AmrZ complexes.  
(A.) & (C.) PalgD DNA fragments designed for FRET experiments contains Cy5 and Cy3 
fluorophores on each end. (A.) WT PalgD. (C.) PalgD with 105bp truncation (-250bp to -
146bp). (B.) Effects of different AmrZ concentrations on observed FRET when the WT 
DNA fragment (A.) was tested. (D.) AmrZR22A failed to induce FRET, and AmrZ induced 
a comparable FRET level of the DNA with 105bp truncation between ZBS2 and ZBS3. 
1µM AmrZ or AmrZR22A was used here. “ns”: not significant; ***: P<0.001. Unpaired, 
two-tailed student t-tests were performed from three independent experiments. 
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Figure 4.9. The 105bp truncation between ZBS2 and ZBS3 disrupts PalgD activation.  
“No” is the lacZ fusion without a promoter. ***: P<0.001. Unpaired, two-tailed student t-
tests were performed based on data from three independent experiments. 
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Table 4.1. Strains, plasmids, and oligonucleotides used in Chapter 4 
Strains/Plasmids Relevant genotype/description/sequence Sources 
Strains   
Escherichia coli   
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New 
England 
Biolabs 
S17λpir pro thi hsdR+ TpR SmR; chromosome::RP4-2 Tc::Mu-
Kan::Tn7/λpir 
(Simon et 
al., 1983) 
P. aeruginosa   
FRD1 mucA22 (Ohman & 
Chakrabarty
, 1981) 
FRD1200 amrZ::xylE-aacC1 in FRD1 (Wozniak et 
al., 2003) 
OSUPA211 
(FRD1/PalgD-
lacZ) 
algD-lacZ transcriptional fusion at the attB site in FRD1 This study 
OSUPA213 Promoterless lacZ at the attB site in FRD1 This study 
OSUPA226 amrZ deletion; WT algD-lacZ transcriptional fusion at 
the attB site in FRD1 
This study 
OSUPA260 ZBS2-scrambled algD-lacZ transcriptional fusion at the 
attB site in FRD1 
This study 
OSUPA261 ZBS3-scrambled algD-lacZ transcriptional fusion at the 
attB site in FRD1 
This study 
OSUPA263 ZBS2/3-scrambled algD-lacZ transcriptional fusion at 
the attB site in FRD1 
This study 
OSUPA283 algD-lacZ transcriptional fusion with a 5bp insertion 
between ZBS2 and ZBS3 in FRD1 
This study 
OSUPA285 algD-lacZ transcriptional fusion with a 10bp insertion 
between ZBS2 and ZBS3 in FRD1 
This study 
OSUPA32 algD-lacZ transcriptional fusion with a 105bp insertion 
between ZBS2 and ZBS3 in FRD1 
 
Plasmids   
mini-CTX-lacZ Vector for transcriptional fusion analyses. TetR (Hoang TT 
Becher A, 
Schweizer 
HP., 2000) 
pBX1 mini-CTX-PalgD-lacZ. Two primers (algD65, algD66) 
were used to amplify the PalgD 
This study 
pBX16 mini-CTX-PalgD-lacZ with the ZBS2 
(CCATTGGCCATTACCAGCCTCCC)  replaced by a 
same-length and same-GC% sequence from the algB 
CDS (GCCTCGAAGACGAAGGCTACAGC). 
Generated using four primers: algD65, 66, 85 and 86 
This study 
   
  Continued 
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Table 4.1. Continued  
pBX17 mini-CTX-PalgD-lacZ with a ZBS2-containing sequence 
(CCATTGGCCATTACCAGCCTCCC) deleted. 
Generated using four primers: algD65, 66, 87 and 88 
This study 
pBX34 mini-CTX-PalgD-lacZ with the ZBS2 
(CCATTGGCCATTACCAGCCTCCC) randomly 
scrambled to (CCGATTTCCTCCCTAGACCCCGA). 
Generated using four primers: algD65, 66, 104 and 105 
This study 
pBX35 mini-CTX-PalgD-lacZ with the ZBS3 
(CTAGTGGCCATTGGCAGGCA) randomly scrambled 
to (AGAGATCCGCTCGTTGACGG). Generated using 
four primers: algD65, 66, 106 and 107 
This study 
pBX37 mini-CTX-PalgD-lacZ with both ZBS2 and ZBS3 
scrambled  
This study 
pBX46 mini-CTX-PalgD-lacZ with a 5bp insertion (CAGTC) 
between ZBS2 and ZBS3. Generated using four primers: 
algD65, 66, 122 and 123 
This study 
pBX48 mini-CTX-PalgD-lacZ with a 10bp insertion 
(CAGTCAGTCA) between ZBS2 and ZBS3. Generated 
using four primers: algD65, 66, 128 and 129 
This study 
pBX66 mini-CTX-PalgD-lacZ with both ZBS1 and ZBS2 
scrambled (total 63bp). Generated using four primers: 
algD65, 66, 144 and 145 
This study 
pBX67 mini-CTX-PalgD-lacZ with both ZBS3 and ZBS4 
scrambled (total 67bp). Generated using four primers: 
algD65, 66, 152 and 153 
This study 
pBX68 mini-CTX-PalgD-lacZ with all four ZBSs scrambled.  This study 
pBX71 mini-CTX-PalgD-lacZ with a 105bp deletion between 
ZBS2 and ZBS3. Generated using four primers: algD65, 
66, 164 and 165 
This study 
Oligonucleotides   
algD65 CCCCAAGCTTCTCTTTCGGCACGCCGAC This study 
algD66 CCGGGATCCCCGACATAGCCCAAACCAAAG This study 
algD71 [6FAM] ACCGTTCGTCTGCAAGTCATG This study 
algD73 ACCAACTTGATGGCCTTTCCG This study 
algD85 GCTGTAGCCTTCGTCTTCGAGGCATTACGCCGGA
GATGGCATTTC 
This study 
algD86 GCCTCGAAGACGAAGGCTACAGCGCCATTACAT
GCAAATTACGATTGC 
This study 
algD87 GCAATCGTAATTTGCATGTAATGGCATTACGCCG
GAGATGGCATTTC 
This study 
algD88 GAAATGCCATCTCCGGCGTAATGCCATTACATGC
AAATTACGATTGC 
This study 
algD104 TCGGGGTCTAGGGAGGAAATCGGATTACGCCGG
AGATGGCATTTC 
This study 
algD105 CCGATTTCCTCCCTAGACCCCGAGCCATTACATG
CAAATTACGATTGC 
This study 
  Continued 
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Table 4.1. Continued  
algD106 CCGTCAACGAGCGGATCTCTTTGCAGAATGCAT
GGCGGCTG 
This study 
algD107 AGAGATCCGCTCGTTGACGGTTTAACGGAAAGG
CCATCAAGTT 
This study 
algD108 CTTAATCTTCGACCCATGCAC This study 
algD109 [6FAM] GGAATCCTTAAGGTTTGCTTAAG This study 
algD110 TCCCGCTCGCGAAATATTTG This study 
algD111 [6FAM] CAAACGGCCGGAACTTCCCT This study 
algD112 TAGTTCGGTCCATAGAATTCAAG This study 
algD122 CCGGAATGAAACAGAgactgAGCCGCTTTTACCGC This study 
algD123 GCGGTAAAAGCGGCTcatgcTCTGTTTCATTCCGG This study 
algD128 CCGGAATGAAACAGAtgactgactgAGCCGCTTTTAC
CGC 
This study 
algD129 GCGGTAAAAGCGGCTcagtcagtcaTCTGTTTCATTCC
GG 
This study 
algD132 GAGACGGTTTCAAGTTGCTCTG This study 
algD144 GCGATTCGCGGATGGCCTCTCTATAACTGAGGC
GAGAT TGGGGAAAAGTCTGTGGGCTG 
This study 
algD145 AGGCCATCCGCGAATCGCCGAGCTACGTCTCAA
CATTCCACCTATGCAAATTACGATTGCAAAG 
This study 
algD146 ATTACGCCGGAGATGGCATTT This study 
algD147 TTGAATTGGGGAAAAGTCTG This study 
algD148 [6FAM] TTTAACGGAAAGGCCATCAAG This study 
algD152 GATGATAAGTGTGAAACTCCCATTTGCATCTTAT
ATCCCCTCGGGTTGCAGAATGCATGGCGGCTG 
This study 
algD153 AATGGGAGTTTCACACTTATCATCGTACGCTAGT
AAGATGAGACGT ATTTCCAAATATTTCGCGAG 
This study 
algD156 [6FAM] TATTTCCAAATATTTCGCGAGC This study 
algD157 (5’-amino modifier C6) 
TCAAGGCGGAAATGCCATCT 
This study 
algD160 (5’-amino modifier C6) 
ATATCCGTTTGATATCACTTGATAC 
This study 
algD164 TGGCCACTAGTTGCAGAATGTCGTAATTTGCATG
TAATGG 
This study 
algD165 CCATTACATGCAAATTACGACATTCTGCAACTAG
TGGCCA 
This study 
algD168 GATACCAACTTGATGGCCTTTC This study 
CTX1 CCTCGTTCCCAGTTTGTTCC (Tart et al., 
2006) 
attB2 GTCGCCGCCGGCGATGC (Tart et al., 
2006) 
attB4 CGCCCTATAGTGAGTCG (Tart et al., 
2006) 
attB5 CGCCCCAACCTCGCTGG (Tart et al., 
2006) 
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Chapter 5. Overall discussion and synopsis 
 
In his book “Adaptability: the art of winning in an age of uncertainty”, Max 
McKeown, a writer and consultant in strategy and leadership, stated that “all failure is 
failure to adapt, all success is successful adaptation”. This quote is widely applicable to 
other disciplines such as evolution biology. All living organisms have adapted to adjust 
themselves upon the entrance into a new “home”.  
The Gram-negative bacterium Pseudomonas aeruginosa is an excellent example of 
an organism that can prosper in diverse environments. Prevalent in natural sites such as 
fresh water and soil, this bacterium is also readily found on/in medical devices and at 
various hospital sites. To make it worse, P. aeruginosa exhibits more recalcitrance to 
disinfectants and other antimicrobial treatments compared with most other bacterial 
species. A large selection of virulence factors produced by this pathogen aids its survival 
against the host immune defense. Although typically a healthy person is not susceptible to 
its infections, P. aeruginosa poses a significant threat to hospitalized patients and those 
with compromised immunity or other complications. Importantly, P. aeruginosa is capable 
of causing both acute and chronic infections. As discussed in detail in Chapter 1, this 
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bacterium adjusts the expression of different virulence factors during the switch between 
acute and chronic infections. This switch is a rather complicated process requiring multiple 
factors such as c-di-GMP signaling and the Gac/Rsm system (Coggan & Wolfgang, 2012; 
Hengge, 2009). Full understanding of the explicit mechanism during this switch is vital to 
the ultimate control of P. aeruginosa infections. 
P. aeruginosa contains an unusually large genome (6.2 Mbp in the type strain 
PAO1), compared to ~4.6 Mbp in Escherichia coli and ~2.0 Mbp in Streptococcus 
pneumoniae (Blattner et al., 1997; Hoskins et al., 2001). 12% of P. aeruginosa genes 
participate in expression control and the regulatory network in P. aeruginosa contains 1020 
interactions, demonstrating a complex nature of regulation in this organism (Galán-
Vásquez, Luna, & Martínez-Antonio, 2011). Within this regulatory network, the 
transcription factor AmrZ plays a central role in coordinating the expression of a variety of 
virulence factors. Previous studies in the Wozniak laboratory have shown that the outcome 
of AmrZ-mediated regulation can be activation (alginate and twitching motility) or 
repression (flagella-mediated motility, Psl and c-di-GMP) (P. J. Baynham et al., 2006; P. 
J. Baynham & Wozniak, 1996; C. J. Jones et al., 2014, 2013; Tart et al., 2006). We also 
determined the crystal structure of AmrZ1-66 when bound by DNA (Pryor et al., 2012). 
These studies have significantly deepened our understanding of AmrZ-mediated regulation 
and demonstrated the global role of AmrZ during P. aeruginosa pathogenesis. However, 
multiple questions need to be addressed. First, the AmrZ-mediated activation mechanism 
of twitching motility remains elusive. In addition, albeit a number of transcription factor 
binding sites have been identified in the algD promoter, the activation mechanism of this 
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promoter is largely unknown. Furthermore, the solved crystal structure only provides 
information of the AmrZ truncation variant AmrZ1-66, and roles of the C-terminal domain 
during AmrZ regulation require further investigation. This thesis has been aimed at 
addressing these questions. 
It is well known that organisms adjust themselves upon environmental changes via 
corresponding cellular responses. For instance, P. aeruginosa cells exhibit substantially 
different gene expression profiles when oxygen is suddenly depleted or between two 
growth modes (e.g., in static biofilm versus planktonic growth) (Dötsch et al., 2012; Trunk 
et al., 2010). In recognition of this, we sought to focus specifically on surface-grown 
bacteria during the study of twitching motility. Distinct activities of pilA transcription 
under various growth conditions demonstrate the remarkable adaptability of this bacterium 
(Figure 2.1). We designed the cellophane-based twitching motility assay to facilitate the 
harvest of the bacterial subpopulation with active twitching motility. Transcription 
profiling experiments were then conducted in order to define the AmrZ regulon and 
identify AmrZ-dependent gene(s) that is required for twitching motility. The AmrZ regulon 
was also defined in two separate studies yet both focused on planktonic bacteria. These 
two studies were carried out by DNA microarray (Elizabeth A. Waligora, unpublished 
data) and by RNA-Seq (C. J. Jones et al., 2014), respectively. The comparison between the 
current study with two previous reports reveals strikingly little overlap. Two microarray 
results only share two common targets (gcbA and PA2081) while there are five AmrZ-
dependent genes/operons (PA0102, PA3235, PA4033, gcbA and the PA5167 operon) 
shared by the current microarray study and RNA-Seq. The diguanylate cyclase-encoding 
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gene gcbA appeared in all three studies, validating its repression by AmrZ. Many other 
AmrZ-dependent processes revealed in the current study however, were not revealed in 
either previous report with planktonic bacteria. Certain genes identified exclusively in this 
thesis encode proteins that are involved in processes such as denitrification as well as 
production of rhamnolipid and pyocin. In addition, AmrZ targets (algD and fleQ) did not 
show differential expression in the current study, which is anticipated owing to a 
significantly lower AmrZ level in PAO1 compared to mucoid strains (C. J. Jones et al., 
2013). Besides growth conditions, other factors such as analysis methods and the strain 
background may also contribute to these differences. The AmrZ regulon defined in the 
current study contains 112 genes with none known to be required for TM. One possibility 
is that these AmrZ-dependent tfp gene(s) are yet identified in previous studies such as 
transposon mutant screening (Jacobs et al., 2003). Identification of this gene(s) may require 
further understanding of the TFP regulatory circuit. As an alternative approach, 
spontaneous suppressor screening was conducted to identify mutations that bypass AmrZ 
regulation and thereby restore TM. However, mutations identified by whole genome 
sequencing do not appear to have a direct link to the TFP system (Appendix A). We are 
therefore unable to define the molecular mechanism of AmrZ-mediated activation of TM. 
To decipher this mechanism, other approaches such as a screen using the overexpression 
vector library should be given special consideration. Meanwhile, as mentioned in Appendix 
A, AmrZ might regulate TM indirectly such as by affecting intracellular cAMP signaling. 
Therefore, it will be instrumental to determine the effect of amrZ inactivation on the 
intracellular cAMP concentration. 
  
145 
 
Findings in Chapter 3 and Chapter 4 have brought novel understandings of how 
AmrZ executes regulation. Many members within the Arc protein superfamily such as Mnt 
and NikR form tetramers, while others exist exclusively as dimers in solution (Schreiter & 
Drennan, 2007). As shown in Chapter 3, we demonstrate that the AmrZ CTD mediates 
tetramerization. In addition, our nano-ESI MS results showed that each AmrZ-DNA 
complex contains four AmrZ monomers, likely an AmrZ tetramer. Further biochemical 
investigations are required to determine which residues in the CTD are involved in 
monomer-monomer interactions that are necessary for tetramerization. A good starting 
approach would be alanine scanning, which can be used to screen for amino acid 
substitutions that negatively impact AmrZ tetramerization. Since the CTD deletion results 
in reduced DNA binding by AmrZ, it is interesting to determine how the CTD contributes 
to DNA binding. This can be explored by resolving the crystal structure of the full length 
AmrZ-DNA complex.  
The discovery of AmrZ tetramerization also facilitates our understanding of the 
algD promoter activation mechanism. Before the current study, many transcription factor 
binding sites have been identified in this complex promoter with half within the far 
upstream region (Figure 4.1). Nevertheless, a detailed understanding of the activation 
mechanism is lacking. A DNA looping model was proposed with little supporting evidence 
(Mohr et al., 1992). In Chapter 4, we identified four AmrZ binding sites within the 
promoter, and both DNA phasing and FRET experiments support the DNA looping model. 
We speculate that AmrZ oligomerization between four AmrZ binding sites directly 
participates in looping out of the intervening DNA, allowing remote transcription factors 
  
146 
 
such as AlgR, Vfr and AlgB to contact proximal transcriptional components. Although 
DNA looping has been observed in multiple bacterial transcription control systems 
including the lac repressor, AraC, and NtrC (Krämer et al., 1987; Lobell & Schleif, 1990; 
Su, Porter, Kustu, & Echols, 1990), the algD promoter may be one of the most complicated 
examples in bacteria that involve multiple transcription factors during DNA loop 
formation. This is a significant advancement in our understanding of transcription 
activation. If our DNA looping model stands true, the loss of AmrZ tetramerization is 
anticipated to result in failed DNA looping, abrogating transcription initiation. It is 
therefore puzzling that the CTD truncation mutant AmrZ1-66 partially activates this 
promoter when overexpressed (Chapter 3). Nano-ESI MS experiments showed that the 
majority of AmrZ1-66 exist as dimers or monomers while a small fraction correspond to 
tetramers (Chapter 3), and AmrZ1-66 binds to DNA as a dimer of dimers (Pryor et al., 
2012). It is therefore important to determine if there is any interaction between two dimer 
pairs of AmrZ1-66 from two binding sites.  
Collectively, here we are able to further enhance our understanding of AmrZ-
mediated regulation. It is clear that efficacious regulation relies on a proper level of AmrZ. 
Therefore, different AmrZ intracellular concentrations allow AmrZ to achieve its 
regulation differentially under diverse conditions. A high concentration of AmrZ in a 
mucoid strain results in activation of alginate production and the repression of the flagella 
machinery and the exopolysaccharide Psl, while in non-mucoid strains, the AmrZ level is 
significantly lower so that alginate production is ceased while the expression of flagella 
and Psl becomes de-repressed (P. J. Baynham & Wozniak, 1996; C. J. Jones et al., 2013; 
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Tart et al., 2006). Therefore, AmrZ plays a vital role for P. aeruginosa in choosing an 
appropriate lifestyle when entering into different environments, such as in the CF airway 
versus the bloodstream. AmrZ is thereby a key contributor for successful adaptation by this 
pathogen. As Max McKeown stated, “Success is successful adaptation”, if we can exploit 
AmrZ-mediated regulation, we may find a new approach to intervene and create the 
“failure to adapt” scenario, making this pathogen more sensitive to antibiotics and other 
antimicrobials, in order to control P. aeruginosa infections.  
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Chapter 5  
 
 
Appendix A. Spontaneous suppressor screening 
 
A1. Results 
In Chapter 2, we designed a novel TM approach that provides a convenient method 
to isolate TM-active subpopulations, and microarray analyses were performed comparing 
transcriptome profiles of WT and amrZ mutants. However, this approach failed to identify 
a tfp gene within the AmrZ regulon. We therefore performed spontaneous suppressor 
screening as an alternative approach to identify the AmrZ-dependent tfp target(s). A 
relatively large-scale spontaneous mutant screening of the AmrZV20A strain, which 
expresses a DNA binding deficient AmrZ variant AmrZV20A, was conducted to identify 
suppressors that adopted genetic changes restoring the TM phenotype. The procedure is 
shown as a flowchart in Figure A1. We look for suppressors in which mutations outside of 
amrZ allow TM to bypass AmrZ-mediated regulation, resulting in restored TM in the 
absence of amrZ. To avoid intragenic revertants, the amrZ gene in each suppressor mutant 
was sequenced to ensure it encodes the same AmrZV20A variant as the parental strain 
(Figure A2B).  
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Total three independent spontaneous suppressors (named M1, M2 and M3) have 
been isolated, all of which have restored TM significantly (Figure A2A). Genomes of these 
three suppressors were subsequently sequenced and compared to that of their parental 
strain AmrZV20A, in order to determine which genetic changes have allowed them to 
restore TM. A limited number of point mutations were identified (Table A1). In the 
suppressor M1, mutations are found in genes encoding the housekeeping sigma factor 
RpoD, major facilitator superfamily transporters, type III secretion proteins and PvdL (a 
pyoverdine biosynthesis protein). The suppressor M3 contains two mutations, one in the 
hypothetical gene PA1279 and the other one in kdpB, which encodes the B chain of a 
potassium transporter. None of the mutated genes identified in M1 and M3 is known to be 
related to TM and it is mysterious how these two suppressors have restored their TM. Two 
mutations were identified in the suppressor M2, one in the T6SS (type VI secretion system) 
gene PA2363 and the other one in pilA. The major pilin PilA is the main subunit of the 
TFP filament and required for TM (J. S. Mattick, Whitchurch, & Alm, 1996). The pilA 
point mutation in suppressor M2 leads to a serine-to-alanine mutation at the 73rd amino 
acid. Serine contains a hydroxyl group and thus is a polar amino acid. This amino acid 
plays important roles in catalytic functions of many enzymes and frequently undergoes 
modifications such as glycosylation and phosphorylation. In P. aeruginosa strain 1244 and 
Neisseria gonnorrhoeae, certain serine residues in type IV major pilins are important 
glycosylation sites (Comer, Marshall, Blanch, Deal, & Castric, 2002; Hegge et al., 2004). 
Since this S73A mutation correlates with restored TM in suppressor M2, we hypothesized 
that Ser73 in PilA represses TFP function, possibly by glycosylation, which is suppressed 
by functional AmrZ.  
  
177 
 
 We thereby attempted to recapitulate this pilA mutation in the ΔamrZ mutant. The 
arabinose-inducible plasmid harboring PilAS73A was placed into a ΔpilA or ΔpilA&ΔamrZ 
double mutant, and TM measured after inducing PilAS73A expression by arabinose. The 
PilAS73A plasmid restored TM in the ΔpilA mutant at a similar level as the one carrying 
WT pilA, suggesting this point mutation variant was produced and interchangeable with its 
wild type counterpart (Figure A3A). However, in the ΔpilA&ΔamrZ mutant, no TM was 
observed when the PilAS73A plasmid was induced (Figure A3B), suggesting the S73A 
mutation in pilA alone is unable to suppress the TM defect in the ΔamrZ mutant. These 
results do not support our hypothesis and we fail to confirm the role of PilAS73A during 
AmrZ-mediated regulation of TM. 
 AmrZ was shown to repress c-di-GMP synthesis (C. J. Jones et al., 2014) and there 
have been a few studies showing the crosstalk between c-di-GMP and the TFP system (Alm 
et al., 1996; Amikam & Galperin, 2006; Jain et al., 2012; Qi et al., 2012). We therefore 
probed the possibility that AmrZ mediates its TM regulation indirectly through modulating 
the level of this second messenger. Intracellular concentrations of c-di-GMP were 
measured in these three suppressors and compared to their parental strain AmrZV20A. In 
suppressors M2 and M3, no change of the c-di-GMP level was observed compared to their 
parental strain. In contrast, the c-di-GMP level in M1 decreased to the WT level (Figure 
A4A), and we thereby suspect that this alteration of the c-di-GMP concentration might 
correlate with restored TM. Therefore, we attempted to elevate the c-di-GMP level in M2 
by overexpressing a diguanylate cyclase-encoding gene gcbA, but no significant reduction 
of TM was observed (Figure A4B). To determine if a reduced c-di-GMP level would 
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restore TM in the ΔamrZ mutant, a plasmid containing the phosphodiesterase gene PA2133 
was placed into this strain and TM was measured. This plasmid restored the smooth colony 
phenotype of the small colony variant ΔwspF, indicating PA2133 production reduced the 
c-di-GMP level (data not shown). However, PA2133 overexpression failed to restore TM 
in the ΔamrZ mutant (Figure A5). Above results indicate that alteration of the c-di-GMP 
level alone is unable to affect the outcome of AmrZ-mediated TM regulation. 
 Collectively, in this project we attempted to use an innovative approach by 
combining spontaneous suppressor screening with next-generation sequencing. Large scale 
screening of the ΔamrZ mutant was conducted to identify spontaneous mutants that 
restored TM, and next-generation sequencing was used to determine mutations in those 
suppressors. A limited number of mutations were identified and only one mutation 
occurred within a tfp gene (pilA) in the suppressor M2. However, we were unable to 
recapitulate the phenotype of this pilA mutation in the ΔamrZ strain. Additional 
investigations were performed in order to identify the role of c-di-GMP during AmrZ-
mediated regulation of TM. Our results did not support the hypothesis that perturbing c-di-
GMP levels affects the outcome of AmrZ-mediated regulation of TM.  
 
A2. Discussion 
 High-fidelity DNA replication is achieved by both accurate dNTP incorporation by 
the DNA polymerase and multiple proofreading and DNA repair mechanisms. 
Nevertheless, mutations still occur naturally and the average mutation rate in E. coli is 
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approximately ~5*10-10 per base pair per genome replication (J. W. Drake, 1991). 
Scientists have been taking advantage of this replication error to screen for mutations that 
cause phenotypic changes of interest. As an example, Nolan et al. used this approach to 
identify suppressors in which TM was restored in the ΔfimL mutant (Nolan et al., 2012). 
Although DNA binding-competent AmrZ is required for TM (P. J. Baynham et al., 2006), 
amrZ mutants, especially those carrying point mutation variants, occasionally display small 
twitching zones. We therefore screened for spontaneous revertants in an amrZ mutant that 
restored TM. This method was proven successful and three revertants were identified, all 
of which have mutations outside of the amrZ gene. In the past, it was extremely difficult 
to map mutation locations in spontaneous suppressors as no marker or label is available. 
This problem has been mostly solved in the next-generation sequencing era. Whole 
genomes sequencing allows the identification of single-nucleotide polymorphisms (SNPs) 
and small insertions/deletions. However, due to technical limitations, detectable maximum 
sizes of insertion/deletions are limited to approximately 50 bp during our Illumina data 
analyses. Possible large insertions/deletions therefore cannot be revealed by our data 
analyses, which may potentially be solved by better software design in the future.  
 In each of the three suppressors, a few mutations are identified, but none could be 
confirmed to be responsible for restored TM. It is therefore intriguing what TM-pertinent 
genetic changes have occurred in these strains. Since our transcriptomics (both DNA 
microarray and RNA-seq) failed to identify TM-related AmrZ targets (Chapter 2 and (C. 
J. Jones et al., 2014)), we suspect that AmrZ regulates a previously unidentified gene(s) 
that is required for TM or indirectly by affecting intracellular signaling such as second 
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messengers c-di-GMP and 3’,5’-cyclic adenosine monophosphate (cAMP). Although our 
perturbations of intracellular c-di-GMP concentrations did not affect TM in the suppressor 
M1 (Figure A4) and the ΔamrZ mutant (Figure A5), we cannot rule out the role of c-di-
GMP during AmrZ-mediated regulation. This is because c-di-GMP signaling is 
subcellularly localized, and its concentrations in different subcellular compartments may 
vary and are critical for differential responses to various stimuli (Merritt et al., 2010). 
Another candidate is cAMP, which plays important roles in signal transduction in both 
prokaryotic and eukaryotic organisms. This molecule plays a critical role in the glucose-
lactose diauxie in E. coli as activation of the lac promoter requires the binding by cAMP-
CRP (cAMP receptor protein) (Fic et al., 2009). In P. aeruginosa, cAMP and the CRP 
homolog Vfr participate in regulation of a number of processes such as T3SS, exotoxins 
and proteases (Fuchs et al., 2010; West, Sample, & Runyenjanecky, 1994; Wolfgang, Lee, 
Gilmore, & Lory, 2003). In addition, vfr disruption results in a TM defect and cAMP is 
implicated in fine control of TM (Beatson, Whitchurch, Jennifer, et al., 2002; Fulcher et 
al., 2010; Nolan et al., 2012; Whitchurch et al., 2005). The regulatory network of the TM-
necessary histidine-kinase protein FimL also intersects with the Vfr-cAMP pathway in the 
way that FimL regulates cAMP synthesis and vfr overexpression in trans restores TM in 
the ΔfimL mutant (Inclan, Huseby, & Engel, 2011; Whitchurch et al., 2005). Intriguingly, 
the PilA production pattern (reduced surface pili amounts but similar in whole cell lysates 
relative to wild type) of the ΔamrZ mutant is similar to the Δvfr mutant and the ΔfimL 
mutant (P. J. Baynham et al., 2006; Beatson, Whitchurch, Annalese, Mattick, & Semmler, 
2002; Whitchurch et al., 2005). In combination with the fact that both AmrZ and Vfr 
activate algD transcription, it is therefore plausible that AmrZ and Vfr might share the 
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same mechanism of TM regulation. The specific mechanism of Vfr-mediated activation of 
TM remains unclear as well and there does not seem to be a hierarchy between these two 
TFs based on transcriptome profiling results (C. J. Jones et al., 2014; Wolfgang et al., 2003; 
Xu & Wozniak, 2015). Future work is needed to understand regulatory mechanisms of TM 
by AmrZ and Vfr, and to determine if AmrZ-mediated regulation intersects with cAMP 
signaling. 
  
A3. Materials and Methods 
Bacterial strains, plasmids, oligonucleotides and growth conditions  
Information of bacterial strains, plasmids, and oligonucleotides employed in this 
study is summarized in Table A2. Bacteria (Escherichia coli and Pseudomonas 
aeruginosa) were grown as previously (Waligora et al., 2010). Briefly, E. coli strains were 
grown in LB (each liter LB contains 10 g tryptone, 5 g yeast extract, 5 g sodium chloride) 
or on LA (LB with 1.5% (w/v) agar). 100 µg/ml ampicillin was used to maintain plasmids 
in E. coli. All P. aeruginosa strains were grown in LBNS or on LANS (LB or LA without 
sodium chloride, respectively). In P. aeruginosa, 300 µg/ml carbenicillin was used to 
maintain plasmids. All strains were grown at 37°C unless stated otherwise. All 
oligonucleotides were ordered desalted from Sigma Aldrich. 
 In-frame deletion and point mutation mutants were generated by overlap extension 
PCR using the gene replacement vector pEX18Ap (Heckman & Pease, 2007; Hoang et al., 
1998). Multi-copy pHERD20T-based plasmids were transferred into P. aeruginosa strains 
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through bi-parental mating with the E. coli helper strain S17-1 (Qiu et al., 2008; Simon et 
al., 1983). 
 
Subsurface twitching assays 
Subsurface twitching assays were performed as a previously described study (Xu 
& Wozniak, 2015). Briefly, a single colony of a strain of interest was resuspended in 400 
µl LBNS, and P10 tips were immersed in the above suspension and used to stab through 
the agar of 1-day-old 1% LANS plates. Plates were incubated upright in a humid chamber 
at room temperature for 5 days, and imaged through white epiluminescence via a 
ChemicDoc imaging system (Bio-Rad). Relative twitching activities (twitching ratios) 
were calculated by dividing diameters of twitching zones by diameters of central colonies. 
 
Spontaneous suppressor screening  
The AmrZV20A strain was used as the parental strain during screening. This strain 
underwent prolonged incubation (8 days) at room temperature during subsurface twitching 
assays. Occasionally stabbed colonies exhibited small twitching zones, from which 
bacteria were streaked out and isolated. These isolates were used for the next cycle of 
prolonged twitching assays. When a bacterial isolate displayed significantly and 
hereditarily restored TM, it was considered as a spontaneous suppressor. During this 
screening process, three independent suppressors were isolated and labeled as M1, M2 and 
M3. 
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Whole genome sequencing 
Strains submitted for next-generation sequencing include PAO1, AmrZV20A 
(WFPA513), ΔamrZ (WFPA205) and suppressors M1, M2 and M3. Whole genomic DNA 
was prepared using the Promega Wizard® Genomic DNA Purification kit (Catalog #: 
A1120) following the manufacture protocol. Subsequent DNA sample preparation and data 
analyses were performed by our collaborator --the Peter White’s research group at Center 
for Microbial Pathogenesis in Nationwide Children’s Hospital, Columbus, OH (Kelly et 
al., 2015). Briefly, DNA samples were prepared for Illumina MiSeq following manufacture 
protocols. Sequences of these strains were aligned to the PAO1 reference using bwa 0.7.4 
(H. Li & Durbin, 2009) and duplicate reads were removed by Picard Tools MarkDuplicates 
(Broad Institute, n.d.). Base quality scores were recalibrated by GATK 1.6 to remove false 
positives that had poorly scored sequencer qualities (McKenna et al., 2010). Variants were 
called at locations where a significant number of the reads are different from the reference 
by GATK 1.6 UnifiedGenotyper and these variants were annotated using known gene 
information from NCBI. 
 
Intracellular c-di-GMP concentration measurements 
Intracellular c-di-GMP concentrations of LANS-grown P. aeruginosa were 
measured by Laura Jennings from the Matthews Parsek laboratory, and the procedure is 
the same as previously described (C. J. Jones et al., 2014).  
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Figure A1. Flowchart of the suppressor screening process.  
Repeated screening cycles were performed initially starting from the AmrZV20A strain, 
later from those isolates that exhibited slightly increased TM. Suppressors were isolated 
when they had restored TM hereditarily, and their amrZ genes were sequenced to ensure 
no intragenic mutation within amrZ. 
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Figure A2. Three suppressors exhibit restored TM and no intragenic mutation within 
amrZ.  
(A.) Three suppressors (M1, M2 and M3) were identified and their TM was measured via 
subsurface twitching assays. (B.) Their amrZ genes were sequenced and confirmed absent 
of intragenic mutations. Data in (A) represent three independent experiments. Unpaired, 
two-tailed student t-tests were performed to determine statistical differences between TM 
of strains. ***: P<0.001. 
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Figure A3. PilAS73A fails to restore TM in the ΔpilA&ΔamrZ mutant.  
The plasmid encoding an empty vector, PilA or PilAS73A was transferred into ΔpilA or 
ΔpilA&ΔamrZ, and TM measured by the subsurface twitching assay in the presence of 1% 
arabinose. Scale bars: 5 mm.  
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Figure A4. The suppressor M1 displays a reduced c-di-GMP level while gcbA 
overexpression in this strain fails to inhibit TM.  
(A.) LANS-grown bacteria were harvested and lysed. Cell extracts were subject to c-di-
GMP measurements, which were normalized to protein amounts. (B.) The plasmid pgcbA 
(pBX22) or the empty vector (pHERD20T) was placed into the suppressor M1, and its TM 
measured via the subsurface twitching assay. Data represent three independent 
experiments. Unpaired, two-tailed student t-tests were used for statistical analyses. ns: not 
significant; *: P<0.05. 
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Figure A5. TM of the ΔamrZ mutant after expressing the plasmid-borne 
phosphodiesterase PA2133.  
The plasmid pJN2133 was transferred into PAO1 or the ΔamrZ mutant, and TM was 
measured in the absence/presence of 0.5% arabinose via the subsurface twitching assay. 
Scale bars: 5 mm. 
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Table A1. Point mutations identified in three suppressor mutants 
Mutant 
# Gene Function Location Coding Change 
Base 
Change 
Amino 
Acid 
Change 
M1 
rpoD Sigma factor ORF nonsynonymous SNV c.C1760G p.T587S 
PA0811 
probable 
major 
facilitator 
superfamily 
(MFS) 
transporter 
ORF nonsynonymous SNV c.C605A p.A202E 
pscQ 
translocation 
protein in type 
III secretion 
ORF nonsynonymous SNV c.A339T p.Q113H 
pscD 
type III 
secretion 
apparatus 
protein 
ORF Stop/gain SNV c.C295T p.Q99X 
pvdL Pyoverdine synthesis ORF 
nonsynonymous 
SNV c.C4238G p.A1413G 
PA2472 probable MFS transporter ORF 
nonsynonymous 
SNV c.T1271C p.I424T 
M2 
PA2363 
Predicted 
component of 
the T6SS 
ORF nonsynonymous SNV c.T728C L243P 
pilA TFP major pilin ORF 
nonsynonymous 
SNV c.T217G S73A 
M3 
PA1259 hypothetical protein ORF 
nonsynonymous 
SNV c.A1433G p.H478R 
kdpB 
potassium-
transporting 
ATPase, B 
chain 
ORF nonsynonymous SNV c.G1789T p.A597S 
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Table A2. Strains, plasmids, and oligonucleotides used in Appendix A 
Strains/Plasmids Relevant genotype/description/sequence Sources 
Strains   
Escherichia coli   
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New 
England 
Biolabs 
S17λpir pro thi hsdR+ TpR SmR; chromosome::RP4-2 Tc::Mu-
Kan::Tn7/λpir 
(Simon et 
al., 1983) 
P. aeruginosa   
PAO1 strain 
background 
  
PAO1 PAO1 wild type D. J. 
Wozniak 
WFPA205 amrZ::tet (P. J. 
Baynham et 
al., 2006) 
WFPA513 AmrZV20A (P. J. 
Baynham et 
al., 2006) 
OSUPA268 ΔpilA (Xu & 
Wozniak, 
2015) 
OSUPA248 M1 This study 
OSUPA251 M2 This study 
OSUPA252 M3 This study 
   
Plasmids   
pHERD20T Arabinose-inducible vector (Qiu et al., 
2008) 
pBX9 pHERD20T-WT pilA. Primers pilA_CDS_F2 and 
pilA_CDS_R were used to amplify the pilA coding 
sequence. 
This study 
pBX41 
 
pHERD20T-PilAS73A. Primers pilA_A, E, F and D were 
used to generate the pilA coding sequence with the S73A 
mutation. 
This study 
pBX22 pHERD20T-gcbA. (C. J. Jones 
et al., 2014) 
  Continued 
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Table A2. Continued 
 
pJN105 Arabinose-inducible vector (J. W. 
Hickman et 
al., 2005) 
pJN2133 pJN105-PA2133 (J. W. 
Hickman et 
al., 2005) 
Oligonucleotides   
pilA_CDS_F2 cgctctagaCAACGGAGAGATTCATGAAAGCTC This study 
pilA_CDS_R cgcgcatgcCGCCTCACCCTCTGAACGAATC This study 
pilA_A tgctctagaGCTTTTCGCTGATGGCGTC (Xu & 
Wozniak, 
2015) 
pilA_E GTACTACTGCTGCTACTGCGAC This study 
pilA_F GTCGCAGTAGCAGCAGTAGTAC This study 
pilA_D aactgcagCGCATAGCACCCGGCAAG (Xu & 
Wozniak, 
2015) 
